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Part 1: Summary 
1. Title of the thesis
Effects of the anti-inflammatory drug diclofenac and the beta-blocker metoprolol in brown trout Salmo 
trutta f. fario and freshwater invertebrates at different levels of biological organization 
2. Graphical abstract
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3. English summary 
Among the wide range of chemicals released by human activities, pharmaceuticals hold a special 
position. They play a vital role in human and livestock health management, and their consumption 
increases constantly. Human pharmaceuticals reach the environment mainly through wastewater 
treatment plants, where they cannot be completely removed. Consequently, trace contaminations are 
frequently detected in aquatic ecosystems. By design, these substances are relatively stable, in the 
human body as well as the environment, and physiologically active at low concentrations. 
Furthermore, their molecular mode of action is usually highly conserved across a broad range of 
different taxa. This makes effects on non-target organisms likely and renders pharmaceuticals a highly 
relevant group of environmental chemicals, which requires further attention. 
Systematic monitoring will be one fundamental cornerstone in future strategies to assess the 
environmental relevance of pharmaceuticals. However, the large amount of different substances can 
hardly be assessed by analytic-chemical means alone. In this context, biological test systems, by which 
effects can be monitored based on their mode of action, rather than every single substance on its own, 
would be a tremendous gain for further monitoring approaches.  
In the project Eff-Pharm, the aim was to prove the feasibility of such systems by creating in vitro assays 
for pharmaceuticals. As a prerequisite for the project, and to identify pharmaceutical classes of 
interest, a detailed literature review provided information on the lacks of knowledge. In vivo studies 
with fish and invertebrates conducted in parallel to the biosensor development delivered manifold 
information necessary for the validation of the new tests. For the in vivo studies, we used a battery of 
different test organisms including the brown trout Salmo trutta f. fario, the crustaceans Gammarus 
fossarum and Daphnia magna, the endobenthic oligochaete Lumbriculus variegatus and the mudsnail 
Potamopyrgus antipodarum, which were exposed to diclofenac (non-steroidal anti-inflammatory drug) 
and metoprolol (beta-adrenergic receptor blocker). Gammarids, oligochaetes, and snails were exposed 
to metoprolol not only at laboratory conditions, but also in an artificial indoor stream system. 
Furthermore, brown trout and gammarids were tested with respect to their response to effluent of a 
wastewater treatment plant, which was known to contain both pharmaceuticals. Whereas the tests 
with invertebrates were conducted with adults only, effects in brown trout were analysed in different 
developmental stages: developing embryos starting from fertilised eggs until two months post hatch, 
and juveniles of six to seven months post hatch. 
This thesis contains the results of the literature study, organismic and histological effects in brown 
trout and responses of biochemical biomarkers (changes in the levels of stress protein Hsp70 and lipid 
peroxides) in trout and invertebrates. 
By the detailed literature review the pharmaceutical groups of non-steroidal anti-inflammatory drugs 
(NSAIDs) and beta-adrenergic receptor blockers (beta-blockers) were identified as most suitable for 
further investigations. Both are consumed in large amounts, frequently detected in surface waters, 
and suspected to act on aquatic organisms already in low concentrations ranges. Furthermore, both 
act via a specific mode of action, which can be exploited for in vitro assays. As active ingredient for the 
further studies, we chose diclofenac, the most controversially discussed NSAID with respect to its 
environmental effect, and metoprolol, the most consumed beta-blocker. In addition, the literature 
review revealed a lack of studies on regionally relevant organisms, as well as benthic invertebrates in 
general. Representatives of these were selected as test organisms for the further investigations. 
The in vivo studies showed that diclofenac reduced the survival of juvenile brown trout at 
concentrations of 100 µg/L and led to increased signs of aggression (bite marks on fins and opercula) 
at 10 µg/L. Histological examinations revealed that liver, gill and kidney in the control group were 
already in a state of cellular reaction. However, effects in liver were more pronounced in diclofenac-
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exposed animals. Brown trout embryos and sac-fry stages did not show any effects in reaction to 
diclofenac up to 100 µg/L. Metoprolol did not affect survival, aggression behaviour or developmental 
parameters in juvenile fish and fish early life stages in concentrations up to 1000 µg/L. However, it led 
to a conspicuous shift in the ratio of erythrocytes to leucocytes. In P. antipodarum, metoprolol tended 
to elevate the level of stress proteins in a laboratory setup, indicating proteotoxic action of the 
substance. In the artificial indoor stream, Hsp70 levels decreased at the highest test concentration, 
indicative of a breakdown of the stress protein system. Apart from this, none of the examined 
organisms showed clear changes of stress protein or lipid peroxide levels in reaction to any of the 
tested pharmaceuticals.  
Brown trout embryo and sac-fry stages exposed to a wastewater treatment plant effluent containing 
both test chemicals in a µg/L range developed in normal time and with higher survival rate, but were 
lighter than lab control animals and had reduced levels of lipid peroxides. This is interpreted as the 
result of energy-consuming oxidative stress response. 
Overall, my results demonstrate the hazard emanating from the NSAID diclofenac for fish health. At 
the same time, the beta-blocker metoprolol has much lower potential to evoke adverse effects in non-
target organisms. Juvenile fish reacted with higher sensitivity than early life stages – which must be 
considered for further risk assessment approaches. Changes in the stress protein level showed to be 
an especially sensitive biomarker for molluscs, but not for the other tested taxa. Finally, the complex 
mixture of substances present in wastewater treatment plant effluents can evoke adverse effects in 
developing fish larvae. However, it remains to be investigated how these effects transfer to other life 
stages and how they will affect populations and whole ecosystems. 
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4. Deutsche Zusammenfassung 
Unter der Vielzahl von Stoffen, die durch menschliche Aktivitäten in die Umwelt eingetragen werden, 
haben Arzneimittel eine besondere Stellung inne. Sie spielen eine essentielle Rolle im 
Gesundheitsmanagement von Menschen und Nutztieren, und ihr Verbrauch steigt stetig weiter an. 
Humanarzneimittel erreichen die Umwelt hauptsächlich über den Abwasserpfad, da sie in Kläranlagen 
nicht vollständig entfernt werden können. In der Folge werden zahlreiche Arzneimittel als 
Mikroverunreinigungen in Gewässern nachgewiesen. Bestimmte Eigenschaften von Arzneimitteln, die 
für die Behandlung von Mensch und Tier erwünscht sind, erweisen sich jedoch in der Umwelt als 
problematisch. Sie sind verhältnismäßig stabil, und konsequenterweise biologisch schlecht abbaubar, 
und bereits in geringen Konzentrationen physiologisch wirksam. Zudem ist ihr molekularer 
Wirkmechanismus in der Regel über eine breite Anzahl an unterschiedlichen Taxa konserviert, was 
Effekte auf Nichtzielorganismen wahrscheinlich macht. Arzneimittel werden deshalb als eine 
hochrelevante Gruppe von Mikroschadstoffen angesehen, welche dringend weiterer Aufmerksamkeit 
bedarf. 
Ein systematisches Monitoring ist einer der Grundpfeiler weiterer Strategien, um die Umweltrelevanz 
von Arzneimittel abzuschätzen. Die gewaltige Menge an unterschiedlichen Substanzen kann jedoch 
kaum nur mit analytisch-chemischen Methoden untersucht werden. In diesem Zusammenhang wären 
biologische Testsysteme, durch welche Effekte von Substanzgruppen mit gleichem Wirkmechanismus 
gemeinsam untersucht werden, anstatt jede Substanz einzeln, ein gewaltiger Schritt in Richtung 
umfassender Monitoringstrategien.  
Ziel des Projektes Eff-Pharm war es, in vitro Assays zum Monitoring ganzer Arzneimittelgruppen zu 
etablieren und ihren Einsatz für verschiedene Umwelmatrices zu validieren. Als Voraussetzung für das 
Projekt, und um relevante Arzneimittelgruppen zu identifizieren, lieferte eine detaillierte 
Literaturstudie wichtige Informationen zu derzeit bestehenden Wissenslücken. In vivo 
Untersuchungen, welche parallel zur Entwicklung der Biosensor-Zelllinien durchgeführt wurden, 
lieferten notwendige Informationen zur Validierung der neuen Testsysteme.  Für die in vivo Studien 
wurde eine Reihe an unterschiedlichen Testorganismen eingesetzt: die Bachforelle Salmo trutta f. 
fario, die Crustaceen Gammarus fossarum und Daphnia magna, der endobenthische Oligochaete 
Lumbriculus variegatus und die Zwergdeckelschnecke Potamopyrgus antipodarum, welche gegenüber 
Diclofenac (nichtsteroidaler Entzündungshemmer) und Metoprolol (Betablocker) exponiert wurden. 
Gammariden, Oligochaeten und Schnecken wurden gegenüber Metoprolol nicht nur unter 
Laborbedingungen, sondern zusätzlich auch in einem Fließrinnen-Mesokosmos exponiert. Zusätzlich 
wurden Bachforellen und Gammariden hinsichtlich ihrer Reaktion auf den Ablauf einer kommunalen 
Kläranlage, welcher nachweislich beide Arzneimittel enthielt, untersucht. Während für die 
Untersuchungen mit Invertebraten nur adulte Tiere verwendet wurden, standen bei Bachforellen 
unterschiedliche Entwicklungsstadien im Fokus: Sich entwickelnde Embryonen vom befruchteten Ei bis 
ca. zwei Monate nach Schlupf, und juvenile Tiere im Alter von sechs bis sieben Monaten. 
Die vorliegende Doktorarbeit enthält die Ergebnisse der Literaturstudie, Daten zu organismischen und 
histologischen Effekten bei der Bachforelle sowie zu biochemischen Biomarkern (Änderungen im Level 
des Stressproteins Hsp70 und von Lipidperoxiden) bei Forellen und Invertebraten. 
Durch die umfassende Literaturstudie wurden die Arzneimittelgruppen der nichtsteroidalen 
Entzündungshemmer (NSAIDs) und beta-adrenergen Rezeptorblocker (Betablocker) als besonders 
geeignet für weitere Untersuchungen identifiziert. Beide Gruppen werden in großen Mengen 
verbraucht, entsprechend häufig in Umweltproben nachgewiesen und stehen im Verdacht bereits in 
geringen Konzentrationen adverse Effekte bei aquatischen Organismen hervorzurufen. Zusätzlich ist  
beiden Gruppen jeweils ein spezifischer Wirkmechanismus zu eigen, welcher für in vitro Systeme 
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ausgenutzt werden kann. Als stellvertretende Substanzen für unsere Studien wählten wir Diclofenac, 
ein NSAID, welches im Hinblick auf seine Umwelteffekte sehr kontrovers diskutiert wird, und 
Metoprolol, den am häufigsten konsumierten Betablocker. Die Literaturstudie ergab zudem, dass 
ökotoxikologische Daten zu Arzneimitteln vor allem für einheimische Arten, insbesondere benthische 
Invertebraten, fehlen. Deshalb wurden solche als Testorganismen für unsere weiteren 
Untersuchungen ausgewählt. 
Die in vivo Untersuchungen zeigten, dass Diclofenac das Überleben von juvenilen Bachforellen in 
Konzentrationen von 100 µg/L und höher verringert. Darüber hinaus wiesen die Tiere ab einer 
Konzentration von 10 µg/L vermehrt Bissverletzungen an den Flossen und Kiemendeckeln auf, was auf 
verstärktes aggressives Verhalten schließen lässt. Die histologische Analyse von Leber, Kieme und 
Niere deuten darauf hin, dass die Tiere bereits in der Laborkontrolle in einem reaktiven 
physiologischen Zustand waren. Die histologischen Veränderungen in der Leber waren jedoch bei 
Diclofenac-exponierten Tieren noch stärker ausgeprägt. Embryonen und Dottersacklarven der 
Bachforelle zeigten im Gegensatz hierzu keine Reaktionen bis zur höchsten getesteten Konzentration 
von 100 µg/L. Der Betablocker Metoprolol hatte bis zur höchsten getesteten Konzentration von 1000 
µg/L keinen Einfluss auf Überleben, Verhalten oder Entwicklung von juvenilen und embryonalen 
Bachforellen. Es zeigte sich jedoch eine auffällige Veränderung des Verhältnisses von Erythrozyten zu 
Leucozyten. Bei der Zwergdeckelschnecke P. antipodarum erhöhte Metoprolol die interne 
Konzentration des Stressproteins Hsp70, was auf einen proteotoxischen Effekt bei Mollusken schließen 
lässt. Unter Fließrinnen-Bedingungen waren jedoch verringerte Hsp70-Konzentrationen zu 
beobachten, was auf einen Zusammenbruch des Stressprotein-Systems unter diesen Bedingungen und 
damit auf stärkere Effekte unter naturnäheren Bedingungen schließen lässt. Abgesehen davon zeigte 
keine der getesteten Arten klare Veränderungen von Stressprotein- oder Lipidperoxid-
Konzentrationen in Reaktion auf die getesteten Arzneimittel.  
Bachforellenlarven, die gegenüber dem Kläranlagenablauf exponiert waren, entwickelten sich 
innerhalb der normalen Zeitspanne und zeigten eine hohe Überlebensrate. Zum Versuchsende waren 
die Larven jedoch leichter als die entsprechenden Kontrolltiere, und wiesen verringerte 
Konzentrationen von Lipidperoxiden auf. Dies kann als Resultat einer energieaufwändigen Antwort auf 
oxidativen Stress angesehen werden.  
Insgesamt unterstreichen die ihm Rahmen meiner Dissertation erzielten Ergebnisse, dass sich das 
NSAID Diclofenac nachteilig auf die Fischgesundheit auswirkt. Gleichzeitig zeigte sich der Betablocker 
Metoprolol als deutlich weniger gefährlich für Nichtzielorganismen. Juvenile Fische reagierten deutlich 
sensitiver auf Arzneimittel als frühe Lebensstadien, was in der weiteren Risikobewertung 
berücksichtigt werden sollte. Änderungen im Stressproteinlevel erwiesen sich als sensitiver Biomarker 
für Mollusken, aber nicht für die anderen getesteten Organismengruppen. Es zeigte sich ebenfalls, dass 
die komplexe Mischung von Stoffen in Kläranlagenabläufen durchaus in der Lage ist, physiologische 
Effekte bei sich entwickelnden Fischlarven hervorzurufen. Es muss jedoch weiter untersucht werden, 
wie sich diese Effekte auf spätere Lebensstadien auswirken, und in welcher Art und Weise sich diese 
Auswirkungen auf Populations- oder Ökosystemebene widerspiegeln.  
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5. Abbreviations 
 
AB-PAS: Alcian blue – periodic acid Schiff staining 
AIS:  artificial indoor stream 
bpm:  beats per minute 
C: Celsius 
cAMP:  cyclic adenosine monophosphate 
CAT:  catalase 
CD: compact disc 
CHPE:  cumene hydroperoxide equivalents (measurement unit of lipid peroxidation 
in FOX-assay) 
COX:  cyclooxygenase 
CYP450:  cytochrome P450 
d: day 
D. magna:  Daphnia magna (Straus, 1820) 
df degrees of freedom 
dpf:  days post fertilisation 
dph:  days post hatch 
dw: dry weight 
e.g.:  exempli gratia = for example 
EU:  European Union 
FSH:  follicle stimulating hormone 
G. fossarum:  Gammarus fossarum (Koch, 1835) 
GSH-Px:  glutathione peroxidase 
GST:  glutathione-S-transferase 
GWT-TUD:  Gesellschaft für Wissens- und Technologietransfer, Technical University of 
Dresden 
h: hour 
HE: Haematoxylin-eosin staining 
HEPES:  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HPLC-MS/MS:  high performance liquid chromatography, coupled to tandem mass 
spectroscopy 
Hsp70:  stress proteins of the heat shock protein family with approximately 
70 kilodalton 
i.a.:  inter alia = among other things 
i.e.:  id est = that is 
ISF Langenargen:  Institut für Seenforschung, Langenargen 
kDa:  kilodalton 
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L: litre 
L. variegatus:  Lumbriculus variegatus (Müller, 1774) 
lh:  luteinizing hormone 
LOEC:  lowest observed effect concentration 
logKow:  decadic logarithm of the octanol-water partition coefficient 
m: meter 
MDA:  malondialdehyde 
MEC: measured environmental concentration 
µg: microgram 
mg: milligram 
mm: millimeter 
MoA:  mode of action 
Ng: nanogram 
NOEC:  no observed effect concentration 
NSAID:  non-steroidal anti-inflammatory drug 
OECD:  Organisation for Economic Co-operation and Development 
P. antipodarum:  Potamopyrgus antipodarum (J.E. Gray, 1843) 
PEC: Predicted environmental concentration 
pH:  negative decadic logarithm of hydrogen ion activity 
pKa:  decadic logarithm of the acid dissociation constant 
PNEC: predicted no-effect concentration 
rcf:  relative centrifugal force 
ROS:  reactive oxygen species 
S. trutta:  Salmo trutta (Linnaeus, 1758) 
SDS:  sodium dodecyl sulfate 
SOD:  superoxide dismutase 
T0-control: Control sampling of the base population at the start of the experiment 
TBARS:  thiobarbituric acid reactive substances (byproduct of lipid peroxidation) 
Tris:  tris(hydroxymethyl)aminomethane 
WWTP:  wastewater treatment plant 
WFD:  (European) Water Framework Directive 
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6. Introduction 
Pharmaceuticals in the environment  
Within the last fifty years, the problem of anthropogenic contaminations in the environment has 
gained increasing attention. In the beginning, the focus rested on large-scale contaminations with 
nutrients like nitrogen and phosphate (Carpenter et al. 1998), or on the devastating effects of 
persistent pesticides (Ratcliffe 1970). Over the years humankind started to realize that our modern 
human lifestyle releases a nearly unmanageable variety of substances into the environment. Large-
scale agroindustry, dependent on monocultures and factory farming, would not be feasible without a 
multitude of pesticides, fertilizers and medicinal products. Modern manufacturing of everyday 
products is based on the production and processing of thousands of industry chemicals. At the same 
time, the diverse combustion processes, which fuel our society, release numerous organic compounds 
and metals into the environment. Moreover, typical everyday culture would hardly be manageable 
without the high abundance of pharmaceuticals, detergents, disinfectants, and cosmetics (Daughton 
and Ternes 1999).  
The underlying pathways are diverse: several substances, like fertilizers and crop protection products, 
are deliberately released at one location, and reach other places via drifting or run-off (Stoate et al. 
2001, Stoate et al. 2009). Substances present in exhaust gases or abrasion products are not 
intentionally released into the environment, but their emission and wide-range dispersal is tolerated. 
Apart from these diffuse entries, wastewater treatment plants are point sources responsible for a large 
amount of substances entering surface waters (Tixier et al. 2003, Triebskorn 2017). Substances of 
everyday use by humans are reaching wastewater through sinks, showers or toilets. Most treatment 
plants in Western Europe effectively remove nitrogen or phosphate, but are not designed to filter 
micropollutants (Luo et al. 2014). Consequently, many of those chemicals pass through wastewater 
treatment unchanged and reach surface waters. Countless studies found a wide range of trace 
substances in environmental compartments, like surface water, groundwater, sediments, soil and 
biota (e.g. Schwarzenbach et al. 2006).  
At the same time, aquatic and terrestrial ecosystems suffer from a wide range of adverse effects. Low 
performance and eventual extinction of various species lead to a great loss of biodiversity (Goudie 
2013). Major driving forces behind this are, certainly, habitat loss and habitat degradation, climatic 
changes or competition with newly introduced species. However, pollution may also play a crucial role 
in this detrimental development. The causal link between specific contaminations and negative 
environmental effects may be apparent in many cases, e.g. eutrophication of water bodies through 
nutrients (Smith 2003), or the drastic decline of various bird species through organochlorine 
compounds (Ratcliffe 1970). However, in the case of micropollutants, this causal link is hard to 
establish. Environmental concentrations range, like the name suggests, on a nanogram to microgram 
per litre scale. In many cases, it is not known whether the substances may exert any effect in such low 
concentrations. For many substance groups, regulating authorities impose an assessment of their eco-
toxic potential, to estimate risks before a substance is introduced into the environment. 
The following piece of work will be restricted to one of the previously described groups of 
micropollutants – pharmaceuticals. This diverse substance group is characterized by several attributes 
giving them potentially high environmental relevance: pharmaceuticals are designed to evoke 
physiological effects in the target organism – whether it is human, pet or livestock animal. The 
responsible biochemical pathways are usually highly conserved. Hence, it can be supposed that the 
effects are nearly similar in closely related species (Fent et al. 2006, Arnold et al. 2014). In contrast to 
crop protection products or biocides – which are poisons that aim to harm specific organisms - 
pharmaceuticals are commonly viewed as positive substance with “healing” properties. Still, the 
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evoked physiological changes and side effects are oftentimes drastic, with far-reaching effects on the 
whole body. For this reason, many preparations are only sold in pharmacies or available on 
prescription, and their package leaflets warn of the manifold side effects. Furthermore, it must not be 
forgotten that various active substances are explicitly designed to harm cells, proteins or genetic 
information - e.g. antibiotics against bacteria, virostatic agents against viruses, or cytostatic agents 
against the own, malignant degenerated body cells. Usually, the active ingredients are highly potent 
and evoke their effects already at extremely low concentrations. Experimental contamination of a lake 
with low ng/L-concentrations of the contraceptive 17α-ethinylestradiol, a synthetic estrogen, resulted 
in decreased reproduction of several fish species, and eventually large-scale alterations of the whole 
freshwater community (Kidd et al. 2014). Likewise, antipsychotics showed to alter vital behaviours, like 
feeding or sociality (Brodin et al. 2013, Brodin et al. 2014). Thus far, the most obvious ecologic effect 
on non-target organisms, directly evoked by pharmaceuticals, was the population decline of several 
vulture species in India and Pakistan. Birds feeding on the carcasses of diclofenac-treated cattle died 
from renal failure and visceral gout (Oaks et al. 2004) leading to the near extinction of several Gyps 
species (Prakash et al. 2003). These pathologies resemble common adverse side effects of the same 
pharmaceutical in humans (Bjorkman 1998, Kawada et al. 2012). However, the link between exposure 
and effect is usually not as clear as in this example. Apart from their high effect potential, 
pharmaceuticals are optimized on chemical stability, so that degradation in wastewater treatment or 
the environment is slow (Fent et al. 2006, Ebert et al. 2014). Overall consumption rates are constantly 
rising over the last years. For Germany, consumption is predicted to rise by 40 to 70 % until 2045 
(Lauruschkus et al. 2017). One reason for this is the demographic development in the Western world. 
The largest amount of pharmaceuticals is consumed by elderly people. Hence, the observed general 
increase of consumption amounts is the logical consequence of an ageing population. Furthermore, 
the better availability of a constantly growing spectrum of medicinal products can also be seen as a 
reason. In several cases, medical indication is not necessarily given – many preparations are used as 
“lifestyle”-products, e.g. prophylactically in sports. Apart from usage and subsequent excretion, 
improper disposal is a major contributor to environmental contaminations (Ebert et al. 2014). In 
addition, in certain areas, discharges from manufacturing have led to strong pollution (Larsson 2014). 
Pharmaceuticals are frequently detected in marine (Arpin-Pont et al. 2014) and freshwater ecosystems 
(Ternes 1998, Santos et al. 2010, Aus der Beek et al. 2016a). Their ubiquitous occurrence in water 
bodies, in combination with their highly potent biological activity, slow degradation and increasing 
consumption explains why these substances are regarded as highly relevant pollutants. 
Legal background, pharmacovigilance and need for monitoring  
When politics became finally aware of the problem, they established a prospective environmental risk 
assessment for the approval of new pharmaceutical preparations for human (2001/83/EG) and 
veterinary use (2001/82/EG), transferred to national law e.g. in the German “Arzneimittelgesetz” § 22. 
In fact, the systematical assessment is carried out only since the implementation of the guidelines 
EMEA/CHMP/SWP/4447/00 (EU 2006b), CVMP/VICH/592/98-FINAL (EU 2000) and 
CVMP/VICH/790/03-FINAL (EU 2004), where detailed information on how to conduct the assessment 
is given. In addition to proving the clinical safety and efficacy, applicants have to investigate whether 
the compound poses a risk to the environment. Environmental risk assessment compares exposure, 
i.e. the calculated or measured environmental concentration, with effect concentrations obtained for 
organisms of different trophic levels. In cases where the predicted exposure is greater than the most 
sensitive effect concentration (including a safety factor addressing experimental uncertainties), an 
unacceptable risk is expected.  
Several aspects of the current legislation are not fully satisfying: preparations already approved before 
the implementation of the directives, which are frequently found in relatively high concentrations in 
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the environment (Arnold et al. 2014), are exempt from environmental risk assessment. Most 
preparations used in everyday life, which constitute the largest amount of consumed pharmaceuticals, 
fall into this category of “legacy pharmaceuticals”. Consequently, mainly newly developed substances 
feature a comprehensive environmental risk assessment. However, even if the environmental risk 
assessment identifies an unacceptable risk of a human pharmaceutical, the approval cannot be refused 
solely for environmental reasons. In this case, human health is regarded to be of paramount 
importance.  
Besides this prospective risk assessment, there are retrospective methods to assure the safety of 
applied pharmaceuticals. The continuous, systematic registration and documentation of side effects in 
humans is called pharmacovigilance. One idea, so far not realized on a larger scale, would be to transfer 
this principle to the environmental sector (Wang et al. 2017). This eco-pharmacovigilance would collect 
undesired environmental effects in retrospect – and possibly lead to a re-evaluation of risk. However, 
this would require a large-scale, systematic monitoring of active pharmaceutical ingredients in the 
environment – which does not currently exist. 
The extant knowledge on environmental contaminations is based on various measuring campaigns, 
mainly by authorities, universities and other research institutions. A comprehensive literature study 
concluded that the data availability is comparably good for Germany, while in many other countries 
only few data are available (Aus der Beek et al. 2016b). Additionally, it has to be born in mind that data 
collected in this manner does not necessarily represent the actual situation. The number of detected 
contaminants in a region depends largely on the number of conducted searches, and the applied 
techniques. For example, the high number of active pharmaceutical ingredients detected in German 
surface water is not necessarily a sign of an especially concerning situation, but mainly a result of the 
high number of studies conducted in this country. Furthermore, the detected concentrations need not 
be completely representative of the general situation. Analytical studies are preferably conducted at 
strongly contaminated sites, possibly leading to an overall bias of the data (Aus der Beek et al. 2016a). 
These points shall not trivialize the problem associated with these substances in the environment. 
Instead, they emphasize the need for a systematic monitoring, to allow a profound assessment of risk. 
However, at this moment, such a monitoring seems hardly feasible – technically as well as financially. 
Investigations via modern chemical-analytical methods (e.g. non-target analytics - Hernández et al. 
2015) are complex, still difficult to interpret, and expensive, especially in the expected low 
concentration ranges. Moreover, most established methods can only detect the substances they are 
looking for. Countless other active substances, metabolites and transformation products would evade 
the search (Brack et al. 2017). Even in the hypothetic case that comprehensive analytics were possible, 
this could only show the presence of certain substances. The potential effect of the complex substance 
mixture could not be assessed. One solution to this dilemma is promised by effect-based monitoring, 
which was investigated in the project Eff-Pharm.  
Scope of the project Eff-Pharm and the thesis 
The research project “From theory to reality – Evaluation of suitable organisms and test systems for 
the biomonitoring of pharmaceuticals”, shortly titled Eff-Pharm, was initiated and funded by the 
German Environment Agency (UBA). Its basic idea was to quantify pharmaceutical ingredients via their 
mode of action. This mode of action is shared between all members of the same substance class, and 
is responsible for the actual pharmacological effect in the treated organism. Common drug targets are 
specific molecules, like receptors, channels or enzymes. Artificially constructed in vitro systems, which 
express the target molecule as sensor, as well as a coupled reporter system, would allow the 
quantification of a whole group of substances with shared mode of action at once. The feasibility of 
this idea was investigated in the first project part. The second part focused on the construction, 
establishment and validation of these systems. 
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Since financial resources were limited, our pioneer project could only investigate practicability for 
selected substance classes. Therefore, one general prerequisite for the further procedure was the 
identification and selection of suitable substance classes. In an extensive literature survey, we 
identified lacks of knowledge and compiled information on ecotoxicity of various pharmaceutical 
ingredients, as a basis to select relevant substances for the further project.  
The effects detected in a potentially created in vitro system had to be related to an ecological context. 
Consequently, this requires a comparison of in vitro to in vivo effects. Besides the selection of suitable 
substance groups, one declared aim of the literature study was to assess suitable organism groups and 
effect endpoints for comparative in vivo investigations.  
In the focus of the in vivo experiments, which were conducted in the laboratory, mesocosms and in 
the field (bypass of a WWTP effluent) were the substance classes of non-steroidal anti-inflammatory 
drugs (NSAIDs) and beta-adrenergic receptor blockers, represented by the pharmaceuticals diclofenac 
and metoprolol. Both are consumed in high amounts and frequently detected in the aquatic 
environment. Whereas numerous data on adverse effects of diclofenac in wildlife were available at 
the start of Eff-Pharm (Oaks et al. 2004, Schwaiger et al. 2004, Triebskorn et al. 2004, Hoeger et al. 
2005, Mehinto et al. 2010), which were, however, controversially discussed with respect to their 
environmental relevance, little was known about the ecotoxicological effect potential of metoprolol. 
Hence, further effect data on both substances were urgently needed – especially on organisms of high 
regional environmental relevance. For this purpose, we chose brown trout and invertebrates including 
e.g. gammarids, as representative inhabitants of Central European stream ecosystems.  
Whereas all experiments with brown trout (including embryo and sac-fry stage tests and tests with 
juvenile fish) were conducted by myself, the tests with invertebrates were run by the cooperation 
partners from Dresden, Frankfurt am Main, and Berlin-Marienfelde, who provided samples for 
suborganismic effect analyses to me. These focused on how, and at which concentrations, diclofenac 
and metoprolol affect stress protein levels and oxidative stress responses in the exposed invertebrates. 
In brown trout, I studied embryo development, survival, behaviour, tissue integrity and also the above 
mentioned stress markers. 
Overarching questions of my thesis: 
 Do the NSAID diclofenac or the beta-blocker metoprolol influence development or health of brown 
trout embryos and juveniles? 
 Are there effects on the stress proteins or lipid peroxides, when fish, crustaceans, annelids or snails 
are exposed to diclofenac or metoprolol? Are these biochemical markers a useful addition to the 
traditional testing battery? 
 In which concentration ranges do in vivo effects occur? Are there differences in sensitivity? 
 Are there adverse effects, when fish or gammarids are exposed to wastewater treatment plant 
effluents? 
It was the general aim of my thesis to provide data for effects of metoprolol and diclofenac in relevant 
aquatic organisms as a basis for the validation of the biosensors developed in Eff-Pharm with respect 
to necessary sensitivity and threshold values.  
General remarks on the project structure and own contributions 
The present thesis contains results of three separate research projects, funded by the German 
Environment Agency (Umweltbundesamt – UBA), entitled “From theory to reality – Evaluation of 
suitable organisms and test systems for the biomonitoring of pharmaceuticals – Part I: Literature 
review (FKZ 3713 634 101), - Part II: Case studies (FKZ 3713 63 4102) and – Part III: Method validation 
(3715 63 4120)”. All three projects are based on each other and are closely intertwined. Hence, they 
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will be referred to as one project, shortly called Eff-Pharm. The following universities and research 
facilities conducted the work cooperatively: 
 University of Tübingen: project coordination, literature research on effect data, in vivo studies in 
brown trout and biochemical analyses of fish, gammarid, oligochaete, gastropod and daphnid 
samples  
 GWT-TUD GmbH, Dresden: literature research on effect data and in vivo studies in gammarids 
 University of Frankfurt am Main: in vivo studies on sediment-dwelling oligochaetes and gastropods 
 German Environment Agency, Dessau-Roßlau and Berlin-Marienfelde: funding, project supervision 
and in vivo experiments on daphnids 
 DVGW Water Technology Center, Karlsruhe: chemical analyses 
 Steinbeis Innovation Center Cell Culture Technology, Mannheim: literature research on in vitro 
systems, development and validation of biosensor systems 
This thesis is mainly based on the tasks performed at the University of Tübingen – with a strong focus 
on literature review, in vivo studies in fish, and biochemical analyses. My own contributions to the 
project are summarized in Table 1. In order to provide the relevant context, the other tasks and results 
will be referred to - but not in close detail. The scientific background and technical realization of the in 
vitro systems was not part of this thesis. The overall results of all project parts are published in 
Triebskorn et al. (2014) and Triebskorn et al. (2017), and the development of the in vitro systems is 
further explained by Bernhard et al. (2017). 
Table 1: Overview on the performed experiments and analyses. Green boxes indicate that the endpoints were evaluated as 
part of this thesis. Yellow boxes indicate that the experiments were performed in the overall project, but not part of this thesis. 
Blank boxes indicate that these experiments were not performed, or endpoints not analysed in the overall project. 
    
S. trutta 
embryo 
S. trutta 
juvenile 
G. 
fossarum 
D. 
magna 
L. 
variegatus 
P. 
antipodarum 
Diclofenac - 
single 
substance 
exposure 
Organismic parameters 1 1 2 2 2 0 
Hsp70 0 1 1 1 1 0 
Lipid peroxides 0 1 1 0 1 0 
Histology 1 1 0 0 0 0 
Metoprolol - 
single 
substance 
exposure 
Organismic parameters 1 1 2 2 2 2 
Hsp70 0 1 1 1 1 1 
Lipid peroxides 0 0 0 0 1 0 
Histology 1 1 0 0 0 0 
Diclofenac + 
Metoprolol - 
mixture 
exposure 
Organismic parameters 0 2 2 2 2 0 
Hsp70 0 2 2 2 2 0 
Lipid peroxides 0 2 2 0 2 0 
Histology 0 2 0 0 0 0 
Metoprolol - 
artificial 
indoor 
stream 
Organismic parameters 0 0 2 0 2 2 
Hsp70 0 0 1 0 0 1 
Lipid peroxides 0 0 0 0 0 0 
Histology 0 0 0 0 0 0 
Wastewater 
treatment 
plant 
effluent 
Organismic parameters 1 0 2 0 0 0 
Hsp70 0 0 1 0 0 0 
Lipid peroxides 1 0 1 0 0 0 
Histology 1 0 0 0 0 0 
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7. Material and Methods 
Literature study 
Search details 
The literature survey in 2013 compiled effect data on 90 pharmaceuticals. Relevant substances were 
selected according to the priority list previously published by Bergmann et al. (2011), based on 
literature data, and communications with the German Environment Agency (UBA). The UBA-selection 
based on measured concentrations in German waters, consumption rates, effect data from 
confidential regulatory studies and problematic physicochemical attributes (e.g. potential persistence, 
bioaccumulation). Relevant biota classes were bacteria, protists, plants/algae, molluscs, crustaceans, 
insects, fish, tetrapods and others (incl. communities). Since the study by Bergmann et al. (2011) had 
already evaluated literature up to 2010, we restricted our search to studies published between 2011 
and 2013. 
Besides studies on single substance and mixture toxicity, reviews on ecotoxicological effects of 
pharmaceuticals were also compiled and evaluated to obtain a better knowledge of the overall 
context. “Web of Knowledge” (incl. databases “Web of Science®”, “BIOSIS Citation IndexSM”, “BIOSIS 
Previews®”, “MEDLINE®” and “Journal Citation Reports®”) served as database for the search, with the 
following search terms: 
- Reviews: pharma* AND eco*, limited by “review”  
- Single substances: specific search entry (summarized in Table 2) for each pharmaceutical 
combined with the search terms: aqua* OR eco* OR tox* 
Substances present in our search were all either prioritized by UBA-internal data, or by the 
summarizing report by Bergmann et al. (2011). Since those prioritization schemes differed in some 
aspects, the respective priority classes are also described in Table 2. Judging on the information given 
in title and abstract, we decided whether to discard the study or evaluate it in closer detail. The sole 
focus rested on aquatic ecotoxicological effects. Hence, studies on effects in humans, i.e. from clinical 
study reports, were not relevant. 
 
Table 2: List of pharmaceuticals with defined priority classes 
P: high priority according to Bergmann et al. and UBA 
Pu: high priority according to UBA 
Pb:  high priority according to Bergmann et al. 
(P): medium priority according to Bergmann et al.  
?: substances requiring further information 
none: substances without priority according to Bergmann et al. 
Pharmaceutical Search entry 
Priority 
class 
(UBA) 
Priority 
class 
(Berg 
mann) 
Priority 
class 
(final) 
Class CAS 
"Sartanic acid" sartane* P  Pu antihypertensive  
14-Hydroxyclarithromycin hydroxyclarithromycin* P  Pu antibiotic 110671-78-8 
17alpha-Ethinylestradiol ethinyl* estradiol* P P P contraceptive 57-63-6 
17beta-Estradiol estradiol* AND pharma*  P Pb hormone 50-28-2 
4-N-Methylaminoantipyrin methylaminoantipyrin* P  Pu analgesic 519-98-2 
6(carboxymethoxy)-4-(2-
chlorophenyl)-5-
(ethoxycarbonyl)-2-
methylpyridine-3-carboxylic acid 
amlodipin* P  Pu antihypertensive  
Acetyl cysteine acetyl cystein*  ? ? mucolytic agent 616-91-1 
Acetylsalicylic acid acetylsalic*    NSAID 50-78-2 
Aciclovir aciclovir*  ? ? antiviral drug 59277-89-3 
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Pharmaceutical Search entry 
Priority 
class 
(UBA) 
Priority 
class 
(Berg 
mann) 
Priority 
class 
(final) 
Class CAS 
Allopurinol allopurinol*    
xanthine oxidase 
inhibitor 
315-30-0 
AMDOPH AMDOPH  (P) (P) analgesic  
Amlodipine amlodipin* P  Pu antihypertensive 88150-42-9 
Amoxicilline amoxicillin* P P P antibiotic 26787-78-0 
Atenolol/ Atenolol acid atenolol*, tenormin* P  Pu betablocker 29122-68-7 
Azitromycin 
azitromycin*, zithromax*, 
azithrocin*, azin* 
P  Pu antibiotic 83905-01-5 
Bezafibrate bezafibrat*  (P) (P) lipid regulator 41859-67-0 
Bisoprolol bisoprolol* P ? Pu betablocker 66722-44-9 
Capecitabin capectiabin*, xeloda* P  Pu cytostatic 15361-50-9 
Carbamazepine carbamazepin* P P P anticonvulsant 298-46-4 
Cefaclor cefaclor* OR cefachlor*  ? ? antibiotic 53994-73-3 
Cefuroxime axetil cefuroxim* axetil*  ? ? antibiotic 64544-07-6 
Chloramphenicole chloramphenicol*  P Pb antibiotic 56-75-7 
Chlortetracycline chlortetracyclin*  P Pb antibiotic 57-62-5 
Ciprofloxacin ciprofloxacin* P P P antibiotic 85721-33-1 
Clarithromycine clarithromycin* P P P antibiotic 81103-11-9 
Clindamycin clindamycin* P ? Pu antibiotic 18323-44-9 
Clopidogrel clopidogrel*  ? ? antiplatelet agent 113665-84-2 
Clotrimazole clotrimazol*  (P) (P) antimycotic 23593-75-1 
Deltamethrin deltamethrin*, decamethrin* P  Pu antiparasitic 52918-63-5 
Desflurane desfluran*  ? ? anesthetic 57041-67-5 
Diatrizoic acid 
diatriz*, iotalam*,  
amidotriz* 
 (P) (P) contrast agent 737-31-5 
Diazepam diazepam*  (P) (P) 
antidepressant/ 
antipsychotic 
439-14-5 
Diclofenac diclofenac* P P P NSAID 15307-86-5 
Dienogest dienogest*, visanne* P  Pu gestagan 65928-58-7 
Dipyridamole dipyridamol*  ? ? antiplatelet agent 58-32-2 
Doxycycline doxycyclin*  P Pb antibiotic 564-25-0 
Duloxetine duloxetin*, cymbalta* P  Pu 
antidepressant/ 
antipsychotic 
116539-59-4 
Entacapone entacapon*  ? ? C-O-M-Inhibitor 130929-57-6 
Eprosartan eprosartan*  ? ? antihypertensive 133040-01-4 
Erythromycin erythromycin*  P Pb antibiotic 114-07-8 
Gabapentin gabapentin*, neurotin*  ? ? anticonvulsant 60142-96-3 
Gemfibrozil gemfibrozil*, lopid* P  Pu lipid regulator 25812-30-0 
Glutaral glutaral*  ? ? desinfectant 111-30-8 
Hydrochlorothiazide hydrochlorothiazid*  ? ? antihypertensive 58-93-5 
Ibuprofen ibuprofen* P (P) P NSAID 15687-27-1 
Imatinib imatinib*, gleevec*, glivec* P  Pu cytostatic 152459-95-5 
Indometacin 
indometacin*, 
indomethacin* 
 (P) (P) NSAID 53-86-1 
Iohexol iohexol*, omnipaq* P (P) P contrast agent 66108-95-0 
Iomeprol iomeprol* P (P) P contrast agent 78649-41-9 
Iopamidol iopamidol*  (P) (P) contrast agent 60166-93-0 
Iopromide iopromid*, ultravist*  (P) (P) contrast agent 73334-07-3 
Ivermectin ivermectin*, stromectol* P  P Antiparasitic 70288-86-7 
Lamotrigin lamotrigin*, lamictal* P  Pu anticonvulsant 84057-84-1 
Levetiracetam levetiracetam*  ? ? anticonvulsant 102767-28-2 
Lincomycin lincomycin*  (P) (P) antibiotic 154-21-2 
Mesalazine mesalazin*  ? ? NSAID 89-57-6 
Mestranol mestranol*  P Pb contraceptive 72-33-3 
Metamizole metamizol* P  Pu analgesic 68-89-3 
Metformin metformin* P  Pu antidiabetic 657-24-9 
Metoprolol metoprolol* P  Pu betablocker 51384-51-1 
Naproxen naproxen* P P P NSAID 22204-53-1 
Norethisterone norethisteron*  P Pb contraceptive 68-22-4 
Opipramol opipramol*  ? ? 
antidepressant/ 
antipsychotic 
315-72-0 
Oxytetracycline oxytetracyclin*  P Pb antibiotic 79-57-2 
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Pharmaceutical Search entry 
Priority 
class 
(UBA) 
Priority 
class 
(Berg 
mann) 
Priority 
class 
(final) 
Class CAS 
Pantoprazole pantoprazol*  ? ? 
proton pump 
inhibitor 
102625-70-7 
Paracetamol 
paracetamol*, 
acetaminophen* 
 P Pb analgesic 103-90-2 
Piperacillin piperacillin*  ? ? antibiotic 61477-96-1 
Pregabalin pregabalin*  ? ? anticonvulsant 148553-50-8 
Primidone primidon*  P Pb anticonvulsant 125-33-7 
Propranolol propanolol*, propranolol*  (P) (P) betablocker 525-66-6 
Quetiapine quetiapin* P ? Pu 
antidepressant/ 
antipsychotic 
11974-69-7 
Ramipril ramipril*  ? ? antihypertensive 87333-19-5 
Roxithromycine roxithromycin*  P Pb antibiotic 80214-83-1 
Sevelamer sevelamer*  ? ? 
phosphate binding 
drug 
52757-95-6 
Simvastatin simvastatin* P ? Pu lipid regulator 79902-63-9 
Strontium ranelate strontium ranelat*  ? ? osteoporose 135459-90-4 
Sulbactam sulbactam*  ? ? antibiotic 68373-14-8 
Sulfadimethoxine sulfadimethoxin*  P Pb antibiotic 122-11-2 
Sulfadimidine 
sulfadimidin*, 
sulfamethazin* 
 P Pb antibiotic 57-68-1 
Sulfamethoxazole sulfamethoxazol* P P P antibiotic 723-46-6 
Tazobactam tazobactam*  ? ? antibiotic 89786-04-9 
Telmisartan telmisartan*  ? ? antihypertensive 144701-48-4 
Tetracycline tetracyclin*  P Pb antibiotic 60-54-8 
Tiamulin tiamulin* P P P antibiotic 55297-95-5 
Tilidine tilidin*  ? ? analgesic 51931-66-9 
Torasemide torasemid*, torsemid*  ? ? diuretic drug 56211-40-6 
Tramadol tramadol*, ryzolt*, ultram* P  Pu analgesic 27203-92-5 
Valproic acid valpro*  ? ? anticonvulsant 99-66-1 
Valsartan 
valsartan*, angiotan*, 
diovan* 
P ? Pu antihypertensive 137862-53-4 
Venlafaxine venlafaxin*  ? ? 
antidepressant/ 
antipsychotic 
93413-69-5 
 
Data evaluation and reliability analysis 
All available publications were evaluated, the following parameters (Table 3) extracted and 
documented in the database “OEKOTOXupgrade”:  
Table 3: Information extracted from examined publications and summarized in the database “OEKOTOXupgrade”. 
Test substance Test organism Exposure Effect data Additional information 
name of effective 
substance 
test organism 
(species) 
test concentrations in water [µg/L or 
µmol/L] 
BCF/BMF citation 
form of the substance 
(salt/conjugate) 
biota group 
test concentrations in sediment 
[µg/kg or µmol/kg] 
NOEC [µg/L 
or µmol/L] 
DOI 
synonyms field/lab/mesocosm dose [µg/kg or µmol/kg] 
LOEC [µg/L 
or µmol/L] 
full text available? 
CAS number effect endpoint duration 
EC10 [µg/L or 
µmol/L] 
EndNote label 
logKow population relevance? acute/sub-acute/chronic? 
EC50 [µg/L or 
µmol/L] 
substance in priority list? 
molar mass standard method? analytical-chemical verification?  comments 
substance class  bioaccumulation investigated?  
reliability (only for selected 
studies) 
field of application     
effective 
substance/medicinal 
product? 
    
single 
substance/mixture? 
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In case the highest test concentration did not evoke an effect, this concentration was included as NOEC 
without corresponding LOEC. If already the lowest concentration evoked an effect, it was included as 
LOEC without corresponding NOEC. All given data on pharmaceutical ingredients was transferred to 
the database. As several publications investigated more than one test substance, the final database 
includes information on pharmaceuticals originally not defined in the priority list. For each endpoint 
per species and test substance given in the publications, a separate row was created. In the following, 
the single rows will be referred to as “database entries”. 
Evaluation was performed in a qualitative way, as this was more appropriate to the heterogeneous 
structure of the data. LOECs were compared to measured environmental concentrations (MECs), which 
were either available from the database given by Bergmann et al. (2011) or from UBA internal data. A 
risk quotient, calculated by dividing the maximum MEC by the minimum LOEC, served as proxy for the 
environmental relevance of the substance.  
For substances of potentially high relevance, the reliability of the underlying publication was evaluated 
more closely. This was done by checking whether the studies fulfilled several reliability criteria, 
proposed by Wright-Walters et al. (2011): 
“ 
1) A thorough description of the experimental design, including exposure regime and replication,  
2) Analytical confirmation of test concentrations  
3) Description of ecologically relevant endpoints and all supplemental morphological information 
collected  
4) Use of test procedures that are based, at least generally, on internationally accepted 
procedures and practices. Newly developed test procedures must be able to be repeated, and 
meet all other required criteria  
5) Clear linkage of reported findings with the exact experimental design, and  
6) Sufficient reporting of results, including system performance, toxicity results, and statistical 
methods employed to ascertain how the data support the conclusions that are drawn 
         “ 
Criteria 1, 2, 3 and 6 were seen as most important. Studies were labelled as “reliable” when these four 
criteria were fulfilled or “conditionally reliable”, when only three criteria were fulfilled. In cases where 
less than three criteria were met or apparent mistakes were identified, the study was labelled as “not 
reliable”.  
Test substances 
Following the conclusions of the literature study (Chapter I), the in vivo experiments investigated non-
steroidal anti-inflammatory drugs and beta-adrenergic receptor blockers, with diclofenac and 
metoprolol as representatives of their respective substance group.  
Diclofenac 
Diclofenac belongs to the substance group of non-steroidal anti-inflammatory drugs (NSAIDs). The 
mode of action of this pharmaceutical class is the inhibition of cyclooxygenase (COX) 1 and 2 (Kawada 
et al. 2012). This prevents the formation of prostaglandins - important mediators in inflammatory 
processes (Funk 2001). Besides this, prostaglandins are involved in various other physiological 
processes, like blood coagulation, vasodilation or protection of the gastric mucosa. Apart from its use 
as an antiphlogistic (anti-inflammatory) drug, diclofenac is commonly used as an antipyretic (anti-
fever) and light analgesic (painkiller) pharmaceutical. Typical applications are creams, pills or injections 
to treat rheumatic symptoms, bruises and strains. The estimated global annual use was 1443 tons in 
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2016 (Lonappan et al. 2016). Various diclofenac-containing products are sold over the counter, making 
them a popular choice for self-medication. Particularly dermal application is regarded as problematic 
from an environmental point of view. Only a small fraction of active substance is absorbed, while the 
major part is washed off unmetabolized (Heberer and Feldmann 2005). Its occurrence in German 
surface waters was reported for the first time by Stumpf et al. (1996). Since then, it is one of the most 
frequently detected substances in surface waters (Aus der Beek et al. 2016b).  
Cyclooxygenase, also called prostaglandin H synthase, is a membrane-bound haemo- and glycoprotein 
that consists of four domains. Highest amounts are found in the endoplasmic reticulum of prostanoid-
forming cells. Its catalytic domain has hydroperoxidase, as well as cyclooxygenase activity (Vane and 
Botting 1998, Simmons et al. 2004). It metabolizes the precursor molecule arachidonic acid to the 
intermediate prostaglandin H2. Further metabolism depends on the respective cell type, and results 
in the following molecules: thromboxane A2, prostacyclin (=prostaglandin I2), prostaglandin E2, 
prostaglandin F2 and prostaglandin D2. Prostaglandins are responsible for the processes of 
inflammatory reactions, pain sensitization, fever, immunosuppression, protection of the 
gastrointestinal tract through mucus secretion, inhibition of vascular contraction, antagonizing platelet 
aggregation, vasodilation in kidney and maybe also complex integrative function in the brain and 
autonomous nervous system (Funk 2001). COX1 is mainly responsible for physiological endogenous 
processes, while the COX2 isoform is inducible by proinflammatory stimuli (Vane and Botting 1998, 
Simmons et al. 2004). NSAIDs block the COX-derived prostaglandin synthesis as a whole (Funk 2001, 
Kawada et al. 2012). Diclofenac is especially potent in inhibiting COX2, with approximately four-fold 
higher selectivity than for COX1 (Gan 2010). Besides the inhibition of prostaglandin and thromboxane 
synthesis, further mechanisms are discussed: inhibition of leukotriene production, inhibition of 
phospholipase A2 or action via the nitric-oxide-cGMP pathway (Gan 2010). Especially the inhibition of 
COX2 has recently been associated with increased cardiovascular risks in human (Cannon and Cannon 
2012). Adverse side effects are often caused by reduced levels of prostaglandin E2, which is produced 
by both COX-isoforms (Kawada et al. 2012).  
Diclofenac is mainly metabolized to hydroxylated and methoxylated derivatives, but also conjugated 
to glucuronide. A wide range of these metabolites, which still possess high similarity to the parent 
substance, is frequently detected in the environment (Lonappan et al. 2016). In the environment, 
direct photolysis is the main process contributing to the removal of diclofenac (Avetta et al. 2016). 
Other processes, like adsorption to particles and sediment, hydrolysis or biological degradation, are of 
minor importance for this substance (Buser et al. 1998). However, while photodegradation is of high 
importance in lakes, its elimination potential is negligible in rivers (Johnson et al. 2013). Furthermore, 
effective removal in conventional wastewater treatment is highly variable (Monteiro and Boxall 2010, 
Lonappan et al. 2016).  
Like many other pharmaceuticals, diclofenac is an ionisable substance. It is a medium weak acid, with 
a pKa around four. Hence, it shifts from non-dissociated to anionic form when the pH increases. About 
99.9 % of diclofenac exists as anion at physiological pH (Ferreira et al. 2005). This has a marked effect 
on its logKow, and consequently its bioconcentration potential (Fu et al. 2009, Schreiber et al. 2011). 
The Kow and theoretical bioconcentration factor (BCF) are high only at low pH-ranges, which are not 
realistic for most aquatic ecosystems. At natural pH conditions, which are usually neutral or slightly 
alcalic, the Kow is considerably smaller (Fu et al. 2009). Common models assume that uptake of 
pharmaceuticals into an organism is mainly based on diffusion through biomembranes and, hence, 
mainly depends on the lipophilicity of a substance. However, in this context it is important to notice 
that cellular uptake of diclofenac is not only possible through passive processes. Active transport via 
monocarboxylate/H+-cotransporters, carriers originally intended for the uptake of carboxylic 
substrates, is highly likely (Choi et al. 2005). 
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In my experiments, diclofenac was applied as sodium salt (CAS 15307-79-6; purity: 100 %; supplier: 
SIGMA-ALDRICH, 3050 Spruce Street, Saint Louis, MO 63103; lot BCBN3367V). In this form, it is readily 
soluble in water (50 g/L) and using additional solvent was not necessary. 
Metoprolol 
Metoprolol is a beta-adrenergic receptor antagonist, commonly called beta-blocker. These 
pharmaceuticals reduce heart rate and blood pressure, and are mainly used for the treatment of 
hypertension, coronary heart disease and migraine. Beta-blockers act by inhibiting beta-adrenergic 
receptors. These receptors belong to the superfamily of G-protein-coupled receptors. Up to now, three 
receptor types are known: β1, mainly located in heart, kidney and adipose tissue. β2, mainly located 
in heart, lung, gastrointestinal tract, liver, pancreas and skeletal muscles. And β3, whose location is not 
as well defined (DeGeorge Jr and Koch 2007). Activation of β-adrenoceptors by the catecholamines 
adrenalin or noradrenalin induces a signalling pathway, which activates adenylyl cyclase and increases 
intracellular cAMP-levels. This induces the myocardial contractile apparatus (DeGeorge Jr and Koch 
2007). Beta-blockers prevent the docking of adrenalin and noradrenalin to the receptor. Thus, they 
counteract the processes involved in the so-called “fight and flight” reactions, with extensive effects 
on an organism’s stress response (Owen et al. 2007). The actual physiological effects of beta-blockers 
strongly depend on the tissue where the receptors are present. In the heart, they influence heart rate 
and contractility, while they lead to vasodilation in blood vessels. In hepatic tissue, they activate 
glycogenolysis and gluconeogenesis. In the kidney, they promote renin release. Effects are usually 
small in resting organisms, but become large as soon as the sympathetic nervous system is activated 
(López-Sendó et al. 2004). In fish, the adrenergic systems is mainly responsible for modulations of 
cardiac output, ventilation, metabolic regulation, skeletal muscle performance and melanophore 
regulation (Owen et al. 2007). 
As high blood pressure, migraine and cardiac problems are very common health impairments in the 
Western world, beta-blockers are an important and frequently used group of pharmaceuticals. Some 
beta-blockers, like propranolol, non-selectively act on beta-adrenergic receptors 1 and 2. Metoprolol, 
in contrast, selectively inhibits only receptor type 1. It is currently the beta-blocker with the highest 
prescription and consumption rate in Germany (IMS Health). Due to its mode of action, which also 
leads to a general “calm-down”, it is also prone to improper use to improve personal performance in 
exams and sports requiring concentration and accuracy (Stoschitzky 2001, Davis et al. 2008). Common 
adverse side effects in humans include bradycardia, atrioventricular block, masking of hypoglycaemia, 
or impotence. It is a lipophilic drug, which is rapidly absorbed and extensively metabolized in gut and 
liver (López-Sendó et al. 2004). Around 85 % is excreted as the three main metabolites (metoprolol 
acid, α-hydroxymetoprolol, O-desmethylmetoprolol) and only 10 % as parent substance (Rubirola et 
al. 2014). Investigations on trout liver spheroids in vitro came to a similar conclusion of ca. 90 % 
metabolite excretion, resulting from several oxidation pathways (Baron et al. 2017). Despite the short 
elimination half-life, it is frequently found in wastewater and surface waters (Godoy et al. 2015) – likely 
due to the sheer overall amount of drug consumed. Furthermore, incorrect disposal of unused 
metoprolol via wastewater could strongly contribute to the environmental concentrations (Brandmayr 
et al. 2015). 
Like all beta-blockers, metoprolol is a weak base, with reported pKa of 9.7, logKOW of 1.88/2.28 and 
logDlipw of 1.43 (Escher et al. 2006, Maurer et al. 2007). Sorption to sludge is expected to be low. 
Elimination of beta-blockers in wastewater treatment mainly depends on the hydraulic retention time 
and ranges between 25 and 75 %. Reported effluent concentrations of metoprolol range between 80 
and 2000 ng/L (Maurer et al. 2007, Scheurer et al. 2010).  Once the drug is excreted, it has high 
hydrolytic stability. Sorption potential ranges from Kd-values of 0.79 to 14.78, with decreasing 
potential at higher pH. It has to be considered as mobile substance, with low immobilization in 
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sediments. Consequently, this leads to the assumption that metoprolol and other beta-blockers may 
accumulate in the aquatic environment (Maszkowska et al. 2014a, Maszkowska et al. 2014b). 
In my experiments, metoprolol was applied as tartrate (CAS 56392-17-7; purity: 98.7 %; supplier: 
SIGMA-ALDRICH, 3050 Spruce Street, Saint Louis, MO 63103; lot BCBH029V). In this form, it is readily 
soluble in water (4.7 g/L) and using additional solvent was not necessary. 
Wastewater treatment plant Eriskirch 
For the semi-field exposure to investigate a well-defined wastewater effluent, we chose the 
wastewater treatment plant (WWTP) Eriskirch (Gmünd 2, 88097 Eriskirch), located 500 m from the 
Schussen estuary at the Lake Constance.   It processes wastewater of ca. 50,000 inhabitant equivalents, 
with a mean throughput of 11,000 m³/d, (Luddeke et al. 2015, Triebskorn 2017, p.41-43) in a three-
staged purification (http://www.av-unteres-schussental.de/data/beschreibung.php - 04.04.2018): 
 Mechanical filtration: Bar screen for the removal of coarse materials, sand trap for settleable 
solids and primary clarifier for the removal of primary sludge. 
 Biological purification: Degradation of organic compounds in activated sludge, with upstream 
denitrification and downstream dosage of precipitant for nitrogen and phosphorus removal. 
 Flocculation filtration: Secondary clarifier and additional treatment with precipitant for 
further removal of phosphorus and filterable substances.  
In this manner, it is representative of the majority of medium-sized German wastewater treatment 
plants. The facility was also investigated in the project SchussenAktivplus, led by the University of 
Tübingen (Triebskorn 2017). Therefore, there is much information on the facility and effluent from 
previous studies. This includes data on effluent concentrations of micropollutants including diclofenac 
and metoprolol, data on effect potentials from various laboratory in vitro tests, effect potentials in 
P. antipodarum and D. rerio, and even data from one-year old rainbow trout exposed in the effluent. 
Mean concentrations of diclofenac and metoprolol measured over three years were 1.3 µg/L and 
1.4 µg/L, respectively.  
Experiments with brown trout  
Test species - Salmo trutta f. fario 
Brown trout Salmo trutta (Linnaeus, 1758) is a prominent member of the family Salmonidae. It is native 
to Europe, Northern Africa and Western Asia, but has also been introduced to other parts of the world. 
The species shows high variability in size, growth, feeding niche and habitat use, and can adapt to a 
wide range of environmental conditions. Habitats range from small streams, up to large rivers, lakes, 
brackish and coastal waters – strongly depending on the life stage and ecotype (Klemetsen et al. 2003). 
Salmo trutta f. fario is the riverine type of the species. In contrast to the other ecotypes, the lacustrine 
lake trout (Salmo trutta f. lacustris) and anadromous sea trout (Salmo trutta f. trutta), they typically 
form resident populations in small to medium streams. The streamlined body, usually of grey to dark 
brown colour on the dorsal side and pale yellow to light brown colour on the ventral side, is a 
characteristic feature of their anatomy. Numerous red and black spots, surrounded by pale halos, mark 
the lateral sides. As carnivorous species, they feature a large mouth with well-developed teeth. The 
adipose fin, a typical feature of salmonids, is marked by a red margin (www.fishbase.se – 14.06.2018).   
The ecotype prefers cold, oxygen-rich waters to forage and breed (Dußling and Berg 2001). Once per 
year, females spawn 500 to 1500 eggs, which are naturally deposited in sand and gravel (Klemetsen et 
al. 2003).The number of spawned eggs is mainly determined by the size of the mother, but there are 
also considerable differences between anadromous and resident forms of brown trout (Jonsson and 
Jonsson 1999). Shortly after fertilisation, eggs are highly sensitive to mechanical shocks. This sensitivity 
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decreases rapidly after the eggs are eyeing (Crisp 1996). As the efficiency of yolk conversion decreases 
with higher temperatures, eggs are larger and yolk-richer in a warmer environment, but the hatching 
embryos are usually smaller. After hatching, larvae remain in the gravel until the yolk sac is consumed 
and subsequently move to the water column to feed. Developmental time is largely dependent on 
ambient temperature (Killeen et al. 1999a, Killeen et al. 1999b) – but usually requires several months 
from fertilized egg to fully developed larvae. Spawning usually starts earlier at higher altitude and 
latitude, to compensate for the slower development at lower temperatures. In growing, juveniles 
transcend from swarming to a territorial behaviour (J. Schindler – personal communication). Young 
individuals become aggressive, form dominance hierarchies and compete intensively with each other 
(Klemetsen et al. 2003). All brown trout are opportunistic carnivores, but may show a certain food 
specialization depending on life stage and current habitat. Small individuals feed predominantly on 
insect larvae and zoobenthos; when growing to a certain size, they also start to become piscivorous. 
As cold-water organisms, their tolerate water temperature ranges between 4 and 19 °C, with optimum 
growth of juveniles at 13-14 °C. The annual 50-percentile oxygen concentration should be above 
9 mg/L, but they can tolerate lower concentrations for a short time. Eggs and larvae have high survival, 
as long as oxygen concentration remains above 7 mg/L and temperature below 12.5 °C. A pH above 
9.2 or below 5 is also considered harmful (Crisp 1996).  
The species itself is a popular food fish, and is commonly raised in aquaculture for consumption and 
fishery restocking. Feral fish suffer from structural and qualitative stream degradation, as well as 
competition from introduced rainbow trout (Oncorhyncus mykiss), which has higher tolerance to a 
wider range of environmental conditions. However, the populations are currently considered as not 
endangered (Dußling and Berg 2001). In some areas, where the species was introduced, they 
themselves became invasive.  
Fish are frequently applied in ecotoxicological research because of several reasons: they are 
comparably easy to keep in the lab and react sensitively to pollutants. Furthermore, their metabolic 
processes are largely similar to other vertebrates, including humans. The so-called read-across-
hypothesis postulates that conservation of human drug targets is higher the closer a taxon is 
phylogenetically related to humans (Rand-Weaver et al. 2013). A recent meta-analysis of 194 
pharmaceutical ingredients and their target proteins reported 80-90 % drug target conservation in 
teleosts (Verbruggen et al. 2018). Hence, it is not surprising that genes coding for cyclooxygenases 
have been found in salmonids and other teleost families (Ishikawa & Herschman 2007), though they 
are only partly similar to human COX (Roberts et al. 2000). Furthermore, the adrenergic system is well 
conserved in vertebrates and beta-adrenergic receptors are found in a variety of fish tissues 
(Massarsky et al. 2011). This makes it likely that the two pharmaceutical groups tested in the 
experiments will affect fish.  
Since brown trout can only be kept in the lab at cold temperatures, spawn only once per year, and 
embryonic development takes a long time, they are no common testing organisms. Typical tests on 
fish toxicity apply model lab species, like zebrafish (Danio rerio), fathead minnow (Pimephales 
promelas), Japanese medaka (Oryzias latipes) or rainbow trout (Oncorhynchus mykiss), as they are 
much easier to handle. Although these species are of high value to derive comparable results in lab 
studies, they lack ecological relevance for Central Europe. For the project, it was important to work 
with a species of high ecological relevance for European stream ecosystems. Hence, I chose the brown 
trout despite its more complicated handling in the lab.   
The embryonic development of brown trout is described in great detail by Killeen et al. (1999a), who 
divided the embryogenesis into 40 different steps and developed an elaborate scoring system. After 
fertilisation, the early embryonic development takes place: blastulation is followed by gastrulation and 
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subsequent differentiation of somites and development of nervous, vascular and alimentary system. 
Head and tail separate from the yolk sac, heart beat is visible and the embryo exhibits first spontaneous 
contractions. At around 30-48 d (6 °C) the eyes become pigmented (= eyed ova stage, eyed egg stage) 
and the yolk sac becomes vascularised, blood vessels spread through the body and body pigmentation 
starts. In the following, fins develop, pigmentation, muscular development and vascularisation 
continue and the gill filaments form. Hatching occurs usually between day 72 and 82 at 6 °C. Embryos 
free themselves from the surrounding chorion, but still depend on nourishment from the yolk sac 
(= eleutheroembryos, sac-fry, “alevins”). The final embryonic development takes place between days 
82-127 (6 °C): Fins are further segmented, pigmentation continues and the dark parr marks appear on 
the sides. Finally, the yolk sac is fully resorbed and the fully developed larvae (= fry) enters its free-
feeding stage. Temperature has a great influence on the speed of development. While the complete 
embryogenesis took 127 d at 6 °C, it only took 80 d at 10 °C (Killeen et al. 1999a).  
For my experiments, I used fish obtained from a commercial fish breeder (Forellenzucht Lohmühle, Am 
Lohmühlebach 85, 72275 Alpirsbach-Ehlenbogen). This breeding facility is regularly controlled and 
rated as category I, disease-free (EU 2006a).The bred variety of brown trout is considered to be robust 
and close to feral forms, and also used for fishery restocking campaigns. Fish originating from this 
source were also applied in other field and laboratory experiments of the University of Tübingen, and 
performed well (Triebskorn 2017). The chosen life stages for my experiments were either eggs within 
24 h of fertilisation, or juvenile fish of four to seven months post hatch.  
All experiments with juvenile brown trout, and tests with larvae that continued over the time of 
consumption of the yolk sac, were approved by the animal welfare committee of the Regional Council 
of Tübingen, Germany (authorization ZP1/12). 
Experimental design 
The studies with brown trout consisted of seven separate experiments: 
[1] May 21st 2014 – June 17th 2014: First exposure of juvenile brown trout to diclofenac (repetition 
necessary due to high control mortality). 
[2] July 29th 2014 – August 28th/29th 2014: Exposure of juvenile brown trout to metoprolol (final 
sampling carried out over two days). 
[3] December 1st 2014 – April 7th 2015: Exposure of brown trout embryo and sac-fry stages to 
diclofenac and metoprolol. 
[4] December 15th 2014 – March 31st/April 14th 2015: Exposure of brown trout embryo and sac-
fry stages to wastewater treatment plant effluent under semi-field conditions (control 
sampled at later time point, due to slower development). 
[5] December 15th 2014 – May 13th 2015: Exposure of brown trout embryo and sac-fry stages to 
wastewater treatment plant effluent under lab conditions.  
[6] July 10th 2015 – August 3rd 2015: Repeated exposure of juvenile brown trout to diclofenac. 
[7] September 15th – October 13th 2015: Exposure of juvenile brown trout to mixtures of 
diclofenac and metoprolol (excluded from this thesis). 
Juvenile brown trout – pharmaceutical exposure (Experiments 1, 2, and 6, described in chapter III) 
The experiments on juvenile brown trout took place in a thermoconstant chamber (settings: 12 h/12 h 
light/dark; 8 °C [experiment 1 and 2], 7 °C [experiment 6]) at the University of Tübingen (Auf der 
Morgenstelle 28, 72076 Tübingen). In the first diclofenac exposure experiment [experiment 1], test 
animals aged ca. 4 month post hatch. Because these young animals performed poorly, I chose to use 
older individuals (ca. 6 months post hatch) for the metoprolol [experiment 2] and second diclofenac 
[experiment 6] exposure. All test solutions were prepared from aerated, filtered tap water (iron filter, 
active charcoal filter, particle filter). Five test concentrations (1st diclofenac: 0.1, 0.5, 1, 10, 100 µg/L; 
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2nd diclofenac: 0.1, 1, 10, 100, 200 µg/L; metoprolol: 0.1, 1, 10, 100, 1000 µg/L – all concentrations 
referring to the base, not the salt) and one control were tested in triplicates, arranged in a randomized 
block design. Each replicate was an individually aerated 25 L glass aquarium containing 13 individual 
fish. Overall, 18 aquaria with 234 fish were used for each experiment. All aquaria were shaded from 
direct light with black plastic sheets. Animals were fed daily with commercial trout feed (1.5 mm, 
Biomar, Brande, Denmark). Twice per week, 1/3 of the test medium was renewed, and excess food 
and faeces removed.  
The first diclofenac experiment lasted 27 days, except the 100 µg/L treatments, which had to be 
terminated already after 14 days due to high mortality of the exposed fish. The metoprolol experiment 
was terminated on days 27 and 28 of exposure. The additional day was necessary, since the number 
of individual fish was too large to be sampled on one single day. In the second diclofenac experiment, 
sampling took place on day 24 – three days earlier than intended. This was due to the high mortality 
in the two highest test concentrations. The earlier sampling made sure that a sufficient number of 
samples for biomarker analysis was available. Fish were anesthetized and killed by an overdose of 
tricaine mesylate (MS-222, 1 g/L, pH 7), followed by a neck-cut. Body length and weight were 
measured, and the individual fish were checked for apparent peculiarities, especially bite marks as sign 
of aggressive behaviour. Histological samples of liver, gill, kidney and heart were fixed in 
glutardialdehyde. Samples of liver, head [experiment 1], and trunk kidney [experiment 6], intended for 
biochemical analyses, and of the remaining fish, intended for chemical analyses of the test substance, 
were snap frozen in liquid nitrogen and stored at -80 °C until further processing. Endpoints of interest 
were survival, body length and weight, marks of aggressive behaviour, levels of the stress protein 
Hsp70 in liver, lipid peroxides in head or trunk kidney, and histological status of liver, kidney, gill and 
heart (only for metoprolol).  
To control for effects of the laboratory exposure itself, I conducted five samplings directly at the fish 
breeding facility. Samplings took place on May 9th2014, July 11th 2014, September 3rd 2014, July 7th 
2015 and August 8th 2015. In this way, the samplings roughly corresponded to the start and end points 
of the juvenile experiments. At each time point, 20 fish were sampled in the same manner as described 
for the exposure experiments.  
Brown trout embryo and sac-fry stages – pharmaceutical exposure (experiment 3, described in chapter III) 
Testing followed the OECD guideline 212 – short term toxicity test on embryo and sac-fry stages (OECD 
1998). The complete experiment took place in a thermo-constant chamber (settings: 10 h/14 h 
light/dark; 7 °C). Per replicate, 30 freshly fertilized eggs (within 24 h of fertilisation) were exposed in 
200 mL glass petri dishes. Because early developmental stages of trout are susceptible to light 
(Hamdorf 1960), the eggs remained in complete darkness until they reached the eyed ova stage. Five 
concentrations of diclofenac (0.1, 0.5, 1, 10, 100 µg/L), five concentrations of metoprolol (0.1, 1, 10, 
100, 1000 µg/L) and one water control were tested in triplicates. Test solutions were prepared from 
artificial water, consisting of deionized Millipore-filtered water combined with essential electrolytes 
(see appendix). Aeration of the single vessels was not possible, as eggs and larvae are highly sensitive 
to agitation (Crisp 1996). ¾ of test medium were renewed every second day.  
In the course of 127 days, fertilized eggs developed to fully grown larvae. At the time, where the yolk 
sac was fully consumed and the larvae would transcend to a free-feeding stage, the exposure was 
terminated. Larvae were killed by an overdose of tricaine mesylate (MS222, 1 g/L, pH 7). Three larvae 
per replicate were cut into a proximal part (containing brain, gills and heart) and distal part (containing 
liver, kidney and alimentary system) - and subsequently fixed in glutardialdehyde solution. The 
remaining 18 – 27 larvae (depending on mortality rates) were snap frozen in liquid nitrogen. Although 
there is detailed information on the various stages of brown trout embryogenesis (Killeen et al. 1999a), 
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I only concentrated on selected developmental parameters. I focused on easily visible and assessable 
developmental stages: eyed ova stage, hatching and yolk-sac resorption. Other investigated 
parameters in the experiment were survival, heart rate seven days post hatch, body mass and, 
exemplarily, histology of kidney. I restricted the histological analysis to kidney, because reported 
reactions are supposedly strongest in this organ, and the gills were only weakly developed in the 
examined life stage.  
Brown trout embryos and sac-fry stages – exposure in wastewater treatment plant effluent (experiments 
4 and 5, described in chapter V) 
The test system at the wastewater treatment plant consisted of two 250 L flow-through aquaria. A first 
trial of the experiment, without previous cooling of the water, was unsuccessful, as all eggs coagulated 
within two weeks. Therefore, effluent water after flocculation filtration was cooled down to 
approximately 9 °C and directed into the first aquarium for aeration. From the first aquarium, water 
flew into the second aquarium, where the actual exposure took place. Six stainless steel sieves were 
placed in the aquarium, each containing 50 freshly fertilized eggs. A control setup was not possible 
directly at the treatment plant. Instead, we installed a control flow-through aquarium receiving its 
water directly from the Lake Constance (ISF – Institut für Seenforschung; Argenweg 50/1, 88085 
Langenargen). Since this water was already cool and oxygen-rich, additional cooling and aeration was 
not necessary. Like at the WWTP, exposure took place in six stainless steel sieves placed in a 250L 
aquarium, each containing 50 individual eggs. After consumption of the yolk sac, fish were fed with 
commercial trout feed (1.5 mm, Biomar, Brande, Denmark). Exposures were terminated three weeks 
after consumption of the yolk sac, which was after 106 days at the WWTP and 120 days at the control 
station.  
In addition to the semi-field exposure, wastewater treatment plant effluent samples were tested in a 
laboratory experiment at the University of Tübingen (Auf der Morgenstelle 28, 72076 Tübingen). Grab 
samples from the effluent aquarium were transported to the laboratory and frozen at -20 °C until 
further use. The thermo-constant chamber was set to 7 °C; light conditions were complete darkness 
until the embryos reached the eyed ova stage, afterwards a 10 h/14 h light/dark cycle was applied. 30 
freshly fertilized eggs were placed in 200 mL petri dishes filled with either tempered, aerated effluent 
or artificial water. Six replicates were set up for each treatment. Exposure lasted until the yolk sac was 
fully consumed – which was 149 days.  
Larvae were killed by an overdose of tricaine mesylate (MS222, 1 g/L, pH 7), four individuals per sieve 
[experiment 4]/ three individuals per petri dish [experiment 5] fixed in cacodylate-buffered 
glutardialdehyde and the remaining individuals were snap frozen in liquid nitrogen. Examined 
endpoints were survival, time until eyed ova stage, time until hatch, heart rate seven days post hatch, 
body mass, lipid peroxides (full body) and kidney histology. 
Additional exposure experiments in Eff-Pharm with invertebrates, from which samples were 
provided for biomarker analyses 
Besides brown trout, invertebrates were examined with respect to their responses to diclofenac and 
metoprolol. Since the experiments were conducted by cooperation partners, who sent samples for 
biomarker analyses, the design of these experiments is only described briefly. Further details are given 
in the respective sections of the final report (Triebskorn et al. 2017). 
Tests with Gammarus fossarum (conducted by GWT-TUD GmbH, Dresden, described in chapter IV 
and V) 
Gammarids, like Gammarus fossarum (Koch, 1835), are an important part of riverine zoobenthos. 
Although not regularly studied in ecotoxicological tests with pharmaceuticals, they are of crucial 
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importance in Central European stream ecosystems. In riverine ecosystems, the genus Gammarus 
usually occurs in great abundance, which makes them the dominant macroinvertebrates in terms of 
biomass. They are commonly regarded as “shredders” that feed on detritus, dead plant material and 
biofilms (“aufwuchs”), but can also flexibly use a wide range of other food. Their feeding behaviours 
include carrion feeding, cannibalism and predation on other macroinvertebrates, as well as weakened 
vertebrates or fish eggs (MacNeil et al. 1997). They are abundant throughout the year, making them a 
highly important food source for fish, but also other vertebrates and macroinvertebrates. Therefore, 
gammarids are of high ecological relevance for lotic and lentic ecosystems (MacNeil et al. 1999). 
G. fossarum applied in the studies originated from a wild population in the Tännichtgrundbach (first-
order stream northwest of Dresden, Germany – which is reportedly free from domestic and industrial 
wastewater). They were used for single substance exposures, as well as mesocosm studies and the 
wastewater treatment plant exposure experiments: 
Single substance exposure (described in chapter IV) 
Briefly, gammarids were exposed to five concentrations of diclofenac (0.49, 1.48, 4.44, 13.33 and 40 
mg/L) or metoprolol (5, 15, 45, 135, 405 mg/L) plus an untreated control over 40 days at 15 °C. Each 
treatment was replicated four times, with 20 individuals per replicate. Besides mortality and 
reproductive parameters, stress proteins and lipid peroxides were examined. In addition to the 
exposed animals, a small portion of the test animal stock at experimental start served as t0-control, to 
investigate the effects of time and overall handling.  16-19 samples per treatment from the diclofenac 
exposure were available for stress protein analyses, and 13-17 samples for examinations of lipid 
peroxidation. From the metoprolol experiment, 30-34 samples were used to investigate stress protein 
levels. Lipid peroxidation was not examined for this experiment. 
WWTP exposure (described in chapter V) 
For the WWTP effluent exposure, gammarids were taken from the stream and subsequently 
transported to the WWTP Eriskirch (described above). As a t0-control, 100 individuals were snap frozen 
in liquid nitrogen before the experiment began. At the WWTP, the animals were placed in 11 glass 
tubes with 20 gammarids and 10 preconditioned leaves of Alnus glutinosa each. These were exposed 
in the flow-through aquarium described previously for brown trout, without previous cooling of the 
water. A control setup was established at the Tännichtgrundbach, with steel cages, containing the glass 
tubes, directly exposed in the stream. Each exposure lasted for 40 days, after which 100 randomly 
chosen gammarids from the WWTP exposure and 70 from the stream exposure were sampled and 
snap frozen in liquid nitrogen. The differing sample sizes were due to higher mortality in the stream 
exposure. All samples stored at -20 °C until further processing and biomarker analyses.  
Tests with Daphnia magna (conducted by UBA, Berlin-Marienfelde, described in chapter IV) 
The water flea Daphnia magna (Straus, 1820) is one of the most well-known species of the crustacean 
order Cladocera. They inhabit small surface waters, like ponds and puddles, in high abundance. 
Females reach lengths up to 6 mm, males usually only around 2 mm (Bellmann 1991 ). Daphnia magna 
is an important part of zooplankton and a substantial food source for larger aquatic animals. As primary 
consumers, they feed on algae, detritus and bacteria filtered from the water. Their carapax opens to 
the ventral side, covering the legs, which are used for filtration. For locomotion, the species relies on 
its branched secondary antennae. Daphnia magna is one of the most commonly tested species in 
regulatory ecotoxicology. This is mainly due to the easy handling in the lab and fast, usually 
parthenogenetic reproduction. When environmental conditions are unfavourable, females produce 
male offspring and populations switch to sexual reproduction. After copulation, females produce 
ephippia, which can survive for several years. At controlled conditions, a culture can be maintained in 
parthenogenetic reproduction over many generations. In this case, the culture consists solely of female 
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animals, and offspring are largely genetically identical to their mother animal. As a side benefit, this 
reduces the effect of genetic confounding factors in experimental setups (Fomin et al. 2003). 
Experiments followed OECD guideline 211 (OECD 2012), and were performed with diclofenac and 
metoprolol over 21 days. Test concentrations were 1.9, 6.25, 12.5, 25 and 50 mg/L diclofenac and 0.1, 
0.5, 2.5, 10 and 25 mg/L metoprolol. Besides survival and reproduction, which were evaluated by the 
project partners, I examined the levels of the stress protein Hsp70 more closely in Chapter IV. 
Tests with the endobenthic oligochaete Lumbriculus variegatus (conducted by University of 
Frankfurt am Main, described in chapter IV) 
Lumbriculus variegatus (Müller, 1774) is a sediment-dwelling oligochaete with wide distribution area. 
It reaches lengths of 40 to 90 mm and widths of 1.5 mm, and is coloured red or brown. It can reproduce 
sexually, but also asexually through splitting (morphallaxis). Usually, it populates the ground area of 
surface waters, where it feeds on substrates in the sediment (Grabow 2000). Hence, the examination 
of this organism allowed a closer look on the effects of diclofenac and metoprolol in an endobenthic 
organism. Through sediment dwelling and sediment-ingestion, the animal is in constant, internal and 
external contact with substances bound to sediment particles. The experiments in Eff-Pharm followed 
OECD guideline 225 (OECD 2007), and exposed the organism to diclofenac- and metoprolol-spiked 
sediment over 28 days. Apical endpoints in the original tests were only survival and reproduction. 
Additionally, another test was carried out per substance, with a modified range of test concentrations 
(0.039, 0.078, 0.156, 0.312, 0.62, 1.25, 2.5, 5 and 10 mg/kg) and the intention to provide samples for 
my analyses of lipid peroxides and stress proteins in Chapter IV.   
Tests with the mudsnail Potamopyrgus antipodarum (conducted by University of Frankfurt am 
Main, described in chapter IV) 
The freshwater mudsnail Potamopyrgus antipodarum (J.E. Gray, 1843) originates from New Zealand, 
but has spread to Europe in the mid-19th century. It lives in freshwater as well as brackish water, and 
has become one of the most abundant gastropods in European surface waters. Their cone-shaped 
shells are coloured red or brown, and reach a height of 4 to 6 mm (Grabow 2000). It dwells in and on 
sediments of stagnant and slow-flowing water, where it feeds on detritus, algae and biofilms (Fomin 
et al. 2003). Recently, it became a popular model species to assess toxicant effects in molluscs. The 
species has the ability to reproduce parthenogenetically, can be kept easily at lab-conditions and has 
a fast reproduction cycle, making it an ideal testing organism to assess reproductive toxicity. 
Experiments were performed according to OECD guideline 242 (OECD 2016), over 28 days with 
metoprolol as testing item. Nominal test concentrations were 0.1, 0.32, 1, 3.2 and 10 mg/L. In addition 
to an untreated negative control, a positive control with 25 ng/L 17α-ethinylestradiol and a 
corresponding solvent control with 10 µg/L DMSO were included in the experimental setup. Solvent 
was only present in the solvent and positive control, not in the negative control or the metoprolol 
treatments. Standard endpoints were mortality and reproduction, evaluated by the project partner, 
but I extended the investigation by analysing stress protein levels in Chapter IV.  
P. antipodarum was only exposed to metoprolol, not diclofenac.  
Mesocosms: Artificial indoor streams (AIS) (conducted by GWT-TUD GmbH, Dresden, described 
in chapter IV) 
To take one step further towards a more realistic exposure scenario, gammarids, oligochaetes and 
gastropods were exposed in artificial indoor streams. These flow-through mesocosms, placed in a 
greenhouse at the TU Dresden, simulate the conditions of small stream ecosystems. The purpose was 
to examine the combined effect of metoprolol exposure and natural stressors, i.e. stream velocity.  
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In each AIS, the test medium had a different concentration of metoprolol (nominal: 0, 0.47, 1.9, 7.5 
and 30 mg/L – measured: 0, 0.22, 0.74, 2.95, 21.95 mg/L). Water temperature was 15 °C and current 
velocity 0.15 m/s. Gravel and stones of various size classes provided a typical environment for the test 
species, but organisms were also kept in enclosed, water-permeable vessels within the stream. The 
system ran for 16 days before the experiment started, which subsequently lasted for 40 d. The pre-
application period was necessary to establish microbial and algae growth (“aufwuchs”) in the stream 
as food source for the exposed invertebrates. Preconditioned alder leaves (Alnus glutinosa) served as 
another food source. In each stream, 165 G. fossarum, 50 individuals of P. antipodarum and 200 L. 
variegatus were exposed without exposure vessels and therefore move freely. Furthermore, six vessels 
with 10 L. variegatus each, six vessels with 20 P. antipodarum each and three vessels with 20 G. 
fossarum each were exposed in each indoor stream. After 28 d, half of the exposure vessels containing 
Lumbriculus and Potamopyrgus were sampled (corresponding to the duration of the normal OECD 
tests). All other organisms were sampled when the experiment was terminated after 40 d. 
Biomarker analyses 
Stress proteins 
Stress proteins, or “heat shock proteins” (Hsps) are a highly conserved group of proteins that are found 
in vertebrates as well as in invertebrates and bacteria (Sanders 1993). They are a diverse group of 
cytoplasmic proteins, which act as chaperones - with vital functions in the correct folding, assembly 
and transmembrane passage of proteins, as well as signal transduction processes (Köhler 2009). Other 
than their original name “heat shock proteins” would suggest, stress proteins may not only be induced 
by heat, but by a wide range of stressors. Furthermore, the presence of these proteins alone is no sign 
of stress, since many of them are present at normal conditions to maintain cellular processes. Stress 
protein concentrations are modulated on the one side by internal factors, e.g. during developmental 
and ontogenetic processes, but also by external stressors. In general, their synthesis is up-regulated as 
response to proteotoxicity (Sanders 1993). According to their molecular weight, Hsps are divided into 
four major families: Hsp90, Hsp70, Hsp60 and low molecular Hsps (Sanders 1993). The most highly 
conserved and largest of those families is Hsp70. Molecular similarity between Hsp70 in different phyla 
is very high (Sanders 1993). The production of new Hsp70 is directly dependent on the intracellular 
concentration of misfolded proteins. Under physiological/unstressed conditions, Hsp70 is bound to the 
protein Hsf (heat shock factor). Misfolded peptides competitively replace Hsf in binding to Hsp70, 
leading to the release of free Hsf. Trimerized Hsf binds to the hse (heat shock element) DNA sequence, 
setting further transcription of Hsp70 genes, and finally synthesis of Hsp70-protein in motion. If 
proteotoxic stress is increasing, so do the concentrations of Hsp70 to counteract protein damage 
(Morimoto 1993). Hence, stress proteins can be used as a biomarker of proteotoxic stress (Lewis et al. 
1999).Various phyla, including fish (Iwama et al. 1998) and aquatic invertebrates (Sanders 1993) 
increase their stress protein synthesis in response to temperature changes, but also chemicals and 
other environmental stressors. However, very high stress intensity also damages the Hsp70-system 
itself, or depletes the energy resources necessary for their synthesis. Consequently, the reaction of 
intracellular levels of Hsp70 to increasing stress intensity follows an optimum curve. After an increase 
at medium stress intensities, the internal concentrations decrease again after the system is 
overwhelmed by high stress. Therefore, analytics of Hsp70 should preferably be used in combination 
with structural biomarkers (Köhler et al. 2001).  
For the analyses presented in this thesis, the levels of the protein itself were quantified via SDS-PAGE, 
coupled to a quantitative immunostaining. Such immunoassays are widely applicable because of the 
broad crossreactivity of Hsp70 antibodies, owing to the high degree of similarity between different 
phyla (Sanders 1993, Lewis et al. 1999). 
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Method 
Depending on the investigated organism, stress protein analyses were performed on different tissue 
types. For Salmo trutta f. fario, I chose to use liver samples. In the case of Gammarus fossarum single 
individuals were used in toto. Because single individuals were too small, pools of two individuals were 
used for Daphnia magna, three for Lumbriculus variegatus and four to six for Potamopyrgus 
antipodarum. Up to processing, all samples remained stored at -80 °C. 
Frozen samples were mechanically homogenized on ice in extraction medium (consisting of 98 % 
concentrated extraction buffer (see appendix) and 2 % protease inhibitor; for L. variegatus, this ratio 
was changed to 96 % extraction buffer and 4 % protease inhibitor). For trout liver, the added volume 
of extraction medium was adjusted to the sample mass (dilution: 1:7).  Volumes of extraction medium 
were 50 µL for G. fossarum, 60-90 µL for P. antipodarum (depending on the pool size), 40 µL for 
L. variegatus and 40-60 µL for D. magna. Homogenized samples were centrifuged at 4 °C and 20000 
rcf for 10 min (Eppendorf 5424R). 5 μL of the supernatant were diluted with 245 μL of 1:10 extraction 
buffer for protein quantification. The remaining supernatant (maximal 60 μL) was diluted with SDS 
buffer (see appendix) in a proportion of two parts supernatant to one part SDS buffer, and boiled at 
97 °C for 5 min. Both mixtures were stored at -20 °C until further usage. 
The protein content was quantified according to Bradford (1976). The tests were performed in 96 well 
plates. A dilution series of bovine serum albumin (BSA) in 1:10 extraction buffer (0.4 mg/mL, 0.2 
mg/mL, 0.1 mg/mL, 0.05 mg/mL, 0.025 mg/mL plus a blank) was used to gain a calibration line. Each 
sample was tested in triplicates. 25 μL of the samples´ supernatant mixture were mixed with 250 μL of 
Bradford mixture (see appendix) and the extinction at 595 nm was measured using an automated 
microplate reader (Bio-Tek Instruments, Winooski VT, USA). 
For the electrophoresis, polyacrylamide minigels (12 % acrylamide, 0.12 % bisacrylamide) were loaded 
with the sample/SDS mixtures. Constant protein amounts (40 μg per sample for S. trutta f. fario, 
G. fossarum, P. antipodarum and D. magna, 60 µg per sample for L. variegatus) were applied to the 
gels, following the results of the Bradford analysis. To allow for a comparison between different gels, 
a standard (S. trutta f. fario full body homogenate) in duplicate was added to every gel. Gel chambers 
were placed in E-buffer + SDS (see appendix). Gels were run for 15 min at a voltage of 80 V, followed 
by 1 h at 120 V to separate the proteins. The proteins were transferred from the minigel to a 
nitrocellulose-membrane via semi-dry Western blot. After the blotting process, the filter was blocked 
in blocking solution (see appendix) for 90 minutes. Subsequently, it was rinsed in TBS for 5 min and 
incubated in the first antibody solution containing monoclonal α-Hsp70 antibody (mouse anti-human 
Hsp70, Dianova, Hamburg, Germany, dilution 1:5000 in 10 % horse serum/TBS) at room temperature 
overnight. 
Following the first antibody incubation, the filter was rinsed in TBS for 5 min and incubated in the 
secondary antibody solution (goat anti-mouse IgG conjugated to peroxidase, Jackson 
Immunoresearch, West Grove, PA, dilution 1:1000 in 10 % horse serum/TBS) for 2 hours at room 
temperature. Then, the filter was rinsed in TBS for 5 min and transferred into the staining solution (see 
appendix) until the protein bands were visibly stained. The reaction was stopped by transferring the 
filter into double-distilled water. 
The filters were dried for one hour and the optical volume (area of bands x average grey value after 
background subtraction) of each protein band was quantified using Image Studio Lite (LI-COR Biosci-
ences, Lincoln, NE). To assure comparability, each sample was related to the Hsp70 standard. 
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Lipid peroxides 
Oxidative stress is among the most common influences aerobic organisms have to cope with. It is 
induced by reactive oxygen species (ROS), like superoxide anions, hydrogen peroxide or hydroxyl 
radicals, which are common by-products of oxidative metabolism. Under physiological/unstressed 
conditions, the generation and clearance of these ROS is in a steady state. If this balance is disrupted, 
oxidative stress arises (Lushchak 2011). This process can, for instance, invoke chain reactions with poly-
unsaturated fatty acids, generating lipid peroxides. Such alterations pose a constant threat for the 
functionality of biological membranes (Valavanidis et al. 2006). Besides internal metabolic processes, 
oxidative stress can be induced by external factors, like temperature, light or chemicals. Without 
effective countermeasures, the oxidation of proteins, lipids and nucleic acids would severely reduce 
an organism’s viability. Usually, these countermeasures include enzymatic and non-enzymatic 
antioxidant defence systems, which counterbalance the effects of ROS. Non-enzymatic defence is 
provided e.g. by radical scavengers or oxygen quenchers. Common molecules are e.g. α-tocopherole, 
β-carotene, ascorbate or flavonoids. Enzymatic defence is given primarily by superoxide-dismutase 
(SOD), catalase (CAT) and glutathione-peroxidase (GSH-Px), supported by a range of ancillary enzymes. 
Consequently, the activity of these enzymes increases when an organism is exposed to oxidative stress. 
Additional to these defence systems, which catch free ROS and render them harmless, cells feature 
various other mechanisms to prevent the formation of ROS or repair inflicted damages (Sies 1993, Sies 
1997).  
Regardless, situations may arise where the antioxidant system is overwhelmed, leading to an 
imbalance of production and reduction of ROS. In these situations, products of reactive processes, like 
lipid peroxides or carbonylated proteins may be present in greater amounts and compromise cellular 
function (Valavanidis et al. 2006).  Still, it must not be forgotten that oxidative products can also play 
key roles in vital cellular functions. Phagocytes release oxidative and lytic enzymes, as well as ROS as a 
measure of host defence against pathogens (Sies 1993, Bonga 1997). Furthermore, the production of 
prostaglandins is dependent on the peroxidation of arachidonic acid by cyclooxygenases, the 
enzymatic target of NSAIDs. It is possible that certain pharmaceuticals, like diclofenac, affect activity 
of antioxidative enzymes or levels of oxidative products in a negative or positive way (McRae et al. 
2018). 
There are various ways to analyse oxidative stress. For instance, one can measure the activity of anti-
oxidative enzymes (Sies 1993, Sies 1997). But it is also possible to directly quantify the product of 
oxidative processes, like carbonylated proteins or lipid peroxides. For my studies, I chose to quantify 
lipid peroxides, because I wanted to focus on one of the final products of oxidative stress. While there 
are also other methods available, like the malondialdehyde (MDA) assay or measurement of 
thiobarbituric acid reactive substances (TBARS), I chose the ferrous oxidation xylenol-orange (FOX) 
assay, as it is a simple and reliable method (Hermes-Lima et al. 1995, Monserrat et al. 2003). The 
method is based on the oxidation of bivalent iron (Fe(II)) to trivalent iron (Fe(III)) via peroxides present 
in the sample. At acidic conditions, trivalent iron forms a complex with xylenol-orange, shifting its 
absorbance peak from 440 nm to 580 nm. Consequently, adding the sample to a reaction mixture of 
FeSO4, H2SO4 and xylenol-orange allows quantifying the amount of lipid peroxides via spectrometric 
measurement.  
Method 
The FOX assay procedure was conducted according to a modified version of the protocol proposed by 
Hermes-Lima et al. (1995). Chosen samples were trout heads (incl. cranium, brain, gills and jaw) from 
the first diclofenac exposure and trout kidney from the second diclofenac exposure. Trout larvae and 
gammarids were used in toto, and for testing of Lumbriculus variegatus, pooling of three individuals 
was necessary.  Samples were stored at -80 °C until further processing. The samples were weighed, 
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diluted in a ratio of 1:3 (trout heads), 1:7 (trout kidney), 1:2 (trout larvae) or 1:10 (Gammarus fossarum, 
Lumbriculus variegatus) with cooled HPLC-grade methanol and mechanically homogenized on ice. 
Subsequently, the homogenized samples were centrifuged at 4 °C at 15000 rcf for 5 min. The 
supernatants were stored at -80 °C until further usage. 
The assay was performed in 96 well plates. Each well was filled with 50 μL of 0.75 mM FeSO4-solution, 
50 μL of 75 mM sulfuric acid, 50 μL of 0.3 mM Xylenol Orange solution, 20 μL of sample supernatant 
and 30 μL of double-distilled water (trout head, trout larvae, gammarids, oligochaetes) or 15 µL of 
supernatant and 35 µL of water (trout kidney). Each sample was tested in triplicates, and a sample 
blank, in which the FeSO4 solution was substituted with water. All data were related to a master blank, 
which consisted of 200 µL of double-distilled water. The samples were incubated for 150 min (trout 
head, G. fossarum) / 135 min (trout kidney) / 300 min (trout larvae) / 48 h (L. variegatus) at room 
temperature. The absorbance at 580 nm was measured using an automated microplate reader (Bio-
Tek Instruments, Winooski VT, USA). After the first measurement, 1 μL of 1 mM cumene hydroperoxide 
solution was added to each well. After an incubation period of 30 min (trout) / 60 min (gammarids, 
oligochaetes), the absorbance at 580 nm was measured again. 
All measurements were automatically set in relation to the master blank value. The value obtained for 
the sample blank was subtracted from the sample values. Cumene hydroperoxide equivalents 
(CHPequiv./mg wet weight) were calculated using the following equation: 
CHPequivalents
mg wet weight
=
A580nm
A580nmCHP
∗ volumeCHP ∗
total volume
sample volume
∗ dilution factor 
volumeCHP = 1 µL; total volume = 200 µL 
Histological analyses 
In addition to biochemical markers, I also studied histological alterations of liver, gills, kidney, and heart 
as structural biomarkers. Histological analyses allow the closer examination of organ health and 
integrity. As mentioned before, biochemical markers, like Hsp70, underlie an optimum response 
kinetic and require further information to interpret results. This information can be given by 
histological analyses. The severity of histological continuously increases with stress intensity. Hence, a 
comparison of Hsp70-levels with histopathological effects allows interpreting whether low Hsp70-
levels are due to low stress intensity or to overwhelming of the defence system by high stress. 
Especially for fish, histopathological alterations are highly useful biomarkers because sufficient 
comparative data are available (e.g. Schwaiger 2001, Triebskorn et al. 2001, Schwaiger et al. 1997, 
Gernhöfer et al. 2001, Zimmerli et al. 2007, Wenger et al. 2010, Steinbach et al. 2014a, Wolf et al. 
2015). 
For my analyses, I examined three primary monitoring organs: gills, liver and kidney – all of high 
importance in the uptake, metabolism and excretion of substances. Furthermore, I investigated the 
heart, because of the specific action of beta-blockers on the cardiovascular system.  
Gills 
The gill is not only the major respiratory organ in fish, but also takes part in osmoregulation and 
excretion of catabolites. Teleosts have five pairs of gill arches on each body side, of which only the 
anterior four take part in respiration. From each gill arch protrudes a multitude of primary filaments, 
lined by numerous secondary lamellae on both sides. Primary filaments consist of cartilaginous 
support, vascular system and multi-layered epithelium. A double layer of epithelial cells builds the 
secondary lamellae: supporting pillar cells and pavement cells are arranged in a ladder-shaped order 
to form capillary channels. This filigree structure allows blood flow in close proximity to the 
surrounding water, which is necessary for the efficient exchange of oxygen and carbon dioxide. As the 
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blood flow direction is opposite to the direction of water flow in the gill, gas exchange ability is highly 
efficient. Further cell types frequently found in the epithelium are mucous cells, located at the edges 
of the primary filament, and chloride cells, on the basement of the secondary lamellae (Blüm et al. 
1989, Takashima and Hibiya 1995).  
Since the gill is in constant, close contact to the surrounding medium, it reacts fast and sensitively to 
environmental changes and disturbances. The first reactions to chemical or physical stressors are 
usually hyperthropy or hyperplasia of epithelial cells. Since the chloride cells are involved in 
osmoregulation and excretion, hyperplasia of these cells is a sign of osmotic or chemical stress. Other 
commonly found pathologies include oedema, vacuolation and inflammations as defensive response, 
but also necrotic changes and haemorrhage in the case of serious injuries. When the pillar cell system 
disintegrates, the capillary lumen expands and fills with blood cells – a symptom called aneurysm 
(telangiectasia). In any case, histological samples have to be interpreted with care, as many of the 
described symptoms can also be evoked by handling of the fish and preparation of the sample 
(Takashima and Hibiya 1995).  
Liver 
The liver is a major metabolic gland, with important function in alimentary, as well as detoxification 
processes. Parenchymal hepatocytes cells surround sinusoids or other blood vessels – giving the tissue 
its typical histological appearance. Bile canaliculi collect the bile secreted by the hepatocytes and direct 
it towards the bile duct. Hepatocytes contain a nucleus with a prominent nucleolus and variable 
amounts of heterochromatin. Furthermore, the cells usually contain large amounts of endoplasmic 
reticulum, due to their high activity in protein synthesis. As the liver stores energy reserves in the form 
of glycogen inside the hepatocytes, this energy reserve usually takes up a large portion of the cell. 
Other storage materials are lipids, stored in small to medium-sized droplets dispersed in the cytoplasm. 
A look at these storage materials allows closer insights into the nutritional status and stress of the 
animal, because energy has to be invested for e.g. detoxification. Glycogen can easily be stained via 
Periodic Acid Schiff (Blüm et al. 1989, Takashima and Hibiya 1995).  
Common pathologies observed in hepatic tissue include hypertrophy or atrophy of hepatocytes, 
dilation of intercellular spaces and blood spaces due to shrinkage of the hepatocytes, loss of storage 
materials, and nuclear pycnosis. Another frequent observation is inflammation and increased 
abundance of macrophages. In the case of strong disturbances, the tissue may become necrotic and 
lose integrity (Takashima and Hibiya 1995).  
Kidney 
The major function of the kidney are excretion, osmoregulation and haematopoiesis. It is divided into 
head kidney, deriving from the pronephros and mainly of hematopoietic function, and the trunk 
kidney, deriving from the mesonephros. The functional units within the trunk kidney are nephrons, as 
in all vertebrates. Primary filtration takes place at the “Corpusculum renis”, which consists of the 
“glomerulus”, surrounded by the “Bowman’s capsule”. Primary urine is transported through the 
proximal and distal parts of the renal tubuli, where proteins and electrolytes are resorbed. The 
resorption of these substances is especially important in freshwater fish, which have to excrete large 
amounts of water entering the body via the gills. Eventually, the urine is excreted via the collecting 
duct and ureter. The glomerular filer consists of [1] the flat endothelial cell forming the capillaries, [2] 
the basal lamina underlying these cells, and [3] large amounts of podocytes, which are also connected 
to the basal lamina from the opposite site. The glomerular capsules consist of a fibrous outer layer of 
connective tissue and an inner epithelium, continuing into the renal tubular epithelium. Tubuli are 
formed by tubulus cells surrounding the lumen, surrounded by a layer of smooth musculature. The 
cells of the proximal tubulus are prismatic and characterized by a prominent “brush border” of 
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microvilli and high abundance of apical vacuoles. In contrast, distal tubular cells are columnar, clear 
and without clearly recognizable brush border. All nephron structures are embedded in interstitial 
hematopoietic tissue (Blüm et al. 1989, Takashima and Hibiya 1995). 
Common pathologies may manifest in alterations of the glomerulus and surrounding structures, like 
hyperplasia or inflammation. Blood cells, cell debris, and foreign matter can be found in the Bowman’s 
capsule, when the filtration structures are damaged. Typical changes in the renal tubuli are 
hypertrophy or atrophy of cells, or accumulations of proteinaceous matter in the tubular cells – so-
called hyaline droplets. The effect is referred to as “hyaline droplet degeneration” (Schwaiger et al. 
2004). Severe cases of this pathology may eventually lead to necrosis of tubular cells. Anomalies are 
often accompanied by dilated tubular lumen (Takashima and Hibiya 1995).   
Heart  
The heart is the central element of the teleost vascular system. From the heart, low-oxygen blood is 
pumped into the capillary network of the gill. After passing the gills, the oxygen-enriched blood flows 
directly towards the organs. After supplying the organs with oxygen, the blood returns to the heart. 
Here, the blood enters into the sinus venosus and passes through the atrium and ventricle before 
leaving the heart again through the bulbus arteriosus. All parts of the heart consist of three elements: 
first, an internal membrane, the endocardium, composed of endothelial cells and connective tissue.  
Second, an intermediate layer – made of muscle in atrium and ventricle, but connective tissue in the 
sinus venosus and bulbus arteriosus. Third, an external membrane, the epicardium, which consists of 
epithelial cells and connective tissue. The wall of the ventricle is thick and rich in muscle, while the wall 
of the atrium is thin and does only contain few muscle fibres. Cardiac muscle appears special in such 
way that its fibres consists of one cell body with only one central nucleus and the fibres bifurcate to 
form am complex, mesh-like structure (Blüm et al. 1989, Takashima and Hibiya 1995). 
Pathological changes of the heart include necrosis of heart muscle cells, but also inflammations of 
cardiac muscle (myocarditis), endocardium or epicardium – characterized by accumulations of 
leucocytes (Takashima and Hibiya 1995). 
Method 
Histological examinations were done for samples of trout gill, kidney, liver, and – only for metoprolol-
exposed animals - heart. The tissue samples were fixed in 2 % glutardialdehyde (dissolved in 0.1 M 
cacodylate buffer, pH 7.6) and stored at 4 °C until further processing. Since the scope of the study 
included only an exemplary overview on the histological effects, three samples per block and 
treatment were investigated, resulting in nine samples per concentration. 
Prior to embedding, the tissue samples were washed three times for ten minutes in 0.1 M cacodylate 
buffer, followed by three times ten minute washing steps in 70 % ethanol. For gills and kidney two 
additional steps for decalcification in a 1:2 mixture of concentrated formic acid and 70 % ethanol was 
added between these steps (1. step 30 min; 2. step 24 h). Further dehydration and embedding in 
paraffin took place in an automated tissue infiltrator (TP 1020, Leica, Wetzlar). 
Histological sections were cut with a sledge microtome (SM 2000 R, Leica, Wetzlar) set to a thickness 
of 3 μm. One part of the slices was stained with haematoxylin-eosin-staining (to visualize nuclei, 
cytoplasm, connective tissue and muscles), the other part with alcian blue-PAS-staining (to visualize 
mucus, glycogen and the fine structures of renal tubuli). 
In a first evaluation step, slides were examined qualitatively to gain an overview and identify occurring 
pathologies. The second step was a semi-quantitative assessment performed in an observer-blinded 
way. The two slides per sample (AB-PAS/HE) were paired, the inscriptions masked, mixed and a random 
number was assigned to each slide pair. Each sample was classified into one of five different categories 
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(1: control, 2: slight reaction, 3: medium reaction, 4: strong reaction, 5: destruction) according to the 
criteria published by Triebskorn et al. 2008. 
Chemical analyses (conducted by TZW) 
To assure that fish were actually exposed to the indicated pharmaceutical concentrations, test media 
of all experiments were sampled regularly. At water sample of each single replicate and a mixture 
sample of all replicates belonging to the same treatment group was taken at the start of the 
experiment, before and after the first medium change, and at the end of the experiment. The 
immediately frozen samples remained stored at -20 °C until further analyses.  
As resources for chemical analyses were limited, we did not analyse all samples. In all cases, the 
mixture samples from test start were analysed. If irregularities or strong deviations from nominal 
concentrations were found, the single samples were checked. Resources were allocated to the 
experiments, where strong effects were visible. Hence, we analysed the water samples from test end 
and biota samples for the second diclofenac experiment [experiment 6].  
The project partner TZW carried out the actual analyses. If necessary, aqueous samples were enriched 
by solid-phase extraction (SPE). Diclofenac and metoprolol were analysed by high performance liquid 
chromatography (HPLC, 1290 series, Agilent, Waldbronn, Germany) coupled to tandem mass 
spectrometry (MS/MS, API 5500, AB Sciex, Foster City, USA) by multiple reaction monitoring in positive 
mode by electrospray ionization. For quantitative analyses, the isotopically labelled standard 
diclofenac-d4 was used for the correction of signal enhancement or suppression caused by matrix 
components. 
Biota samples were freeze-dried, pooled (to achieve the required amount of sample) and 
homogenized. Turtle food (Engergil, JBL GmbH, Neuhofen, Germany) containing complete freeze-dried 
fish and crustaceans was used as co-extracted matrix. Samples were extracted in an ultrasonic bath, 
centrifuged and the supernatant blown down to dryness.  The dry residue was reconstituted and 
injected into the LC-MS/MS system. A matrix matched calibration with turtle food was prepared for 
quantification. For the analysis of biota, samples were treated with the same analytical 
instrumentation as described for water samples. All samples were spiked with the isotopically labelled 
internal standard diclofenac-d4 for the correction of matrix effects. 
The detailed procedures are described in the final Eff-Pharm report (Triebskorn et al. 2017). 
Statistical evaluation 
Statistical analyses were carried out using R 3.2.1 (packages: lme4, lmerTest) and SAS JMP 11. For 
parametric tests, data were checked for normal distribution visually via quantile-quantile-plots and 
histograms; homogeneity of variance was tested with either Levene’s or Fligner-Killeen-Test.  
For most organisms/endpoints, a lowest observed effect concentration (LOEC) and no observed effect 
concentration (NOEC) were derived, if possible. The LOEC is defined as the lowest tested 
concentration, at which a statistically significant difference to the control is visible. The NOEC is the 
highest tested concentration without statistically significant difference to the control. 
Experiments with brown trout 
Fish mortality data were analysed using COX-regression, with experimental block as nesting factor. 
Juvenile length and body mass were analysed with nested ANOVAs, stress protein and lipid peroxide 
levels with linear models, including experimental block as cofactor. In the case of lipid peroxides in 
[experiment 6], data had to be log10-transformed and sample mass was used as additional covariate. 
The occurrence of bite injuries was analysed via generalized linear mixed model (binomial distribution, 
aquarium identity as random factor). The general significance level was set to α=0.05, but was adjusted 
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via sequential Bonferroni when multiple comparisons had to be made. In cases where no differences 
between groups were visible, I went without mathematical testing. Since all histological analyses were 
exemplary, and not carried out for all individuals, I stuck to descriptive statistics for those parameters. 
All results from hatchery controls were only used as qualitative references and omitted from 
mathematical analyses.  
Experiments with invertebrates 
If necessary, data were transformed to fit the assumptions of parametric testing. The respective 
transformations are given in the results section. For the single substance treatments, mean body mass, 
stress protein and lipid peroxidation levels were compared with either one-way ANOVA, when 
homogeneity of variance was given, or Welch-ANOVA for unequal variances. If a significant overall 
difference was found, Tukey-Kramer post hoc tests were used to identify differences between single 
treatments. In the WWTP and AIS exposure, treatments were compared using linear models. The 
general significance level was set to α=0.05. 
Pseudoreplication 
An obvious problem with the investigated mesocosm system and the WWTP-exposure is 
pseudoreplication (Hurlbert 1984). The project did not offer the resources to test multiple replicates 
of each complex treatment. Nevertheless, we decided that these experiments under more realistic 
conditions were useful and should be conducted despite the experimental limitations. 
For the mesocosm experiment, only five artificial indoor streams were available, which did not allow 
real replication of the treatments. One measure to ameliorate this problem was to expose the 
organisms in several separate enclosures inside each stream. This may prevent initially small-scale 
events from affecting the whole system, but the general pseudoreplication problem could not be 
solved. We chose to conduct the experiment, and interpret the results with care and based on 
biological plausibility. First, we had the results from the single-substance exposure in the laboratory as 
reference to interpret the results. Second, the testing of an ascending range of concentrations allowed 
identifying potential concentration-response-relationships. Especially in cases, where no clear 
concentration-response is visible, the results may be influenced by factors other than the treatment 
and have to be treated with utmost care. However, if a clear relationship is visible, this is a strong sign 
of biological plausibility. Third, the results obtained for different organisms and different endpoints in 
the same system can support each other. If several metrics point to the same direction, this is again a 
sign of biological plausibility.  
In the semi-field exposure, I had only one aquarium at the WWTP and one at the control station. 
Organisms were exposed in separate compartments within the aquarium to prevent small 
disturbances from affecting all test organisms, but the treatment remained without real replication. 
Even if there had been several different aquaria at each station, pseudreplication would have persisted 
because the aquaria would have shared the same influent. My conclusions drawn from this experiment 
are therefore of qualitative, andecdotal nature. To cope with this problem, at least to a certain extent, 
I initiated the laboratory experiment with WWTP effluent samples. This allowed a higher degree of 
control over experimental conditions and better possibilities for replication, but simultaneously 
reduced the degree of realism.  The conclusions from both experiments are restricted to the 
investigated WWTP in Eriskirch and cannot be generalised to other WWTPs. Interpretation in a broader 
context will only be meaningful in combination with results from other studies on WWTP effluent 
effects.  
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8. Results and Discussion 
Chapter I: Literature study  
Report: Triebskorn et al. 2014 - From theory to reality – Evaluation of suitable organisms and test 
systems for the biomonitoring of pharmaceuticals. Part I: Literature review 
Aims 
The first chapter is based on part 1 of Eff-Pharm, which consisted of a comprehensive literature review, 
split into two parts A and B. Part A identified suitable test substances and organisms for further in vivo 
investigations. Part B collated the basic background and possible methods for the creation of in vitro 
test systems. As the focus of the thesis rests on the in vivo examinations, this chapter refers to part A 
of the literature review only.  
In a previous project funded by the UBA, Bergmann et al. (2011) collected monitoring and effect data 
on pharmaceuticals from published literature, which served as a basis for our own study. Studies on 
pharmaceutical effects, published between 2011 and 2013, were collected and evaluated. In 
combination with our own results, this evaluation had the following goals: 
1) Identification of suitable substance groups for further testing. 
2) Overview on the amount of published data for specific pharmaceutical and organism groups. 
3) Identification of sensitive test organisms and biota groups, where information is lacking. 
4) Compilation of lowest observed effect concentrations (LOECs) for priority pharmaceuticals. 
5) Assessment of mixture toxicity effects.  
6) Assessment of population relevance of the extracted effect endpoints. 
7) Assessing reliability/credibility of studies reporting low effect concentrations. 
Results 
The initial screening of literature databases yielded 452 publications, which were analysed more 
closely. 232 were of direct relevance by providing effect data on one or several of the 90 
pharmaceuticals of interest. 95 publications provided additional information on the overall topic.  
In style of the original database created by Bergmann et al. (2011), which was named OEKOTOX, we 
called the newly generated database OEKOTOXupgrade. It contained 1678 entries, extracted from the 
232 relevant publications. The much higher number of entries is explained by the fact that many 
publications contained information on multiple pharmaceuticals, species, or effect endpoints.  
The most frequently addressed drug classes were antibiotics, non-steroidal anti-inflammatory drugs 
(NSAIDs), anticonvulsants, antiparasitics, beta-blockers, and contraceptives. The by far most 
frequently investigated organism group was fish (based on the number of publications). It was followed 
by molluscs, plants/algae, crustaceans, and bacteria – which were all investigated in roughly the same 
number of studies. Only a small number of studies investigated protists, tetrapods, insects, or whole 
communities. Although we found studies on 144 different species/community types, only 49 species 
were investigated in more than one study. Only Cyprinus carpio, Danio rerio, Oncorhynchus mykiss, 
Oryzias latipes, Pimephales promelas, Pseudokirchneriella subcapitata, Daphnia magna, Dreissena 
polymorpha, and Mytilus galloprovincialis were examined in more than five different studies.   
In the evaluation of relevant pharmaceutical classes, organism groups, and effect endpoints, the 
results have to be interpreted with care. Doubtless, the data are biased. As mentioned before, certain 
substance classes and organism groups are investigated more frequently than others. Therefore, there 
is a higher probability to find relevant effect data for these classes and groups. A first screening of the 
lowest LOECs extracted from the studies identified protozoans, represented by only the species 
Tetrahymena pyriformis, as most sensitive organism group. The species, investigated by the endpoint 
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chemotaxis behaviour, showed extremely low effect concentrations for eight substance classes. 
However, all data originated from a single publication, which was also judged as being not sufficiently 
reliable. Other sensitive organism groups were molluscs and fish. Other sensitive effect endpoints were 
behavioural alterations, vitellogenin induction, growth, reproduction, histopathological changes, 
molecular stress biomarkers, oxidative stress biomarkers, receptor binding and gene expression 
changes.  
The actual assessment of relevance compared the obtained LOECs with measured environmental 
concentrations (MECs), provided by the UBA. This deviates from regular pharmaceutical risk 
assessment, where predicted no-effect concentrations (PNEC - calculated by dividing a NOEC by an 
appropriate assessment factor) are compared to predicted environmental concentrations (PEC). 
Consequently, the quality of the resulting MEC/LOEC quotient cannot be directly compared with a 
usual PEC/PNEC risk quotient. While a PEC/PNEC-quotient higher than one indicates a risk for the 
environment – with a high margin of safety, a MEC/LOEC-quotient higher than one indicates that 
environmental effects are to be expected. We considered substances with a MEC/LOEC-quotient 
higher than 0.1 as highly relevant, which would include a small safety factor of 10. A variety of 
substances showed such high quotients for several organismic groups. Among them, NSAIDs like 
diclofenac and ibuprofen, the analgesic paracetamol, and antibiotics like sulfamethoxazole, 
erythromycin, sulfadimidine and oxytetracycline were particularly noticeable. But also beta-blockers 
like propranolol and metoprolol, or sex hormones like 17β-estradiol and 17α-ethinylestradiol.  
The assessment of reliability proved to be an essential part of the analysis. 72 publications, all reporting 
low effect concentrations, were examined more closely. Only nine of them were considered as reliable, 
while 49 were conditionally reliable and 14 were not reliable. Many studies suffered from the lack of 
analytic-chemical verification of test concentrations, flaws in experimental design, or improper 
reporting of essential study details, and lack of concentration-dependence. When excluding unreliable 
studies, the protozoan Tetrahymena pyriformis was no longer the most sensitive organism tested. 
Instead, the three fish species Danio rerio, Oryzias latipes, and Oncorhynchus mykiss remained the 
organisms with most sensitive reactions to pharmaceuticals. Those three were also among the most 
frequently investigated organisms overall. Concerning invertebrates, the mussel Ellliptio complanata 
and the mudsnail Potamopyrgus antipodarum reacted sensitively in the few cases where they were 
examined.  
The original evaluation of the most relevant pharmaceuticals was strongly influenced by the reliability 
analysis. A large portion of LOECs close to MECs had been derived from unreliable studies. When 
excluding those studies, the NSAIDs diclofenac stood out by still showing high MEC/LOEC ratios in all 
four organismic groups. Other pharmaceuticals with high MEC/LOEC ratios in at least one or two 
organismic groups were sex hormones, antibiotics and beta-blockers.  
Mixture toxicity was addressed in only few of the investigated studies. The obtained results are 
equivocal and no mode-of-action related endpoints were examined. 
106 studies examined endpoints regarded as population-relevant: mainly by examining survival or 
mortality, growth and reproduction, but also behavioural effects and visible community changes. 
Especially endocrine active substances induced effects already in low concentrations.  
Discussion 
Overall, the literature review revealed diverse shortcomings, above all the strong heterogeneity of 
data. Oftentimes, only a single dataset was available for a species, rendering comparisons difficult. 
While several substances are intensively studied, most others are almost completely neglected. 
Because of this strong bias, an objective selection of test substances is hardly possible. However, in 
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combination with the results of the literature study on in vitro systems, two substance groups were 
promising for the further goal of developing biosensor systems. NSAIDs and beta-blockers are 
pharmaceutical groups acting via specific pathways. This can be exploited in the construction of in vitro 
assays. At the same time, these pharmaceutical groups are among the ones showing the most 
prominent effects in published studies. As representatives of the respective groups, we proposed the 
substances diclofenac and metoprolol. The consumption rate of diclofenac is not as high as that of 
other NSAIDS, like ibuprofen or acetylsalicylic acid (IMS Health). Nevertheless, reported environmental 
effects on vultures are drastic, and its effect on aquatic ecosystems is controversially discussed. This 
has led to its inclusion in the watch list of the European Water Framework directive (EU 2013). Further 
information on the substance was urgently needed at the time when our literature study was finished. 
Metoprolol is the beta-blocker with the by far highest consumption rate (IMS Health). However, 
relatively little is known on its effects in aquatic biota. In vivo examinations should help to further 
substantiate our knowledge on both substances. 
Although the collected studies applied a wide range of different species, only a small proportion of 
them contributed more than a single effect value for a single substance. This renders the identification 
of sensitive species, based on the current literature, hardly possible. In fish, most studies applied 
established model species. Due to the sheer amount of studies on these species, there are several 
cases where they react with high sensitivity. Therefore, it was inherently more likely to find sensitive 
effects for these organisms. It remains unclear if other, less established species would be more 
sensitive and, hence, of higher relevance for ecotoxicological testing. Furthermore, studies on 
ecologically relevant invertebrates, like gammarids or endobenthic organisms, were scarce. Hence, it 
cannot be reasonably assessed how species of our regional ecosystems react to pharmaceutical 
contaminations.  
Moreover, only few studies investigated the same endpoint in the same test organism for different 
pharmaceuticals – or focused on sensitivity differences of various taxa exposed to the same 
pharmaceuticals. The selected endpoints were highly diverse, but rarely linked to the substance mode 
of action, and ecological relevance remained questionable in many cases. Similar conclusions were 
drawn in a review by Brausch et al. (2012), who also stressed out the lack of chronic data on benthic 
invertebrates and fish, and need for mode-of action (MoA)-based endpoints. 
It was especially concerning that a large proportion of the studies reporting on sensitive results was 
not completely reliable. Many experiments did not verify their exposure concentrations via analytical-
chemical methods, but based the results solely on nominal concentrations. However, this is an 
essential part in sound study design in ecotoxicology – to account for dosing errors, adsorption or 
substance degradation. Furthermore, several publications did not report their experimental design and 
results in sufficient detail, which would be the fundamental pillar of transparent science. Additional 
problems were low sample sizes and too few tested concentrations, which give random effects much 
higher influence than desired. These problems with published ecotoxicological research have also been 
noted in other literature reviews (e.g. Harris et al. 2014). Recent projects like CRED (Criteria for 
Reporting and Evaluating ecotoxicity Data) aim to provide guidance and support for scientists and 
evaluators, in order to improve transparency and reliability of published data (Moermond et al. 2015). 
As a conclusion of our literature review, we endorsed the use of non-standard species and non-
standard endpoints for further analyses – as those allow investigating effects that might otherwise be 
overlooked. In addition, we claimed that future studies must meet a certain quality in experimental 
design and reporting to be of use for the scientific community. 
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Chapter II: Need for effect-based monitoring  
Paper: Triebskorn et al. 2015 - Monitoring Primary Effects of Pharmaceuticals in the Aquatic 
Environment with Mode of Action-Specific in Vitro Biotests 
Our literature research illustrated the current heterogeneity and paucity of actual knowledge on the 
effects of pharmaceutical effects in the environment and useful methods for their monitoring. It is a 
common agreement that the systematic and global monitoring of pharmaceuticals and other 
substance classes is a prerequisite to evaluate the risk of chemical contamination. With few exceptions, 
e.g. the monitoring of steroid hormones, monitoring techniques are still based on traditional analytical 
chemistry identifying single substances. The gained information is without doubt very useful, but the 
sheer complexity of environmental contaminations would overwhelm its possibilities. The number of 
chemical products is large and constantly increasing. Furthermore, biotic and abiotic processes 
generate various different metabolites and transformation products, in addition to the parent 
substance. Moreover, in the environment, the substances are always present in a complex mixture 
that might act in addition or synergism, so the focus on single substance will most likely underestimate 
risks.  
One possible solution to integrate and, to some extent, simplify this complexity, is to monitor 
substances based on their mode-of-action (MoA). Many different substances act on the same 
molecular target, which is ultimately responsible for the evoked effects in biota. Applicability of such 
MoA-based techniques in monitoring has been shown (Escher et al. 2014), but needs to be extended. 
For pharmaceuticals, such techniques only exist for steroid hormones, e.g. based on the MoA via 
estrogen or androgen receptors. However, especially in the field of pharmaceuticals, there are much 
more potential applications. A variety of different substances, belonging to the same substance class, 
usually acts on the same molecular drug target. The basic idea for further monitoring systems is to 
create in vitro test systems, which express the drug target as a sensor plus a reporter system to 
recognize the sensor’s state and immediately quantify the effect via fluorescence signal changes 
(Oldach and Zhang 2014). This would be a great improvement compared to traditional reporter gene 
assays, which require considerable time for the underlying signal transduction pathway, and are prone 
to interference by other effects. The method could elegantly bridge the current gap between analytical 
chemistry and in vivo effects. This could not only add to the battery of monitoring techniques, but be 
also used for the characterization of mixture effects or the examination of wastewater treatment plant 
efficiency.  
Of course, it will still need a wide array of different in vitro systems to cover the most common 
pharmaceutical MoAs in environmental samples. Therefore, our first step was to exemplarily prove 
the feasibility of such in vitro systems for two highly important drug targets. First, beta-adrenoceptors, 
which are the drug target of antihypertensive pharmaceuticals belonging to the class of beta-blockers. 
Second, cyclooxygenases, an enzyme class which is targeted by the class of non-steroidal anti-
inflammatory drugs (NSAIDs). Our choice of these substances was based on the fact that these two 
substance groups have a clearly defined MoA. At the same time, effects on their molecular drug target 
have wide implications on the physiology of an organism, which may lead to diverse side-effects. Our 
literature study listed them among the groups of highest priority, because of the high consumption 
and likeliness of environmental effects. When the cell culture systems are finally created, they must 
be optimized to not only function at sterile lab conditions, but also at environmental conditions, where 
various other factors might be interfering. Furthermore, they need to be validated by biomarkers and 
population-relevant endpoints in various biota of environmental relevance: in our case, we chose fish, 
crustaceans and endobenthic organisms. The results of these validation efforts are presented in the 
following chapters III – V:  
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Chapter III: Experiments with brown trout  
Paper: Schwarz et al. 2017 - Impact of the NSAID diclofenac on survival, development, behavior and 
health of embryonic and juvenile stages of brown trout, Salmo trutta f. fario 
Report: Triebskorn et al. 2017 - EFF-Pharm: Effects of pharmaceuticals (nonsteroidal anti-inflammatory 
drugs and beta-blockers) in fish and invertebrates and their detection by newly developed in vitro-
bioassays – Final report  WP3A 
Aims 
When evaluating the available literature, it became clear that only few studies are directed to 
investigate effects in regionally relevant species. While it makes sense to conduct studies for direct 
regulatory purposes with standard model species, it is the opportunity of free academic research to 
deviate from the standard procedures. The goals of the studies with brown trout were: 
 To investigate potential adverse effects of pharmaceuticals in a species of high ecological 
relevance for Central European stream ecosystems. For this, I selected brown trout, which is 
considered as sensitive towards environmental stressors and might be less tolerant than fish 
model species. By comparison to literature data, conclusions on sensitivity variations of 
different species can be drawn – to exemplary assess if approaches with model species are 
protective enough for regional biocoenosis.  
 To gain further knowledge on the ecotoxic effects of diclofenac and metoprolol. Both are sold 
since before the European pharmaceutical legislation came into action. Hence, it is doubted 
that a rigorous environmental risk assessment for both substances was submitted. For 
diclofenac, various publically available studies hint on potential hazards, but are also 
controversially discussed. Metoprolol is sold and consumed in high amounts, but only few 
studies on its effects are available. Therefore, I aimed to further improve the knowledge basis 
on the environmental risk of both substances. 
 Apart from the overall assessment of ecotoxicity for the species itself, I also aimed to compare 
different life stages. For diclofenac, studies on adult individuals are available in literature. 
Hence, my focus lay on juveniles (in reference to their length, also called “fingerlings”) and the 
earliest developmental stages from freshly fertilized egg to free-feeding larvae (fry). The 
testing of different life stages allows identifying vulnerable stages, which are most relevant for 
ecotoxicity assessment.  
 Apart from standard endpoints - like development time, growth, or mortality - biomarker 
analyses were the prime interest of the investigations. Adding two biochemical markers - 
stress protein and lipid peroxide levels – allowed to identify changes on the biochemical level. 
Since this is no standard procedure for fish testing, these results would help to conclude 
whether such biochemical markers are a useful extension in risk assessment. Both biomarkers 
can be analysed for a broad range of taxa, including fish as well as invertebrates. Hence, I could 
also conduct these analyses for other test organisms and compare between taxa. Additionally, 
I applied histological examinations, which are a widely applied method to gain further 
knowledge on the health condition of the test animals. Tissue and organs react before the 
changes are seen on the organismic level. Hence, by histological analyses, one is able to either 
get more sensitive results than just looking at the organismic level, or interpret the results seen 
on the organismic level in a more comprehensive manner. For regulatory purposes, the 
method is usually considered as too expensive, since it is time consuming and requires 
expertise to evaluate and interpret the results.  
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Effects of diclofenac and metoprolol in brown trout embryo and sac-fry stages 
Developing brown trout were exposed to diclofenac and metoprolol from fertilised egg until 
consumption of the yolk sac [experiment 3]. During the exposure, pH ranged between 6.46 and 7.3 
(mean: 6.8), temperature between 6.7 and 7.6 °C (mean: 7.13 °C), and oxygen saturation between 59.6 
and 81.4 % (mean: 73.4 %). Measured concentrations of diclofenac and metoprolol were, partly, below 
the nominal concentrations. Hence, the mean measured concentrations were used for the further 
comparisons (Diclofenac: 0.06, 0.51, 0.75, 7.8, 74.6 µg; Metoprolol: 0.06, 1, 9.8, 70.1, 998 µg/L).  
Trout larvae developed normally within the 127 day experiment. With survival rates between 94.6 and 
100 %, overall mortality was very low. Embryos of all treatments reached the eyed ova stage between 
29 and 33 dpf; hatching took place between 63 and 70 dpf. At 1 µg/L diclofenac, hatching rate was 
slightly lower than in the control – but this effect was not seen in all other diclofenac treatments. Heart 
rate was on an equal level for all tested treatments and ranged between 45 and 60 bpm (mean = 51.17 
bpm). Body mass was slightly lower at 7.8 µg/L diclofenac, which was mainly caused by one replicate 
of this treatment (mean: 78.24 mg in the replicate, compared to an overall mean of 94.1 mg; overall 
range between 63.9 and 123.9 mg) and non-significant (linear mixed model, df=5/11.65, F=0.7623, 
p=0.5944). Histological analyses of kidney revealed mild reactions in several samples of all treatments 
(large vacuoles in tubular cells, reactions of glomeruli, increased vesicularisation in tubuli), with no 
visible influence of the diclofenac treatment. The test was regarded as valid, as control survival was 
above 70 %, oxygen saturation above 60 % (except one replicate, where it was 59.6 %) and inter-vessel 
temperature differences smaller 1.5 °C.  
Effects of diclofenac in juvenile brown trout 
Exposure conditions during the first diclofenac exposure [experiment 1] were in an acceptable range 
(temperature: 7.92 ± 0.4 °C, pH: 8.49 ± 0.02, oxygen: 96.1 ± 0.65 %) and the measured concentrations 
of diclofenac were close to the nominal values. Hence, all evaluations of the experiment were based 
on nominal concentrations. Mortality in the first diclofenac exposure of juveniles was high. This was 
especially prominent at the highest test concentration (100 µg/L). This treatment was ended ahead of 
schedule, already after 14 days, due to the high mortality (>60 %) of the exposed fish. At this time 
point, a clear difference in comparison to the other treatment was obvious (COX-regression, df=5, 
χ²=43.54, p<0.0001). However, all other treatments – including the control – experienced elevated 
mortality rates (≈ 40 %) during the further course of the study. Even though these did not reach the 
rates observed for 100 µg/L, the control mortality by far exceeded 10 %, which was the validity 
criterion for the test. For this reason, a repetition of the experiment was deemed necessary. Body 
length of fish in this first experiment varied between 2.8 and 4.4 cm (mean: 3.6 cm), body mass 
between 0.13 and 0.79 g (mean: 0.4 g), both measured at the end of the experiment. This was 
considerably larger than the fish had been at the hatchery (mean length: 3.0 cm, mean weight: 0.19 g), 
indicating strong growth during the exposure. There were no differences in size between the control 
and the treatments (length: nested ANOVA, df=5, F=1.3698, p=0.2412; weight: nested ANOVA, df=5, 
F=1.6892, p=0.1431). Relative stress protein levels ranged between 0.15 and 2.36 (mean: 1.38), but 
were not affected by any treatment (linear model, df=5/103, F=0.4174, p=0.8357). Lipid peroxide levels 
turned out to be highly variable, with a minimum level of 0.95 and maximum of 30.84 CHPE. A 
significant effect in the full model (linear model, df 6/119, F=11.1, p<0.001) was mainly driven by the 
covariate sample mass. The level of lipid peroxides was visibly decreased at 100 µg/L (mean: 9.7 CHPE, 
with two samples showing very high values, in contrast to 18.0 CHPE in the other treatments), but due 
to the shorter exposure time, this treatment is not directly comparable to the others. The hatchery 
control samples taken at a time corresponding to the end of the exposure also had low levels of lipid 
peroxides (mean: 8.1 CHPE) 
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When juvenile trout were tested in the second diclofenac experiment [experiment 6], exposure 
conditions were in an acceptable range (temperature: 6.91 ± 0.18 °C, pH: 8.52 ± 0.04, oxygen: 95.36 ± 
1.1 %) and the real diclofenac concentrations were close to the nominal concentrations. Furthermore, 
tissue analyses showed diclofenac to be present in fish tissue. It was not detectable at the two lowest 
exposures, but at mean concentrations of 10.2, 84.5 and 169.5 µg/kg dw for the three highest 
treatments. Effects of diclofenac on mortality were obvious. While mortality remained within 10 % for 
the control, it increased in a roughly concentration-dependent manner, with highest mortality rates 
(>40 %) at 100 and 200 µg/L (nested COX-analysis, df=5, χ²=13.457, p=0.0194). Step-wise comparisons 
revealed the two highest concentrations to be significantly different to the control, resulting in a 
LOECmortality of 100 µg/L and NOECmortality of 10 µg/L.  Besides elevated mortality, animals showed bite 
injuries on fins and opercula, attributable to intraspecific aggression. The frequency of these injuries 
was low in the controls, but increased with ascending diclofenac concentration. Significance was 
reached at 10 µg/L (GLMM, df=5, n=161, F=5.2463, p=0.0015), resulting in a LOECinjuries of 10 and 
NOECinjuries of 1 µg/L. Again, standard body length (4.8 - 7.5 cm, mean: 6.02 cm), body mass (1.37 – 5.59 
g, mean: 2.95 g) and stress proteins (0.87 – 2.19, mean: 1.47) were not affected by diclofenac. Lipid 
peroxides did show a slightly significant overall effect in the full model (linear model, df=35/123, 
F=1.639, p=0.02581), drawn by effects of block and sample mass, but without effect of test 
concentration. Overall, the variance of lipid peroxide levels was very high (12.59 – 100.7 CHPE, mean: 
81.38 CHPE). Fish from the hatchery controls were of comparable size at time point 1 (start of the 
experiment, mean length: 6.14 g, mean weight: 3.25 g) and were considerably larger at time point 2 
(end of the experiment, mean length: 7.68 cm, mean weight: 7.29 g). Stress protein levels were slightly 
larger in animals kept in the lab than in hatchery control animals (first hatchery control: 1.33, second 
hatchery control: 1.24). This effect was even more pronounced for lipid peroxides, where the levels 
were considerably higher in lab-exposed fish (first hatchery control: 42.96 CHPE, second hatchery 
control: 42.75 CHPE).  
When looking at the histological samples, all examined tissues showed noticeable changes. The most 
prominent effects were: hypertrophy of gill epithelial cells, resulting in an overall thickened 
appearance of the secondary lamellae. Liver tissue was often depleted of glycogen, with dilated 
intercellular spaces and frequent inflammative spots. Kidneys had accumulated hyaline material in 
tubular cells and showed frequent aggregations of melanomacrophages. In several cases, the 
hematopoietic tissue showed degenerations, leading to a perforated appearance of the tissue. Many 
symptoms could also be seen in the control, but the frequency of strong reactions was higher in 
diclofenac-treated fish – especially concerning the liver. The most severe alterations were seen in the 
two highest treatments. These effects were seen in the qualitative, as well as the semi-quantitative 
assessment.  
Effects of metoprolol in juvenile brown trout  
Exposure conditions during the experiment [experiment 2] were in the intended range (temperature: 
7.82 ± 0.18 °C, pH: 8.23 ± 0.02, oxygen: 94.9 ± 0.65 %), except for the concentrations of metoprolol – 
which turned out to be lower than planned. Since the concentrations deviated more than 20 % from 
the nominal, the evaluations were based on mean measured concentrations (0.094, 0.95, 6.9, 86, 
745 µg/L). 
Overall mortality in the experiment was low, with no animals at all dying in the control and only 
occasional mortality in the metoprolol-treated groups (nested COX-analysis; df=5, χ²=0.0319, p=1.0). 
Fish showed high variation in size, with standard body length varying between 3.9 and 6.7 cm (mean = 
5.2 cm) and body mass between 0.73 and 3.71 g (mean = 1.8 g). Neither of them showed any difference 
between the control and the metoprolol treatment groups (length: nested ANOVA, df=5, F=0.3146, 
p=0.9039; mass: nested ANOVA, df=5, F=0.0519, 0.9983). The animals were only slightly taller than at 
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the start of the experiment, where the mean fish weight was 1.52 g. A comparison with fish of the 
second hatchery control, where mean length was 7.33 cm and mean weight was 6.24 g, made clear 
that growth was much slower under the given laboratory conditions. A large percentage of 45 to 60 % 
of animals showed bite marks on their fins. The extent of these injuries was not as severe, as it was 
later observed in the second diclofenac exposure. However, the effect was present in both the 
treatment and the control groups (Likelihood-ratio, n=225, df=10, χ2=8.546, p=0.5757). 
The observed relative stress proteins levels ranged from 0.81 to 2.02 (mean = 1.3), with a very similar 
pattern for the control and each treatment group (linear model, df=5/202, F=0.1355, p=0.984). The 
hatchery control corresponding to the experimental start had a median Hsp70-level in a much higher 
range, but the hatchery control corresponding to the end was in a range comparable to the lab results.  
Common histopathological findings in the liver were reduced glycogen content, slightly enlarged 
intercellular spaces, as well as occasional inflammations, large lipid vacuoles, and macrophage 
aggregations. In general, the tissue of fish from the hatchery control was in better condition than that 
of laboratory fish. Reported findings were observed in the lab control, as well as in the highest 
metoprolol exposure concentration, without noticeable treatment effect. The kidney of laboratory 
control animals showed visible reactions, like hyaline inclusions in the proximal tubuli and occasionally 
altered structure of the hematopoietic tissue. These reactions were even more pronounced in 
metoprolol-exposed fish. In addition to hyaline droplets in the tubuli, multiple samples showed 
reactions of the glomerular structure and necrotic changes. Yet, the effects were not completely 
concentration-dependent, with samples from the 6.9 µg/L treatment displaying the highest proportion 
of stronger reactions, and all other metoprolol treatment showing reactions of similar severity. 
Comparable to the effects reported for diclofenac, the gill structure appeared thickened through 
hyperplasia and hypertrophy of epithelial and interlamellar cells. Occasionally, other alterations, like 
lamellar fusion, oedema, increased abundance of mucus cells, or epithelial lifting, appeared. Again, the 
difference of laboratory experiment in comparison to the hatchery control was obvious, but there was 
no apparent treatment-related effect. The heart tissue itself was not altered, but there was a 
conspicuous shift in the ratio of erythrocytes to leucocytes in the blood remaining within the ventricle. 
Between control and the highest test concentration this was seen as trend, but not as significant 
difference. 
Discussion 
Diclofenac 
Through the chemical analyses, we could show that juvenile brown trout takes up diclofenac into its 
tissue. However, the detected concentrations also suggest that there is no strong bioaccumulation.  
Due to the small size of the juvenile fish, the amount of tissue did not suffice to analyse concentrations 
in isolated liver or kidney samples. Instead, the tested tissue consisted mainly of muscle and spine. My 
results are in accordance with earlier studies (Schwaiger et al. 2004, Memmert et al. 2013), which 
report great variance in the bioaccumulative ability of different tissues – with usually low accumulation 
in muscle tissue. The low logPOW of diclofenac at neutral or slightly alkaline pH supports the assumption 
of low bioaccumulation at my experimental conditions. The tissue concentrations do not allow deriving 
plasma concentrations. Fish plasma models are usually based on lipophilicity (Fu et al. 2009, Schreiber 
et al. 2011) and would suggest a plasma accumulation factor around 2.5 at physiological fish pH. 
However, there may also be active processes involved in the uptake of diclofenac (Choi et al. 2005), 
further increasing plasma or tissue concentrations. Furthermore, physiological processes like 
enterohepatic cycling prolong the retention time in the organism (Hoeger et al. 2008). Trout exposed 
to 81 µg/L diclofenac exhibited plasma concentrations near the human therapeutic level, which 
suggests a plasma BCF of 4 (Cuklev et al. 2011). In fathead minnow, reported plasma BCFs are even 
higher, with the human therapeutic level being reached at water concentrations of 25 µg/L (Bickley et 
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al. 2017). I did not measure plasma concentrations in my experiments, but the cited literature suggests 
that concentrations of 10 to 100 µg/L diclofenac are sufficient to lead to physiologically active plasma 
concentrations in fish.  
The lack of effects on embryonic brown trout matches with literature results. For brown trout embryos, 
an earlier study reported a NOEC of 500 µg/L, based on investigations of mortality and developmental 
parameters (LfW 2004). In most studies on other fish species, like Danio rerio (Hallare et al. 2004, van 
den Brandhof and Montforts 2010, Memmert et al. 2013), Oncorhynchus mykiss (Memmert et al. 2013) 
or Cyprinus carpio (Stepanova et al. 2013), only concentrations higher than 1 mg/L evoked significant 
effects. However, one study on Danio rerio showed that diclofenac and other NSAIDs increased 
mortality of male fish at concentrations of 1000 µg/L (Ji et al. 2013). Juvenile brown trout in my study 
reacted with much higher sensitivity than other species and also their own early life stages. Mortality 
increased already at concentrations in the low µg/L-range. Similar effects are reported for stickleback 
Gasterosteus aculeatus (Näslund et al. 2017), albeit only at slightly higher concentrations of 320 µg/L. 
This difference in concentration is likely due to sensitivity differences attributable to species and life 
stage. Furthermore, in a mesocosm experiment on diclofenac, survival of Gasterosteus aculeatus was 
reduced in two of three replicates at 4.1 µg/L (Joachim 2017). The authors concluded that the observed 
mortality must be due to a combination of different stressors. Apart from this, other studies did not 
report mortality at low diclofenac concentrations. The LC50 for adult carp is 71 mg/L (Islas-Flores et al. 
2013, Saucedo-Vence et al. 2014), but none of the studies on trout applying a similar concentration 
range as in my study (Schwaiger et al. 2004, Hoeger et al. 2005, Mehinto et al. 2010, Memmert et al. 
2013) reported increased mortality. Overall, this suggests that the investigated juvenile life stage of 
brown trout is far more susceptible to diclofenac than adult or early life stages.  
Histological examinations shed further light on the physiological reasons for the increased mortality. 
The lab control already displayed a range of tissue reactions, which can be regarded as compensatory 
adaptations to the laboratory conditions. Gill and kidney are actively involved in osmoregulation and 
electrolyte metabolism. Hence, they may react plastically to changes in pH, salinity or temperature 
(Bonga 1997), which are inevitable when fish are transferred from the hatchery to the lab. Reactions 
in the liver were, to a certain extent, already present in fish from the hatchery. This and the high weight 
gain of hatchery fish in the same time are indications of the high energy demand and metabolic activity 
of the tested juvenile life stage. During the exposure, the fish received a diet that sufficed for 
maintenance, but did not allow the strong growth targeted in commercial trout farming. This means 
that the test fish had potentially less energy reserves to deal with stressful situations than fish fed ad 
libitum. Additionally, the lab exposure was semi-static with regular water exchanges. This is a less 
natural and more stressful condition, in contrast to the large flow-through system at the hatchery. 
However, the lab situation alone cannot be the reason for the observed mortality rates at high 
diclofenac concentrations. Mortality in lab controls was low, compared to the other treatments. 
Results suggest an adverse effect of the pharmaceutical treatment, because severity of histological 
reactions, especially in the liver, tended to be higher in diclofenac-exposed individuals. A variety of 
previous studies found evidence for histological effects of diclofenac in fish. 18 month old Salmo trutta 
exposed to 1.15 µg/L diclofenac suffered from increased monocyte infiltration in liver, telangiectasis 
in gill, and hyaline droplets and mild tubular necrosis in kidney (Hoeger et al. 2005). In rainbow trout 
Oncorhynchus mykiss, histological examinations by Schwaiger et al. (2004) reported pillar cell necrosis 
in gills and tubular hyaline droplet degeneration and interstitial nephritis in kidney, but no effects in 
liver at 5 µg/L. Ultrastructural examinations of the same animals (Triebskorn et al. 2004) confirmed the 
pathologies in gills and kidneys. Furthermore, they found effects in liver tissue, like the collapse of 
cellular compartmentation, glycogen depletion, and macrophage infiltration. In a later study, which 
applied the same species, Mehinto et al. (2010) documented symptoms like renal tubular cell necrosis 
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and hyperplasia of intestinal villi at 1 µg/L diclofenac. Birzle (2015) did the most thorough examination 
of histological alterations in rainbow trout: through morphometric measurements of histological 
sections he showed that diclofenac, i.a. increased the amount of hyaline droplets in kidney tubuli at 
25 µg/L and evoked thickening of secondary gill lamellae at 5 µg/L. In a rainbow trout ELS test, 
Memmert et al. 2013 did not find any histological effects up to 320 µg/L diclofenac, but slight effects 
on gills at 1000 µg/L. Bickley et al. (2017) examined kidney histology in fathead minnow Pimephales 
promelas, and found increased cellularity and inflammations in fish exposed to 25 µg/L. In three-spined 
stickleback Gasterosteus aculeatus, examined kidneys featured renal hematopoietic hyperplasia at 
5 µg/L. In contrast to the findings in rainbow trout (Schwaiger et al. 2004, Birzle 2015), fathead minnow 
(Bickley et al. 2017) or stickleback (Näslund et al. 2017), there was no specific pathology associated 
with my diclofenac exposure. These studies showed clear pathological reactions of fish kidney but less 
conclusive results on liver – which is the opposite of my findings. The mentioned differences in 
histological reactions are likely due to species and life-stage. Overall, my data suggest that a 
combination of basal level of stress, sensitive life-stage and diclofenac as toxic agent led to the 
observed pathologies and high mortality rates in µg/L concentrations.  
Another unexpected finding was the apparent effect of diclofenac on behaviour, significant at 
concentrations higher than 1 µg/L. The true extent of this reaction was likely masked by the high 
mortality in most diclofenac treatments. Most recovered carcasses showed bite marks, but I could not 
clearly determine whether they were inflicted ante or post mortem. Hence, the actual frequency of 
bite marks may have been even higher than shown in the results. Fin erosion is among the frequently 
observed phenomena in commercial salmonid farming. The parameter varies in relation to factors like 
stocking density (Jones et al. 2011), feeding conditions (Noble et al. 2007, Cañon Jones et al. 2010), or 
water parameters (Bosakowski and Wagner 1994). Aggression behaviour in reaction to analgesic 
exposure has not yet been reported. However, prostaglandins play an important role in many cellular 
processes. It has been shown that environmentally relevant concentrations of diclofenac drastically 
decrease dopamine levels in the brain of the African catfish Rhamdia quelen (Guiloski et al. 2017). This 
influence on the levels of neurotransmitters could manifest in complex behavioural changes. Other 
behavioural reactions, like loss of balance, respiratory stress or erratic swimming, were reported for 
Rhamdia quelen at much higher concentrations of diclofenac (Ajima et al. 2015). Nassef et al. (2010) 
reported that diclofenac affected feeding but not swimming behaviour, and concluded that behaviour 
is a more sensitive endpoint than mortality. Unfortunately, this study only examined one concentration 
of 1 mg/L. Moreover, several studies suggest that NSAIDs influence the levels of sex steroids. In the 
tiger fish Hoplias malabaricus, diclofenac reduced plasma testosterone (Guiloski et al. 2015) and in the 
African clawed frog Xenopus laevis, it increased aromatase activity and altered male calling behaviour 
(Efosa et al. 2017). Sex hormones play a major role in mating and territoriality behaviour – which could 
also explain the observed effects. In my case, I did not actually observe the aggression behaviour, and 
could only indirectly judge by the frequency of bite marks. It may be that diclofenac does not directly 
increase aggressiveness, but instead reduces defensive behaviour. Through its pain-relieving ability or 
the general weakening of the body condition, diclofenac may dullen the senses of victim fish, making 
them more prone to conspecific attacks. The suffered injuries may also be linked to the increased 
mortality rates. Potentially lethal infections are more likely to occur when animals are injured. On the 
other hand, the increased aggression behaviour could also be triggered by density changes through 
mortality. Young brown trout from hatcheries transcend from swarming to territorial behaviour, when 
density is low (J. Schindler – personal communication). If mortality reduces the density below a 
threshold level, this may lead to an aggression response. However, bite mark frequency was low in the 
two lowest test concentrations, despite the relatively high mortality in these treatments. Another 
explanation comes from the findings of Birzle (2015), who showed that diclofenac leads to perforations 
of the cornea in rainbow trout. Trout rely heavily on visual cues for orientation and foraging (Klemetsen 
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et al. 2003). If a similar effect is evoked in brown trout, the behavioural effects can be interpreted as 
panic reactions due to visual disturbance. There were no apparent macroscopic effects on the brown 
trout eyes in my study, but due to strong pigmentation, this effect is more difficult to quantify in brown 
trout compared to rainbow trout. Finally, I must acknowledge that my experimental setup was not 
designed to answer questions on behavioural effects in full detail. These effects were not anticipated, 
and therefore not included in the planning. Further studies could focus on behavioural endpoints by 
monitoring activity and inter-individual behaviours to put my findings into perspective.   
Diclofenac had no effect on Hsp70 and lipid peroxidation in brown trout juveniles. There are few 
studies on the effects of NSAIDs on stress protein induction. Hallare et al. (2004) could not find any 
effect of diclofenac on Hsp70 in Danio rerio up to 2 mg/L. However, ibuprofen led to increased Hsp70-
levels in rainbow trout fry (Gravel and Vijayan 2007). The same study found no such effect for salicylic 
acid, another NSAID. Several studies investigated oxidative stress biomarkers in response to diclofenac 
exposure, with inconsistent results. Oxidative damage is the major reason suspected to be responsible 
for the strong adverse effects of acidic NSAIDs on gastric mucosa in mammals (Sánchez et al. 2002). 
Diclofenac increased hydroperoxide content and lipid peroxidation in carp at 7.1 mg/L (Saucedo-Vence 
et al. 2014) and induced reactive oxygen species in rainbow trout cell assays with an EC50 of 44.5 µg/L 
(Fernandez et al. 2013). Oxidative stress induced by NSAIDs is likely mediated through superoxide 
anions generated during metabolism by CYP450. This is, for example, seen in the livers of inanga 
Galaxias maculatus exposed to diclofenac  (McRae et al. 2018), where lipid peroxidation and CAT 
activity were both increased. In contrast, renal lipid peroxidation of the same animals was reduced.  In 
hepatocytes of Oreochromis niloticus, the expression of GST-genes was up-regulated in a 
concentration dependent manner (Gröner et al. 2015). Danio rerio had decreased levels of lipid 
peroxides at 20 µg/L diclofenac, but none of the other parameters of the oxidative stress response 
were affected up to 60 mg/L (Praskova et al. 2014). Mortality rates of Cyprinus carpio were first 
affected at concentrations of 3 mg/L, but oxidative stress biomarkers, e.g. TBARS, were significantly 
lower already at 30 µg/L (Stepanova et al. 2013). Trophic exposure of tiger fish Hoplias malabaricus to 
2 µg/kg diclofenac increased SOD and CAT activity, as well as the hydroperoxide level, but reduced GST 
activity (Guiloski et al. 2015). In the catfish Rhamdia quelen, various oxidative stress biomarkers, like 
lipid peroxidation, CAT-activity or SOD-activity, were reduced at 0.2 µg/L (Guiloski et al. 2017). 
However, the activity of GST was increased, which can be interpreted as a protective effect – a possible 
explanation why no protein carbonylation or DNA damage was seen in this study. For the same species, 
Ghelfi et al. (2016) reported that diclofenac increased the activity of SOD in kidney at 0.2 µg/L, but had 
no effect on lipid peroxides – which would fit this pattern. In stickleback Gasterosteus aculeatus 
exposed to diclofenac in a mesocosm, antioxidative defence was increased at 4.1 µg/L. Moreover, the 
authors reported immune destabilisation due to leucoyte oxidative stress (Joachim 2017). The 
oxidative stress response is a complex process, which may be an explanation for the divergent findings. 
If diclofenac induces protection mechanism against ROS, like increased activity of superoxide 
dismutase, glutathione-S-transferase, or catalase, this may prevent the peroxidation of lipids, proteins 
or DNA. Furthermore, cyclooxygenases themselves possess peroxidase activity (Simmons et al. 2004). 
Their inhibition through NSAIDs could inhibit lipid peroxidation, thereby counteracting or masking 
other effects.  
Metoprolol 
Our study could not identify an influence of metoprolol on hatching or survival of brown trout. A recent 
study by Gröner et al. (2017b) exposed Nile tilapia Oreochromis niloticus to metoprolol from fertilized 
egg until 80 dph came to a similar conclusion. However, Gröner et al. (2017b) showed growth 
(measured by wet weight, length and condition index) to be reduced in a concentration-dependent 
manner, reaching significance at 11 µg/L. The experiment, in view of the much faster development of 
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tilapia compared to trout, spanned over a much broader range of life stages. The growth effect was 
not yet visible after only 8 dhp, which suggests that it is mainly relevant in fry and juveniles, not in 
larval stages. My embryo and sac-fry exposure did not continue into these later stages - explaining the 
lack of a growth effect.  In tilapia, there were no effects on mRNA expression of biotransformation 
enzymes (Gröner et al. 2017b), but decreased expression of lh (luteinizing hormone) and FSH (follicle-
stimulating hormone) mRNA, and increased vitellogenin mRNA hint on a potential endocrine activity 
of the substance. Histological effects in the gill were only vague, and seen as first defensive reactions 
towards adverse conditions in the surrounding medium. In comparison, effect concentrations as low 
as 1 µg/L were found for cytological and histological changes in adult rainbow trout Oncorhynchus 
mykiss (Triebskorn et al. 2007). In the liver, these effects (reduction of glycogen stores, membrane 
material within cells, changes of the endoplasmic reticulum, loss of compartmentation) were most 
pronounced and concentration-dependent. In kidney, thickening of basal membrane, altered 
endocytic channels and increased amounts of macrophages were only observed at 1 and 500 µg/L, but 
not in the other test concentrations. In gills, the major effects were epithelial lifting, hypertrophy of 
mucus and chloride cells, macrophage infiltration, and dilation of the endoplasmic reticulum. These 
effects are, in great parts, different to the observations in my experiment. However, it is important to 
bear in mind the substantial differences in the experimental design: first, the applied species was 
different, although rainbow trout and brown trout are closely related. Second, the animals in my 
experiments were of a much younger life stage. Third, many of the effects described by Triebskorn et 
al. (2007) were on an ultrastructural level, which views the cellular structures in greater detail and, 
thus, has higher sensitivity. Fourth, reactions to metoprolol in the liver of brown trout may be 
concealed by the already sub-optimal state of the control animals. Steinbach et al. (2014b) observed 
histological effect on the vascular system, visible by liver congestion and changes of the pericardium 
and myocardium of juvenile rainbow trout exposed to atenolol. Furthermore, they identified beta-
blocker effects on several blood parameters, like lactate and haemoglobin content, glucose 
concentration, or haematocrit. Although I could not observe a negative effect on liver or heart tissue 
integrity, my results also pointed towards alterations of fish blood parameters. The observed 
difference in the ratio of blood cells is only a first indication. It was an incidental finding during the 
examination of the heart – and we had originally not intended to examine the blood. Further studies, 
with blood smears taken exactly for this purpose, will be necessary to make a broader statement 
concerning this endpoint.  
Stress proteins were not affected by any treatment at all. Given the large sample size, it is reasonable 
to assume that metoprolol does not exert proteotoxic effects in trout.  
Considering the overall results, with medium-intensity stress evoked by the lab exposure itself, the 
results are not that surprising. The stress response in fish is largely mediated by catecholamines. Via 
beta-adrenergic receptors, these stress hormones lead to mobilization of energy reserves in liver and 
increased ventilation and heart rate, which also manifests in tissue alterations – primarily in the gill 
(Bonga 1997). Metoprolol blocks the respective receptors and may prevent this stress response. This 
could actually counteract effects like the ones observed in my experiments. This could lead to a 
situation, where the negative implications of increased detoxification activity are balanced by 
beneficial effects through catecholamine receptor blocking. 
Sensitivity of different life stages to diclofenac and metoprolol 
In my experiments, I exposed two different life stages of the same species and the same brood stock 
to similar concentrations of diclofenac and metoprolol. For metoprolol, both life stages did not show 
strong effects. In the experiments with diclofenac, juvenile fish showed severe effects, while early life 
stages did not react at all. The pH of both exposures differed: embryos developed in artificial water 
with neutral pH, whereas juveniles were exposed to slightly alkaline filtered tap water. This can have 
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great influence on the toxicity of ionisable pharmaceuticals (Boström and Berglund 2015). For alkaline 
substances like metoprolol, toxicity should increase with pH, while for acidic substances, like 
diclofenac, toxicity should be lower at higher pH. However, the juvenile trout reacted sensitively to 
diclofenac, despite the high pH. Consequently, I conclude that brown trout embryos and 
eleutheroembryos are less sensitive towards diclofenac than older life stages. This could be due to 
their independence from external feeding, but also differences in metabolism. In cell culture 
experiments, van Leeuwen et al. (2011) suggested that the actual toxic effect of diclofenac is due to 
intermediate products of the CYP450-metabolism. CYP450 or other enzymes can differ in their life-
stage-specific expression (Andersson and Förlin 1992), which influences the reactions to toxicants. The 
low susceptibility of early life stages was also seen in other studies on brown trout (LfW 2004) and 
rainbow trout (Memmert et al. 2013). All studies reporting sensitive reactions of fish exposed to 
diclofenac (Schwaiger et al. 2004, Triebskorn et al. 2004, Birzle 2015, Näslund et al. 2017) used older 
individuals. When ecotoxicity data are only obtained for early life stages, this might underestimate the 
risk. Future studies must be aware of this fact and should apply the most susceptible age class for a 
protective risk assessment. 
Chapter IV: Biomarker effects in invertebrates 
Paper: Jungmann et al. 2017 - Health effects of metoprolol in epibenthic and endobenthic 
invertebrates – A basis to validate future in vitro biotests for effect-based biomonitoring  
Report: Triebskorn et al. 2017 - EFF-Pharm: Effects of pharmaceuticals (nonsteroidal anti-inflammatory 
drugs and beta-blockers) in fish and invertebrates and their detection by newly developed in vitro-
bioassays – Final report  WP3A, WP4, WP6 
Aims 
For the assessment of pharmaceutical ecotoxicity to invertebrates, the water flea Daphnia magna is 
usually the most common investigated organism. In our studies, we ventured beyond this. Not only by 
additionally testing pharmaceutical effects in gammarids, gastropods, and sediment-dwelling 
oligochaetes, but also by investigating additional endpoints of toxicity. Invertebrate studies focus 
mainly only on organismic parameters, like survival, reproduction, or growth. I expanded this range of 
endpoints with biochemical analyses of stress proteins and lipid peroxides.  
Biomarker effects of diclofenac in gammarids, daphnids and oligochaetes 
In general, analyses of stress proteins in gammarids turned out to be more difficult than in fish. A 
considerable portion of samples showed no or only a very weak signal after immunostaining. Relative 
Hsp70-levels varied between 0 and 1.03, with a mean of 0.19. Exposure to diclofenac did not affect the 
stress protein levels of gammarids (ANOVA, df=5/97, F=0.7660, p=0.5765; data transformed by cubic 
root). Lipid peroxide levels ranged between 5.18 and 57.16 CHPE, with a mean of 18.23 CHPE – which 
was close to the mean of 17.94 CHPE for the t0 control. There was a slight, non-significant tendency for 
the degree of lipid peroxidation to decrease with increasing diclofenac concentration (Welch-ANOVA, 
df=5, F=2.0571, p=0.0898). In contrast, body mass seemed to slightly increase with exposure 
concentration. Interestingly, the animals of the t0-control were heavier than the control animals 
sampled at the end of the experiment (mean t0: 16.96 mg; mean experiment: 13.63 mg).  
Hsp70-levels in D. magna varied between 0.27 and 1.64 (mean: 1.0) and showed no difference 
between the treatments (linear model, df=5/15, F=0.3356, p=0.8835). Sample size was small, since 
pools of two individuals were necessary to achieve the required protein amount, and was even smaller 
for the two highest diclofenac treatments, which experienced high mortality. 
The analysis of stress proteins in the oligochaetes proved to be a great technical challenge for the 
applied method. Several adjustments of the standard procedure were necessary to obtain quantifiable 
 47 
 
amounts of Hsp70 (pooling of samples, loading with higher protein mass – all changes are already 
mentioned in the Material and Methods section). Finally, the immunostaining yielded weak, barely 
measurable signals. However, the necessity to pool the samples, both for the analysis of stress proteins 
and lipid peroxides, resulted in a very low number of replicates for each treatment. Except for a single 
sample of the highest treatment (rel. Hsp70-level: 0.8651), all stress protein levels were in a 
comparable, low range (0.0015-0.4740, mean: 0.1546). The observed variability appeared higher at 
diclofenac-treated groups, with several visible outliers, but there was no overall treatment-related 
difference (ANOVA, df=5/24, F=0.5211, p=0.7579, data transformed by cubic root). Lipid peroxide 
levels varied between 13.59 and 36.68 CHPE, with a mean of 20.98 CHPE, without apparent differences 
between treatments (ANOVA, df=5/24, F=0.4661, p=0.7975, data transformed by square-root).  
Biomarker effects of metoprolol in gammarids, daphnids, gastropods and oligochaetes 
Due to 100 % mortality in the 135 and 405 mg/L metoprolol treatments, stress proteins could only be 
examined for the three lowest test concentrations in the gammarid experiment. For the 45 mg/L 
treatment, sample size was reduced due to the already high mortality in this group. Relative Hsp70-
levels of gammarids exposed to metoprolol varied between 0.018 and 1.23, with a mean of 0.47. There 
were no differences between the treatments and the control (ANOVA, df=3/98, F=0.1333, p=0.9400; 
data transformed by square-root), but the levels were overall higher than in the corresponding t0-
control (mean: 0.29).  
When exposed in the artificial indoor streams, the stress protein levels were visibly reduced (0.003-
1.14, mean: 0.23), compared to the respective t0 control (mean: 0.42). However, none of the AIS-
treatments differed from the AIS-control (linear model, df=5/67, F=1.835, p=0.1178). Individuals 
exposed to the highest treatment (21.95 mg/L) were smaller than control animals (linear model, 
df=5/84, F=3.168, p=0.0114), while there was no difference to the other treatments. 
Stress protein levels of metoprolol-treated D. magna ranged between 0.29 and 1.29 (mean: 0.75). Like 
for diclofenac, sample size in the higher treatments was greatly reduced due to high mortality. The 
treatments with sufficient sample size did not show an apparent difference to the control group.  
P. antipodarum experienced an obvious, concentration-dependent increase of relative Hsp70-level 
with rising metoprolol-concentration in the single-substance laboratory experiment. In the highest test 
concentrations of 10 mg/L, Hsp70-levels were significantly higher than in the negative control (linear 
model, df=5/30, F=3.22, p=0.01915). This difference was even more pronounced in contrast to the 
solvent control. However, since the only other treatment receiving solvent was the positive control, a 
direct comparison between solvent control and metoprolol treatments is not meaningful. Overall, 
levels varied between 0.04 and 1.0. In contrast to the batch experiment, Hsp70-levels were not 
affected in the AIS-setup after 28 d (linear model, df=5/36, F=1.819, p=0.1339). After 40 days, the 
highest concentration (21.95 mg/L) led to reduced Hsp70-levels (linear model, df=5/36, F=2.906, 
p=0.02645). 
In oligochaetes exposed to metoprolol, stress protein levels showed high variability (0.0002-0.3685, 
mean: 0.1161), compared to constantly low levels in the control (0.0151-0.1078, mean: 0.0481). 
However, only the lowest treatment concentration differed visibly from the control. The higher-
concentrations treatments differed only slightly from the control, and the observed difference in 
means was non-significant (ANOVA, df=5/20, F=2.2054, p=0.0942; data transformed by cubic root). 
Lipid peroxide levels tended to be higher at metoprolol-treatments (Kendall’s Tau, n=30, τ=0.2847, 
p=0.0371), but there was no clearly observable difference of any treatment compared to the control. 
Lipid peroxide levels varied between 16.89 and 25.47 CHPE, with a mean of 20.74 CHPE. In the AIS 
setup, the oligochaetes escaped from their enclosures and investigation of biochemical markers was 
not possible.  
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Discussion 
Overall, I could not observe any response in stress protein levels of G. fossarum exposed to either 
diclofenac or metoprolol. Even in treatment groups that already experienced high mortality, Hsp70-
levels did not differ from the control. This suggests that both pharmaceuticals do not exhibit 
proteotoxic effects. However, it is also possible that the Hsp70-system was already overwhelmed in 
these organisms and therefore did not show any further changes. In this case, the applied 
concentrations were either generally too high to see the reaction phase of the stress protein response, 
or the test concentration spacing was an unfortunate choice. The observed difference in stress protein 
levels between lab-kept animals and the t0-control from the field shows that, in general, changes can 
be evoked. The difference could, on the one side, be due to stress of the animals by handling and 
experimental procedure. On the other side, it may be also attributable to the different age and 
reproductive state. The tendency of decreased levels of lipid peroxides with increasing diclofenac-
concentrations could hint at an ameliorative effect of the pharmaceutical, like it is observed for fish 
(McRae et al. 2018). Via its mode of action, diclofenac inhibits oxygenases, which have peroxidation 
ability. Due to the high variation observed in the data, the trend is vague and non-significant. The lower 
proportion of adult individuals and egg-bearing females in diclofenac-exposed experimental groups 
explains the observed tendency of higher body mass in gammarids in those groups. With less energy 
invested in reproduction, the individuals can remain heavier. The lower weight of lab-exposed 
individuals overall could also be due to this energy conservation, but also to the potentially stressful 
lab conditions. Furthermore, the different age structure could also confound the results obtained in 
my biomarker analyses. In summary, there was no difference in stress protein levels evoked by the 
tested concentrations of diclofenac and metoprolol, even in concentrations leading to drastic mortality 
and reduction of reproductive parameters. Lipid peroxides were, if anything, reduced by diclofenac – 
showing no indication for oxidative stress exhibited by the substance, but rather an ameliorating 
effect. Yet, I am restricted to a conclusion concerning lipid peroxides, since no further tests concerning 
other oxidative parameters (e.g. catalase or superoxide-dismutase activity) were within the scope of 
this study. In the amphipod Hyalella azteca, effluents from a NSAID manufacturing plant led to 
increased activities of antioxidative enzymes and also increased levels of hydroperoxides, lipid 
peroxides and carbonylated proteins (Novoa-Luna et al. 2016). The effluent concentrations of four 
measured NSAIDs, diclofenac, ibuprofen, naproxen and paracetamol, ranged between 1 and 3 mg/L 
each. This complex mixture is hardly comparable to the single substance exposure in our case.  
In an earlier study on the effects of diclofenac in D. magna, the lowest concentration to evoke changes 
of the Hsp70-levels was 30 mg/L (Haap et al. 2008). At these concentrations, the mortality in our 
experiment was so high that I did not have enough samples to make a reliable statement on the stress 
protein levels. At lower test concentrations, where the sample size was not reduced in such a drastic 
way, both diclofenac and metoprolol did not evoke differences in stress protein levels, compared to 
the untreated control.  
Unfortunately, several factors complicate the interpretation of the results obtained for L. variegatus. 
The applied technique for stress protein quantification did not work as well on this organism as it did 
on the others. Overall, blotted protein bands were only weakly stained, resulting in low measured 
signal, which gives noise much greater influence. For the FOX-assay, a high dilution and long incubation 
times were necessary – still resulting only in low measured extinction values. All this introduces further 
inaccuracies into the final calculation of the CHP-equivalents. However, the biggest problem is the very 
limited number of replicates. Instead of originally planned fifteen individuals, I ended up with results 
on five pooled samples. Although the observed results did to some extent hint on potential effects of 
the tested pharmaceuticals, the database is not clear enough to make a sound statement.  
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The only tested invertebrate with a visible reaction of the Hsp70-system was P. antipodarum. Stress 
protein levels increased with ascending metoprolol concentration and were significantly higher in the 
highest tested concentration compared to the negative control. Because the variation in the negative 
control was high, these differences were not as clear for the lower metoprolol concentrations. A 
comparison to the solvent control is difficult, because none of the metoprolol treatments used a 
solvent, too. The solvent control served only as a reference for the positive control with ethinyl 
estradiol, which is required by the underlying guideline 242 (OECD 2016). However, in general the 
results from the solvent control support the conclusion drawn from the comparisons to the negative 
control. Metoprolol is likely to exert proteotoxic action in this species. In the highest test 
concentration, which resulted in drastic reduction of the reproductive output, the Hsp70-system was 
still in reaction and had not reached a state of degradation. In tendency, the biomarker already reacted 
in a concentration range that did not affect the standard parameter reproduction. Therefore, future 
approaches could benefit from the inclusion of stress protein analyses in molluscs - increasing 
sensitivity by detecting physiological changes before the alterations manifest in reduced reproduction. 
The method worked well for this organism, but again, individuals had to be grouped into larger pools. 
This reduced the sample size, and resulted in only six pools per treatment. Further investigations with 
higher sample size would be helpful before drawing definitive conclusions. Contardo-Jara et al. (2010) 
found an increase of hsp70-mRNA in the zebra mussel Dreissena polymorpha at concentrations as low 
at 0.534 μg/L metoprolol, which is close to the concentrations where Hsp70-levels tended to increase 
in our study. It may be that the stress protein system of molluscs reacts to metoprolol in a more 
sensitive manner than in other invertebrate taxa. Further studies with other species of gastropods or 
bivalves could help shedding light on this issue. The results of the AIS-experiment stand in contrast to 
the batch experiments, because the stress protein level was decreased by metoprolol in the 
mesocosms. However, the concentration evoking a decrease of Hsp70 in the AIS was considerably 
higher than the ones tested in the batch experiment. This high concentration, combined with physically 
stressful conditions in the flow-through, may be responsible for a beginning breakdown of the Hsp70-
system. While the animals were still coping with the combined stress of stream and metoprolol after 
28 days, the system might be overwhelmed after a longer time – resulting in strongly reduced levels 
of Hsp70 at the highest test concentration. 
Chapter V: Laboratory and semi-field studies with effluents 
Report: Triebskorn et al. 2017 - EFF-Pharm: Effects of pharmaceuticals (nonsteroidal anti-inflammatory 
drugs and beta-blockers) in fish and invertebrates and their detection by newly developed in vitro-
bioassays – Final report  WP5 
Aims 
One intended field of application for the developed in vitro biotests is the quality assessment of 
wastewater and/or wastewater treatment. In this context, it is important to know whether the mixture 
of substances present in treated wastewater is able to evoke effects in biota. Hence, I wanted to gain 
own experimental experience with respect to the question whether wastewater treatment plant 
effluents exert an impact on developing brown trout embryos and gammarids. In separate 
experiments, I exposed brown trout from fertilized egg to free-feeding larvae to the effluent of a 
conventional three-stage treatment plant: once in a semi-field situation directly at the plant, and once 
in a laboratory setting with water samples taken from the effluent. The evaluation of organismic 
parameters was complemented by analysing lipid peroxidation and assessing histological integrity of 
larval organs. Gammarids were only exposed in a semi-field experiment, which was complemented by 
biochemical analyses of lipid peroxides and stress proteins.  
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Organismic and biomarker effects in embryonic brown trout  
In the WWTP Eriskirch, mean temperature was 8.87 °C, conductivity 1261.4 µS/cm and oxygen 
saturation 76 %. These conditions differed strongly from the field control side at the ISF Langenargen 
(temperature: 7.42 °C, conductivity: 317.4 µS/cm, O2-saturation: 97 %). Chemical analyses of the water 
showed concentrations of 1.44 µg/L diclofenac and 1.39 µg/L metoprolol in the WWTP effluent. 
Previous analyses of the effluent already showed that the conventional treatment effectively reduces 
turbidity, but does not remove micropollutants like 1-H-benzotriazole, carbamazepine, diclofenac or 
sulfamethoxazole to a sufficient proportion (<50 % elimination). Another peculiarity were increased 
levels of perfluorooctanesulfonic acid (PFOS) in this particular WWTP (Triebskorn 2017, p166-170). The 
control water from the Lake Constance was not contaminated with measurable concentrations of both 
diclofenac and metoprolol. At both sites, the embryos reached the eyed ova stage after 31 dph. They 
finished hatching on day 50 at the WWTP and on day 64 at the control site. At the WWTP, embryonic 
development was finished 79 dph and the experiment ended after 106 days. Development took longer 
at the control site, where yolk sacs were consumed 99 dph and the experiment was terminated after 
120 days. Unfortunately, the larvae at the WWTP escaped from one of the sieves, leaving only five of 
six sieves for sampling at the end of the experiment. Mortality was higher in the control (20 %) than in 
the WWTP effluent exposure (9 %), but a large part of the control mortality occurred after swim-up of 
the larvae. The number of malformed larvae was negligible in relation to the overall number (3 of 434 
individuals at the final sampling). Heart rate was slightly higher at the WWTP than at the control site 
(76 vs. 74 bpm) but overall variation was high (60-99 bpm). Larvae from the control site were much 
larger (235.3 vs. 106.1 mg) than those from the WWTP and had slightly lower levels of lipid peroxides 
(4.34 vs. 5.0 CHPE).  
The water parameters of the lab experiment were in the intended range. Temperature was between 
6.1 and 6.7 °C (mean: 6.36 °C), pH between 7.6 and 8.2 (mean: 7.8) and oxygen saturation between 
92.5 and 123 % (mean: 102 %). The conductivity of the WWTP effluent (mean: 1288.5 µS/cm) was 
considerably higher than that of artificial water (mean: 755.5 µS/cm). At 35 dph, the vast majority of 
embryos of both treatments reached the eyed ova stage. Last stragglers had reached this stage at 43 
dph. First embryos hatched at 71 dph and all embryos had hatched at 84 dph, with one replicate of the 
control not starting until 81 dph. For the biggest part of this phase, embryos exposed to WWTP effluent 
seemed to develop slightly faster, but the control embryos joined up fast during the last days. Heart 
rate varied between 42 and 54 bpm (mean: 45.1 bpm). Embryogenesis was finished after 149 days of 
exposure. Mortality rates were variable (0-55 %), but on average not different between the two 
treatments. Observed mortality happened mainly after the larvae had hatched. Like in the field 
experiment, malformation rates were negligible. Control larvae were considerably heavier than the 
ones exposed to WWTP effluent (control: 73-147 mg, mean: 115.5 mg; effluent: 48-130 mg, mean: 
147 mg; linear model, df=1/138, F=17.42, p<0.0001). A similar effect was seen for lipid peroxides 
(linear model, df=1/138, F=42.714, p=0.0018), which were also lower in the effluent-exposed larvae 
(control: 0.07-8.80 CHPE, mean: 4.67 CHPE; effluent: 1.79-7.41 CHPE, mean: 3.79 CHPE). Overall, the 
kidney of larvae were in a good histological state. There were no histological differences between the 
control and the effluent-exposed larvae. Most individuals were in a control state, few showed mild to 
moderate reactions. Observed peculiarities of renal histology were vacuolization in tubular cells - likely 
an age-related effect that was also observed in the single-substance exposure of trout larvae - and 
slight alterations of the hematopoietic tissue (large vacuoles in hematopoietic cells). In two cases, 
necrosis of single cells was observed. 
Due to the large variations in overall exposure conditions, the direct comparison between both field 
sites is not meaningful. The obtained values should rather be taken as overall qualitative reference for 
the lab experiment. The most important finding in the field experiment was that embryos/larvae 
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exposed to WWTP effluent developed normally and did not exhibit high mortality. Therefore, I can 
conclude that the effluent of the WWTP Eriskirch does not have drastic effects on this particular life 
stage of brown trout. However, this finding is exemplary and cannot be generalized to other WWTPs, 
which may deal with a completely different mixture of chemicals and other purification rates.  
The high heartbeat rate in the field exposures compared to the lab data can be attributed to the higher 
temperature in in the field. Likewise, the faster hatching in the field is also due to temperature effects. 
This may also be seen in the differences in hatching time between the single substance exposure 
experiments [experiment 3] and the WWTP effluent exposure experiment in the lab [experiment 5]. 
While hatching in the single substance exposure was finished after 70 days, it took 84 days for the 
WWTP effluent exposure. These experiments took place in separate thermo-constant chambers – 
whose mean temperatures differed by approximately 1 °C. This further illustrates the strong effect of 
even slight temperature differences on trout development. However, compared to the data published 
by Killeen et al. 1999a, the development of the embryos in my laboratory experiments seems slow. In 
the published study, eyed ova stage is reached after 30 days, hatching is finished after 82 days and the 
embryo is fully developed after 127 days at 6 °C. Hence, embryos in my experiments developed slower, 
even though they were exposed at a higher temperature. In the single-substance exposure 
experiment, embryonic development was also slower than suggested by literature data. A likely 
explanation is plasticity in this parameter, for example depending on the genetic origin. Female brown 
trout show great variability in egg number and egg size depending on genetic and environmental 
parameters (Jonsson and Jonsson 1999). Hence, there may also be variability in developmental times. 
All eggs/embryos used for my experiment came from the same stock of animals and all my obtained 
results are consistent within themselves. In the previous experiments with effluent samples in the 
project SchussenAktivplus, effluent after flocculation filtration had no significantly negative effects on 
hatching or survival of zebrafish embryos (Triebskorn 2017, p.228-229), which matches my results. 
However, various in vitro assays pointed at adverse effect potentials in the water: those included 
increased mutagenicity, dioxin-like activity, estrogenic, anti-estrogenic and androgenic activities 
(Triebskorn 2017, p.202-226). 
The most interesting effect of the effluent exposure experiment in the lab was the reduced body mass 
compared to the control. In contrast to the field experiment, the larvae did not receive any feed, since 
the exposure was terminated before the yolk sac was fully consumed. Therefore, I can assume that all 
exposed larvae were supported with the same amount of resources from beginning to end. This 
suggests that larvae from effluents could not allocate as much resources into growth as their 
conspecifics in the control did. Most likely, they had to invest more into detoxification of the chemical 
cocktail they received through the exposure medium. This could be pharmaceuticals like diclofenac 
and metoprolol, but also other organic substances (biocides, detergents…) or salts – which is reflected 
in the much higher conductivity of the effluent. 
Regarding the results on lipid peroxides, there are two possible explanations for the reduced level in 
the effluent-exposed larvae. On the one side, certain substances in wastewater (e.g. pharmaceuticals 
on a variety of synthetic anti-oxidants (Sies 1993)) may exhibit an anti-oxidative effect, reducing 
oxidative stress. Even with other substances present, which might increase oxidative stress, the net 
effect still could be positive. On the other side, the vast diversity of different trace substances in the 
effluent could induce the overall oxidative stress response of the organism, e.g. by protective enzymes. 
In contrast, organisms raised in pristine water containing no more than the essential electrolytes, have 
less reason for this induction. Such effects were discussed for NSAIDs in Chapter III. Increased levels of 
antioxidant enzymes would reduce the effects of oxidative stress (Martinez-Rodriguez et al. 2018), like 
the level of lipid peroxides, but also come at an increased resource cost. In view of the reduced body 
mass in effluent exposed larvae in the lab, this hypothesis is plausible. One year-old rainbow trout 
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exposed in effluent of the same WWTP displayed increased levels of the detoxifying enzyme Cyp1A1, 
and showed histological reactions in the liver tissue (Triebskorn 2017, p.235-238). This can be 
interpreted as result of higher metabolic activity, and would fit well to my results – though the 
investigated life stage was different. Future studies could investigate effects on oxidative stress more 
closely by having a look on the activity of antioxidative enzymes like catalase, ascorbate-peroxidase or 
superoxide dismutase. 
Biomarker effects in gammarids 
Environmental parameters also differed in this experiment. In the WWTP effluent, pH was 6.1, 
conductivity 1053 µS/cm, temperature 14.35 °C and oxygen saturation 93 %. At the first sampling in 
the stream (t0), pH was 6.7, conductivity 731 µS/cm, temperature 12.0 °C and oxygen saturation 86 %. 
At the second sampling in the field (t40), corresponding to the end of the exposure, pH was 7.6, 
conductivity 732 µS/cm, temperature 13.2 °C and oxygen saturation 92 %. 
Lipid peroxides were of a comparable level in effluent-exposed gammarids and the t40 control (mean: 
57.0 CHPE). Values obtained for the control at the start of the experiment (t0) were higher (mean: 
68.4 CHPE), but did not differ significantly (linear model, df=2/91, F=2.651, p=0.07604, log-
transformed data). Body mass showed great differences between all treatment groups (linear model, 
df=2/91, F=25.39, p<0.0001, fourth-root transformed). Control individuals sampled after 40 days (8.6-
22.5 mg, mean: 14.77 mg) were heavier than at the beginning (5.6-20.5 mg, mean: 11.28 mg), and 
individuals exposed in the effluent (10.5-21.9 mg, mean: 17.35 mg) had an even bigger body mass than 
t40 and t0. Hsp70-levels in t0 control animals (mean: 0.36) were lower than those of the t40 control, 
which resulted in an overall significant difference (linear model, df=2/98, F=3.845, p=0.02469, square-
root transformed). There were no differences in Hsp70-level between the t40 control and the effluent-
exposed animals (0-1.02, mean: 0.42). 
Based on our results it seems likely that the chemicals present in the wastewater effluent exhibit no 
oxidative or proteotoxic effects on gammarids. On the other hand, it would also be possible that the 
oxidative and anti-oxidative substances balance each other so that no net effect remains to be seen. 
Moreover, it may also be that the induction of cellular defence mechanisms prevents damage. Since 
the Hsp70-system of gammarids did not react in the single substance exposure at concentrations 
exceeding the wastewater effluent concentrations by orders of magnitude, my results are not 
surprising. One year-old rainbow trout exposed to the effluent had no increased levels of Hsp70 
(Triebskorn 2017, p.235-238). In a field study on G. fossarum at wastewater-exposed streams, Hsp70 
expression depended on season, but the reactions to effluent exposure were inconclusive. However, 
the stress protein Hsp90, which is closely associated with steroid hormone interactions, was decreased 
downstream the WWTP discharge (Schirling et al. 2005). In a supposedly polluted stream, which had 
previously suffered from high crayfish mortality, Hsp70-levels in gammarids and trout were distinctly 
elevated (Triebskorn et al. 2002). Gammarids from the Schussen river, in which the WWTP Eriskrich 
discharges its effluent, showed higher Hsp70-levels at sites downstream of WWTPs (Triebskorn 2017, 
p.323-324). The differences in body weight between all samplings are most likely due to age, 
temperature and nutritional conditions. All animals derived from the same stock population, but the 
effluent and t40 animals had 40 days more to feed than the t0 control animals. Moreover, the effluent 
seems to provide a warm environment with good nutritional conditions (high bacterial 
biomass/aufwuchs) for gammarids – reflected in the higher body mass. This also seems to 
counterbalance potential chemical stress on the first glance. However, females exposed to the effluent 
also showed reduced fecundity, which fits to adverse effects on P. antipodarum reproduction in earlier 
studies (Triebskorn 2017, p.231-233). Hence, the long-term population effects of effluent exposure 
should be more drastic. Comparable effects were found in Gammarus pulex exposed to estrogen-
containing wastewaters (Schneider et al. 2015): effluent-exposed cohorts were bigger, but also had 
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altered sex ratio and fecundity. In another case, fecundity and fertility of G. fossarum were reduced, 
but enzymatic parameters like glutathione-S-transferase activity were unaltered by WWTP effluents 
(Wigh et al. 2017). Besides several sensitive insect orders, Gammarus pulex and Gammarus fossarum 
are among the most sensitive invertebrates in river ecosystems, and wastewater discharge is one 
important cause for the degradation of these systems (Berger et al. 2016).   
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9. Summarizing assessment of data obtained in Eff-Pharm 
In the project Eff-Pharm, we investigated the impact of the pharmaceuticals diclofenac and metoprolol 
in a wide variety of different organisms, quantified via several endpoints. Table 4 summarizes the 
obtained effect concentrations of all experiments. In the following, I will provide a summarizing 
assessment of these combined results. 
Table 4: Summary of effect concentrations obtained in Eff-Pharm. Results in grey were not part of this thesis. The most 
prominent effects identified in this thesis are highlighted in red.  
Test organism Endpoint Diclofenac Metoprolol 
Salmo trutta 
 (embryo) 
  
  
Survival 
NOEC ≥ 74.6 µg/L NOEC ≥ 998 µg/L 
Growth 
Development 
Histological state 
Salmo trutta 
 (juvenile) 
  
  
  
Survival NOEC = 10 µg/L - decrease 
NOEC ≥ 745 µg/L 
Bite marks NOEC = 1 µg/L - increase 
Stress proteins 
NOEC ≥ 200 µg/L 
NOEC ≥ 745 µg/L 
Lipid peroxides Not tested 
Histological state Reactions in all treatments Kidney reacting at 0.094 µg/L 
Gammarus 
fossarum 
(batch) 
  
  
Mortality NOEC = 8000 µg/L - increase NOEC = 15000 µg/L - increase 
Reproduction NOEC = 790 µg/L - decrease NOEC = 5000 µg/L - decrease 
Stress proteins 
No effect up to 24,100 µg/L 
NOEC ≥45,000 µg/L 
Lipid peroxides Not tested 
Gammarus 
fossarum 
(AIS) 
  
  
  
Mortality 
Not tested 
NOEC ≥ 21,950 µg/L 
Reproduction NOEC = 740 µg/L - decrease 
Stress proteins NOEC ≥ 21,950 µg/L 
Lipid peroxides NOEC ≥ 21,950 µg/L 
Body mass NOEC = 2950 µg/L - decrease 
Daphnia 
magna 
Immobility EC50 = 25,200 µg/L - increase EC50 = 2000 µg/L - increase 
Reproduction EC50 = 15,000 µg/L - decrease EC50 = 2900 µg/L - decrease 
Stress proteins NOEC ≥ 53,700 µg/L NOEC ≥ 3200 µg/L 
Lumbriculus 
variegatus 
Reproduction NOEC = 80 mg/kg dw NOEC = 160 mg/kg dw 
Stress proteins Increasing variance Tendentially increasing 
Lipid peroxides NOEC ≥ 10 mg/kg dw Increase 
Potamopyrgus 
antipodarum 
(batch) 
Reproduction 
Not tested 
NOEC = 3200 µg/L - decrease 
Stress proteins NOEC = 3200 µg/L - increase 
Potamopyrgus 
antipodarum  
(AIS) 
Reproduction 
Not tested 
NOEC < 220 µg/L – decrease 
Stress proteins NOEC = 2950 µg/L - decrease 
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Effects of diclofenac 
Diclofenac had negative effects on gammarid survival at concentrations in the low mg/L range. For 
daphnids, effect concentrations were even higher. The endobenthic oligochaete Lumbriculus 
variegatus was first affected at concentrations of 160 mg/kg diclofenac. In a study by Nieto et al. (2017) 
another sediment invertebrate, the non-biting midge Chironomus riparius, showed reduced 
emergence at 34 mg/kg diclofenac. In comparison to the tested invertebrates, brown trout was a much 
more sensitive test organism, with negative effects on behaviour and mortality at low to medium µg/L-
concentrations. One possible explanation for these differences is that human cyclooxygenases 
(prostaglandin synthase) share more structural similarities with those of teleosts than to those of 
invertebrates (Gunnarsson et al. 2008, Rand-Weaver et al. 2013, Verbruggen et al. 2018, 
http://ecodrug.org/ - 18.06.2018). In almost all studies that reported effects of diclofenac in low 
concentrations, fish were the examined organism (Schwaiger et al. 2004, Birzle 2015, Bickley et al. 
2017, Näslund et al. 2017). An exception is the sea urchin Paracentrotus lividus, which showed to be 
an invertebrate with high sensitivity to diclofenac (Ribeiro et al. 2015). Sea urchins are 
deuterostomians, and therefore phylogenetically more closely related to humans than protostomian 
invertebrates. Further conclusions on the general sensitivity of echinoderms are difficult, because they 
are rarely applied in ecotoxicological research.  
Recent studies also pointed out that molluscs may be sensitive towards NSAIDs: Ericson et al. (2010) 
examined the marine blue mussel Mytilus edulis and reported on a lower scope for growth at 100 µg/L. 
However, the effect was not concentration-dependent and strong effects, like lower byssus strength 
and lower number of byssus threads, were first evoked at concentrations of 10 mg/L. Schmidt et al. 
(2011) showed that diclofenac leads to DNA-damage and induces oxidative stress in Mytilus spec. at 
concentrations as low as 1 µg/L. Bonnefille et al. (2018) found effects on tyrosine and tryptophan 
metabolism of Mytilus galloprovincialis at 122 µg/L diclofenac, which could influence osmoregulation 
or reproduction. They also pointed out that other modes of action beyond COX-inhibition, i.e. effects 
on monoamine oxidase, may be primarily responsible for the effects observed in molluscs. In the 
mesocosm experiments described by Joachim (2017) and James-Casas and Andres (2017), which 
investigated a broad range of different taxa in the same system, suborganismic effects in molluscs 
were even more sensitive endpoints than those of fish. Unfortunately, molluscs are not a regular test 
species in the environmental risk assessment of pharmaceuticals. Due to their sensitivity, it is advisable 
that further studies are conducted, especially on freshwater-dwelling species, to enlarge the database 
for this taxon.  
A mechanism which is not tackled in my own studies, is the suspected action of NSAIDs on the 
vertebrate reproductive system. In vitro studies pointed out that diclofenac has the potential to 
interfere with steroid metabolism and inhibits the metabolism of important sex hormones like 17α-
hydroxyprogesterone or androstendione (Fernandes et al. 2011). In hepatocytes of Oreochromis 
niloticus it up-regulated the expression of genes for the production of vitellogenin (Gröner et al. 2015). 
The same result was seen in Oryzias latipes already at concentrations of 1 µg/L (Hong et al. 2007). In 
the frog Xenopus laevis, diclofenac altered sex hormone levels, induced the synthesis of vitellogenin, 
and altered male calling behaviour (Efosa et al. 2017). Chae et al. (2015) reported teratogenic effects 
on the protein level for the same species. Various reproductive parameters, like hatchability and 
fecundity, were decreased in medaka in a two-generation experiment, albeit only at a concentration 
of 10 mg/L (Lee et al. 2011). In a medaka ovulation assay, Yokota et al. (2016) demonstrated an in vitro 
antiovulatory effect of diclofenac at 30 mg/L. Moreover, the effect was clearly shown to be a 
cyclooxygenase-mediated effects, because it was negated by co-exposure to prostaglandin E2. In vivo, 
the effect was much more pronounced: fecundity was reduced at 0.1 mg/L, fertility at 0.05 mg/L, and 
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the gonadosomatic index already at 0.0125 mg/L. The higher sensitivity in this case is likely due to the 
longer exposure time in the in vivo experiment.  
Diclofenac is among the most controversially discussed pharmaceuticals in respect to its 
environmental risk. After its detrimental effects on Asian vulture populations was uncovered (Oaks et 
al. 2004), various studies examined its effects in other taxa and ecosystems. In fish, multiple studies 
found histological alterations at low µg/L concentrations (Schwaiger et al. 2004, Triebskorn et al. 2004, 
Hoeger et al. 2005, Mehinto et al. 2010), while others did not find these effects at all, or only at much 
higher concentrations (Memmert et al. 2013, Stepanova et al. 2013, Praskova et al. 2014). A study re-
evaluating several of the published findings questioned the reliability of the low-concentration effects 
(Wolf et al. 2014). It is true that histological analyses require the assessor to have profound knowledge 
and are, to a certain degree, prone to subjective interpretation. However, the growing body of 
evidence compiled during the last years supports the hypothesis that low-concentrations of diclofenac 
can actually affect the integrity of several fish organs (Bickley et al. 2017, Gröner et al. 2017a, Näslund 
et al. 2017). For those studies, histological assessment was done in a blinded fashion, increasing 
objectivity of the results. Birzle (2015) even conducted elaborate biometric measurements of 
histological sections to avoid observer bias – and received highly convincing results. My results add 
right into this body of evidence. While my histological results were not as clear as seen in some other 
studies, the effects on the organismic level are of high relevance.  
The most sensitive organism to diclofenac was the brown trout Salmo trutta f. fario, with a 
LOECbite marks of 10 µg/L. 
Effects of metoprolol 
Metoprolol did not evoke substantial effects in brown trout embryos and juveniles up to 998 or 
745 µg/L, respectively. The observed qualitative histological reactions did not transfer to observable 
health impairments. Acute tests in fish already showed that fish mortality is not affected by metoprolol 
until concentrations reach higher mg/L-ranges (Huggett et al. 2002, van den Brandhof and Montforts 
2010, Moermond and Smit 2016). The crustaceans G. fossarum and D. magna showed first reactions 
in the high µg/L to low mg/L-range. Likewise, the gastropod P. antipodarum displayed effects in a 
comparable concentration range. Effect in L. variegatus are based on sediment concentrations, and 
are therefore not directly comparable to water concentrations. For gammarids, as well as gastropods, 
sensitivity to metoprolol increased when the organisms dwelled in an artificial stream situation 
(Buchberger et al. 2018). Sensitivity comparisons between the tested vertebrate and invertebrate 
species are difficult. The highest tested concentrations in the fish experiment approximately 
correspond to the lowest in the invertebrate experiments. I do not know how the fish would have 
reacted, if they were exposed to slightly higher concentrations. Sun et al. (2014) reported that 
zebrafish embryos exposed to 16 mg/L metoprolol suffered reduced hatching and increased mortality. 
Furthermore, heart rate was reduced at 1 mg/L, albeit not in a completely concentration-dependent 
manner. Due to restrictions of animal testing, elaborate pre-testing and range-finding experiments 
were not possible for fish in my experiments. Therefore, the concentrations based on literature data 
for adult rainbow trout (Triebskorn et al. 2007). In retrospect, these concentrations were too low to 
derive effect concentrations. However, they traversed an environmentally relevant range, as well as 
considerably higher concentrations, without finding worrying effects. In a comparative study published 
by Moermond and Smit (2016), which was based on regulatory and literature data, crustaceans were 
identified as the most sensitive taxon in terms of traditional endpoints, with a lowest NOEC of 3.1 mg/L. 
The observed effect was reduced reproduction in a 9 d test with Daphnia magna (Dzialowski et al. 
2006).  A study over six generations of D. magna by Dietrich et al. (2010) yielded a very low LOEC of 
1.2 µg/L, but cannot be regarded as fully reliable : the authors tested only a single concentration, and 
the results were not consistent with those of a mixture treatment in the same experiment. So far, only 
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results for acute tests are available for crustacean species other than D. magna (Huggett et al. 2002, 
Fraysse and Garric 2005, Nalecz-Jawecki and Persoone 2006). Chronic effect data on algae, also 
reviewed by Moermond and Smit (2016), ranged from 6.14 to 24.3 mg/L. The review based its 
assessment of fish toxicity on a reported NOEC on fish growth and development of 12.6 mg/L for Danio 
rerio (van den Brandhof and Montforts 2010). However, the more recent results by Gröner et al. 
(2017b), which reported at NOEC for fish growth of 1.1 µg/L, should also be taken into account.  
In view of the obtained biomarker results, the most striking finding is the increase of stress protein 
levels in P. antipodarum exposed to metoprolol. The decrease of Hsp70, observed in snails exposed to 
the highest concentration in the AIS, does not necessarily contradict this finding. Due to technical 
difficulties in the test setup, there was a concentration gap between 2.95 and 21.95 mg/L. I can only 
speculate on potential effects, if further intermediate concentrations would have been tested. In the 
40d-sampling, reproduction decreased to near zero at the highest test concentration, but was not 
affected at lower concentrations. It is likely that the organisms exposed to 21.95 suffered drastic 
physiological stress, which also led to overwhelming of the Hsp70-system (Köhler et al. 2001). In my 
studies, I did not examine the effects of metoprolol on lipid peroxidation in the single substance 
experiments with trout, gammarids, and gastropods. Lipid peroxide levels of gammarids exposed to 
metoprolol in the AIS did not react to any of the exposure concentrations. However, in L. variegatus 
the levels of lipid peroxides tended to be higher at rising test concentrations. A recent study showed 
that metoprolol can lead to oxidative stress in carp Cyprinus carpio, visible by increased levels of 
hydroperoxides, lipid peroxides and carbonylated protein, as well as increased activity of superoxide-
dismutase and catalase, in concentrations as low as 10 ng/L (Martinez-Rodriguez et al. 2018). The 
underlying assumption is that the metabolism of metoprolol produces and releases free radicals. A 
similar effect may be true for the tested oligochaetes. Because the trend was weak and the results are 
only based on one indicator of oxidative stress, I view my results as a first indication of oxidative effects 
of metoprolol in invertebrates, rather than definitive evidence.  
In comparison to reported environmental concentrations, our own observed lowest effect 
concentrations do not seem worrisome. WWTP effluent concentrations range up to 5 µg/L (Maurer et 
al. 2007, Scheurer et al. 2010, Meyer et al. 2016), which is high, compared to other pharmaceuticals, 
but still considerably lower than our effect values. Moermond and Smit (2016) derived an EQS of 
62 µg/L from the above cited studies for metoprolol ecotoxicity. This is considerably higher than 
surface water and even WWTP effluent concentrations. An environmental risk assessment of atenolol, 
another beta-blocker, also identified a low risk quotient for the substance (Küster et al. 2010). In 
contrast, ERAs by Godoy et al. (2015) concluded that that atenolol, metoprolol and propranolol can 
pose a risk, but also referred to the paucity of relevant effect data. Within the substance class of beta-
blockers, propranolol seems to be the one with the greatest adverse effect potential. It affects sea 
urchin development at concentrations higher 5 µg/L (Ribeiro et al. 2015), has a LC50 of 130 µg/L for 
Danio rerio larvae (Sun et al. 2014), decreases growth of medaka at 500 µg/L (Huggett et al. 2002) and 
was generally identified as one of the pharmaceuticals with the highest risk ratios (Fent et al. 2006, 
Donnachie et al. 2016). Another potential problem arises from suspected endocrine effects of beta-
blockers (Massarsky et al. 2011), which are supported by the recent findings of tilapia mRNA 
expression (Gröner et al. 2015, Gröner et al. 2017b) and effects of propranolol on medaka sex steroid 
levels (Huggett et al. 2002). None of the conducted studies so far, including ours, can answer the 
question, whether beta-blockers have adverse long-term effects on fish populations through 
interference with endocrine pathways. For this purpose, elaborate fully-life-cycle or multi-generation 
tests will be necessary. One must not forget that the cited evaluations base on single substances, 
whereas a mixture of all different beta-blockers is present in the environment. Combination toxicity 
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must be assessed for these substances with shared mode of action to achieve a more realistic risk 
assessment. 
The most sensitive organism to metoprolol in a laboratory setting was the water flea Daphnia 
magna, with a LC50 of 2 mg/L. The most sensitive organism in the AIS was the mudsnail 
Potamopyrgus antipodarum, with a LOECreproduction of 0.22 mg/L. 
Stress proteins and lipid peroxides as additional endpoints 
In the majority of cases, the levels of stress proteins and lipid peroxides were not significantly affected 
by the treatment at all. Nevertheless, differences attributable to other factors were common. 
Gammarids showed distinct differences in Hsp70 according to their age, when animals sampled at the 
end of the experiments were compared to the t0-control. Likewise, trout exposed in the lab differed 
in comparison to their conspecifics at the hatchery. In addition to literature data, this demonstrates 
that the Hsp70-system can react plastically to environmental conditions (Schirling et al. 2005). Field 
data, which showed that fish exposed to differentially polluted streams differ in their stress protein 
levels, support this assumption (Triebskorn et al. 2002, Wilhelm et al. 2017). Besides pollution, other 
environmental (Iwama et al. 1998) and seasonal effects are of high importance (Köhler et al. 2001). 
My results were always standardized to the total amount of protein, and effects were always 
quantified in relation to the respective control. Hence, the effect of such confounding factors should 
be low in our laboratory experiments, but is nicely demonstrated by the differences to hatchery or t0 
controls. In our case, hints on induced changes by pharmaceuticals were only seen for metoprolol in 
snails. In the past, the gastropod stress protein system has already proved to be highly inducible by 
environmental stressors, like in the terrestrial snail Xeropicta derbentina exposed to heat (Dieterich et 
al. 2015). This suggests that quantification of Hsp70 is an especially useful additional biomarker for 
gastropods. For the other tested taxa, there is no sensitivity benefit in comparison to the traditional 
endpoints. However, this conclusion is restricted to the two tested pharmaceuticals and cannot be 
generalized for other stressors. Especially for brown trout and gammarids, the method itself worked 
fairly well and the sample sizes were sufficient to allow a confident interpretation of the results. 
Lipid peroxidation was a useful addition to the testing battery for trout embryos exposed to effluent 
samples. In adult individuals, the results were highly variable but did not show an overall tendency, 
despite the high sample size. In this context, future studies will fare better when examining a wider 
range of oxidative stress biomarkers. Not only the final, damaged molecular components, like lipid 
peroxides and carbonylated proteins, but also defensive systems like catalase, glutathione-S-
transferase, or superoxide-dismutase activity. This will allow putting results of one endpoint into a 
broader physiological context, but is of course only possible when there is sufficient sample mass for 
all assays. 
A major problem encountered in the biochemical analyses of most tested invertebrates was the low 
sample size. The numbers derived from the official OECD guidelines and originally sufficed for the 
determination of apical endpoints. However, the need for pooling two, three, or even six individuals 
to achieve the necessary weight, drastically reduced the sample size. Therefore, statistical security of 
the results is low, especially in combination with high variation. For small invertebrates (below 10 mg) 
the test setups according to standard OECD guidelines do not yield enough samples for a thorough 
analysis of the applied biochemical markers. These tests would need to apply a higher number of 
replicates, which is difficult to implement and even more labour-intensive. The Hsp70 quantification 
was easy to implement for S. trutta and P. antipodarum, challenging for D. magna and G. fossarum, 
and very problematic for L. variegatus. Protein content was low, and there was hardly any signal after 
protein band staining, even when applying a higher-than-usual protein amount. These major problems 
could be due to a large proportion of the animals consisting of digestive tract and its content, which 
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decreases the volume of actual annelid sample and introduces further confounding factors. It may also 
be that Lumbriculus has in general a very low base level of Hsp70. Overall, I cannot recommend this 
technique for further investigations on this particular organism.  
Stress proteins are endorsed as additional biomarkers for experiments with molluscs, but not for 
aquatic oligochaetes.  
Environmental relevance 
Reported environmental concentrations of diclofenac and metoprolol are diverse, and differ 
considerably depending on country and water body. For metoprolol, Ternes (1998) reported median 
concentrations of 0.045 µg/L, but the much newer review of Hughes et al. (2013) concluded on a 
median of 0.1045 µg/L. In strongly contaminated rivers, maximum metoprolol concentrations can 
reach up to 0.52 µg/L (Meyer et al. 2016) or even 8.04 µg/L (Hughes et al. 2013). However, even these 
extreme concentrations are much lower than the lowest NOECs resulting from our studies. Hence, an 
environmental risk of metoprolol as single substance is unlikely. Aus der Beek et al. (2016b) 
summarized global concentrations of diclofenac and reported a mean concentration of 0.16 µg/L for 
German surface waters. Correspondingly, Letzel et al. (2009) calculated a worst-case PEC of 0.14 µg/L. 
Other reported PECs vary from low to medium ng/L-ranges, rarely above 0.1 µg/L (Letzel et al. 2009, 
Johnson et al. 2013). The obtained NOEC of 1 µg/L for brown trout behaviour was in the range of 
wastewater treatment plant effluent concentrations (Ternes 1998, Letzel et al. 2009) and only one 
order of magnitude higher than some reported MECs for surface water. This is an alarming result, 
especially considering that the effects were on an organismic level, with high relevance for the overall 
population. Moreover, the endpoints behaviour, mortality, and histological integrity also reacted at 
lower concentrations, albeit not to an extent to reach statistical significance. Transfer of data from 
pure laboratory setups to the environment is always associated with uncertainties. It is likely that the 
artificial fishkeeping conditions acted as additional stressor. But, as shown in the flow channel 
experiments for metoprolol, environmental conditions may also act as additional stressors and 
increase sensitivity. In the wild, fish encounter a range of challenging situations, like fluctuations in 
water parameters, limited food availability, competition or exposure to adverse chemical stressors. In 
such stressful conditions, toxicants like diclofenac could act as the final trigger leading to large-scale 
detrimental effects. To date, I am not aware of any studies linking fish population declines to NSAIDs. 
In fact, such studies are hardly possible and not realistic, because natural streams always contain 
complex mixtures of chemicals. Our own studies on WWTP effluents demonstrated the high plasticity 
of biological endpoints, and their variability in reaction to environmental parameters. There were no 
obvious adverse effects on brown trout and gammarids, but the field experiments lacked controls that 
allowed sufficient comparability. When additional environmental effects were accounted for in the lab 
experiment, the effluent alone had a considerable influence on brown trout larval growth, even though 
it did not yet transfer to effects on survival. Considering that the applied early life stage is less sensitive 
than juvenile fish, the effluent may lead to stronger effects in older individuals. Other studies have 
shown that reduced pollution through WWTP upgrade can in fact improve the health of fish in the 
receiving water (Maier et al. 2015, Wilhelm et al. 2017). Although fish were the most sensitive 
organism in our study, we must not neglect effects on invertebrates. Sensitivities may greatly differ for 
other substances. A wide range of insects, crustaceans, and other invertebrates showed to be highly 
sensitive to changes in river systems through wastewater treatment plant discharges (Berger et al. 
2016). Undoubtedly, effects of chemicals are only one of many stressors: degenerated habitat 
structure, competition by invasive species, or climate change are also of major importance in 
freshwater ecosystems. Nevertheless, as there is reason to believe that pharmaceuticals influence the 
health and survival of freshwater biota, we must take action to ameliorate these effects.   
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The veterinary use of diclofenac, with specific reference to effects in necrophagous birds, was assessed 
by the European Medicines Agency (EMEA/V/A/107 - EMA 2014). In view of the high risk for vultures, 
its use is largely restricted in European countries. In many European states, including Germany, it is 
not allowed to be used for this purpose at all. In contrast to the acknowledgement of terrestrial 
environmental risk, the situation is not as clear for the aquatic environment.  At the time when the 
project Eff-Pharm was initiated, diclofenac was added to the watch list for potential priority substances 
of the European framework directive (EU 2013, EU 2015). The aim was to generate further monitoring 
data and gain information on potential environmental implications (Schröder et al. 2016). A 
tremendous amount of studies found evidence for adverse effects of the pharmaceutical at low µg/L-
concentrations, with our own studies adding to this body of evidence. James-Casas and Andres (2017) 
summarized effect concentrations from literature and a mesocosm study conducted at the same 
institution (Joachim 2017), and compared them to measured environmental concentrations: they 
concluded that, if only standard endpoints on the organismic level are considered (PNEC = 1.11 µg/L), 
calculated risk quotients are acceptable in all but a worst-case urban scenario. However, if 
suborganismic effects are included (PNEC = 0.025 µg/L), there is a high risk for both rural and urban 
scenarios. In a preliminary report of the joint research council (Loos et al. 2017), it is concluded that 
the data situation for diclofenac is by now sufficient. Hence, it can be removed from the watch list. The 
substance’s risk quotient is worrisome – it remains to be seen which further actions will be 
implemented in European legislation to cope with this problem. 
10. Conclusions 
In vivo studies on NSAIDs, beta-blockers and wastewater treatment plant effluents 
Our studies revealed that diclofenac, but not metoprolol, poses a high risk to the aquatic organisms by 
adversely affecting juvenile fish in concentrations near those found in the environment. Mortality 
increased at 100 µg/L, histological state of major metabolic organs deteriorated, and fish showed 
conspicuous behavioural alterations already at 10 µg/L. Earlier life stages of the same species proved 
to be more resilient to the pharmaceutical exposure. In contrast to fish, freshwater invertebrates 
reacted with much lower sensitivity to diclofenac. In general, these invertebrates reacted slightly more 
sensitive to metoprolol, albeit in concentration ranges considerably higher than those reported for 
European surface waters. Stress proteins and lipid peroxides as biomarkers of effect did not, if at all, 
react more sensitively than traditional endpoints for the majority of investigated biota. One exception 
were gastropods, where the Hsp70-system reacted sensitively to metoprolol exposure. In this 
particular case, the addition of this biomarker might be a useful addition to the testing battery – but 
should be examined in greater detail. However, the suitability of Hsp70 and lipid peroxides as 
biomarkers may be different when substances with other modes of action are investigated. Our studies 
on trout larvae and gammarids revealed reactions when the organisms were exposed to the complex 
mixture of substances present in wastewater treatment plant effluents. While the results were 
inconclusive, and likely influenced by other environmental factors, for gammarids, the body mass of 
trout larvae was considerably reduced by the effluent water. At the same time, analyses of lipid 
peroxides proved to be a useful additional biomarker in this case, but should be supplemented with 
other biochemical markers of oxidative stress to facilitate interpretation of the results. 
In vitro systems as potential monitoring tools 
Besides the wide range of generated in vivo effect data, the project Eff-Pharm also managed to create 
the desired in vitro systems for quantification of beta-blockers and cyclooxygenase-inhibitors 
(Bernhard et al. 2017). The systems achieve the final result within few minutes, largely limiting the 
confounding effect of cytotoxicity in the sample. Detection limits were 2 µg/L for beta-blockers 
(measured in metoprolol-equivalents) and 0.5 µg/L for NSAIDs (measured in diclofenac-equivalents). 
Therefore, the sensitivity is below the most sensitive effects found in our own studies, and in the range 
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of the most sensitive effects overall. Further testing and modifications are undertaken to adapt the 
procedure for application in the field. Moreover, the basic principle can be adapted to a variety of 
other pharmaceutical groups, to generate a larger battery of useful in vitro systems. 
These systems will eventually allow quantification of pharmaceutical mixtures and other substances 
sharing the same mode of action in environmental samples. This will be a highly useful additional 
technique for the monitoring of surface waters. One of the major challenges in the implementation of 
the WFD is the vast number of chemicals and mixtures, with insufficient analytical procedures 
available. Here, effect-based tools promise to be a way for solution-oriented monitoring (Brack et al. 
2017). Furthermore, comparisons of influent and effluent effects could pose an efficient tool for the 
investigation of wastewater treatment plant purification efficiency. Another potential use is the 
assessment of metabolites and transformation product, in respect to their remaining effects according 
to the parent mode of action. They may also guide further, systematic assessments of mixture toxicity 
in vivo: a combination of in vitro analyses and in vivo ecotoxicity tests of pharmaceutical mixtures could 
give us further insights into the mechanisms of mixture toxicity. It remains to be seen how these 
techniques can be implemented into a broader, regulatory context.  
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The report is shortened to exclude the part on in vitro systems, which was not part of this thesis. 
 
Abstract  
In order to identify sensitive organisms, biological endpoints in vivo and suitable in vitro test systems 
for the biomonitoring of pharmaceuticals, a two-part literature search was conducted.  
In the first part, the database OEKOTOX established by Bergmann et al. (2011) [1] was upgraded with 
effect data published between 2011 and 2013 for 90 pharmaceuticals of high priority. From all 
available data the lowest effect concentrations were identified and the most sensitive organisms and 
effect endpoints were determined. In addition, effect data were assessed with respect to their relation 
to measured environmental concentrations (MECs) in German surface waters by calculations of risk 
quotients MECmax/LOECmin. Publications providing the lowest effect data were evaluated with respect 
to their reliability according to the criteria of Wright-Walters et al. (2011) [2]. Out of 72 publications 
investigated for their reliability, 9 were “reliable”, 49 “conditionally reliable” and 14 “not reliable” (of 
which 4 were, in part, conditionally reliable).  
Prior to the reliability check, the analgesics paracetamol, diclofenac and ibuprofen, the ß-blocker 
propranolol, the antibiotics sulfamethoxazole and erythromycin and the lipid regulator gemfibrozil 
were identified as environmentally most relevant pharmaceuticals. The relevance was defined by 
MECmax/LOECmin-values >0.1 for a minimum of 3 different biota classes. After assessment of publication 
reliability, however, only for diclofenac MECmax/LOECmin-values >0.1 were found in more than 3 biota 
classes. As further important pharmaceuticals propranolol, sulfamethoxazole, bezafibrate, 17α-
ethinlyestradiol, 17β-estradiol and oxytetracycline were identified with MECmax/LOECmin-values >0.1 for 
2 biota classes.  
Prior to the reliability assessment, the ciliate Tetrahymena pyriformis, zebrafish (Danio rerio), rainbow 
trout (Oncorhynchus mykiss), medaka (Oryzias latipes), the mussel Elliptio complanata, and the 
mudsnail Potamopyrgus antipodarum were identified as most sensitive organisms for 
pharmaceuticals. The most sensitive effect endpoints were chemotaxis, behavior, vitellogenin 
synthesis, growth rate, reproduction, histopathological alterations, molecular stress biomarkers, 
oxidative stress markers, receptor binding, and gene expression. All extremely low LOECs (in the range 
of pg/L) for chemotaxis alterations in Tetrahymena pyriformis, however, derive from only a single 
publication by Lang & Köhidai (2012) [3], the reliability of which, however, could not be proven.  
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In the second part, a literature search was conducted with the aim to evaluate the state of knowledge 
in the field of in vitro testing of pharmaceutical effects, to discover advantages and disadvantages of 
biochemical and cell-based assays and to suggest possibilities for the realisation of cell-based tools for 
a mode of action-based biomonitoring of pharmaceuticals. Promising approaches for ß-
adrenoreceptor blockers and cyclooxygenase-inhibitors (analgesics) are presented.  
As a future perspective for a biomonitoring of pharmaceuticals, the development of mode of action-
based in vitro test systems for ß-blockers and NSAIDs are recommended. Their suitability to reflect in 
vivo responses of organisms which have been identified to be sensitive in part 1 of this study, or which 
are relevant for German aquatic ecosystems should be assessed, and they should be validated by in 
vivo studies to be conducted in parallel to their establishment. 
Kurzbeschreibung  
Mit dem Ziel, sensitive Organismen und organismische Endpunkte sowie geeignete in vitro-
Testsysteme für ein Biomonitoring von Arzneimitteln zu identifizieren, wurde eine zweiteilige 
Literaturstudie durchgeführt.  
Im ersten Teil wurde die von Bergmann et al. (2011) [1] erstellte Datenbank OEKOTOX um Wirkdaten 
für 90 Arzneimittel von hoher Priorität bis 2013 erweitert. Von allen verfügbaren Daten wurden die 
niedrigsten Effektwerte identifiziert und die sensitivsten Organismen bzw. Effektendpunkte bestimmt. 
Darüber hinaus wurden die Effektkonzentrationen zu gemessenen Umweltkonzentrationen in 
Deutschen Oberflächengewässern (MECs) in Beziehung gestellt und Risikoquotienten MECmax/LOECmin 
berechnet. Diejenigen Publikationen, in denen die empfindlichsten Endpunkte bzw. Organismen 
enthalten waren, wurden auf der Basis der von Wright-Walters et al. (2011) [2] genannten Kriterien 
auf Reliabilität geprüft. Von 72 auf Reliabilität überprüften Publikationen wurden 9 als „reliabel“, 49 
als „bedingt reliabel“ und 14 als „nicht reliabel“ (von denen 4 in Teilen bedingt reliabel waren) 
klassifiziert.  
Vor der Reliabilitätsprüfung wurden in der vorliegenden Literaturstudie als Pharmazeutika mit 
höchster Umweltrelevanz die Schmerzmittel Paracetamol, Diclofenac und Ibuprofen, der ß-Blocker 
Propranolol, die Antibiotika Sulfamethoxazol und Erythromycin und der Lipidsenker Gemfibrozil 
identifiziert. Die Umweltrelevanz wurde auf der Basis eines Risikoquotienten (MECmax/LOECmin) >0.1 für 
mindestens 3 Organismengruppen) definiert. Nach erfolgter Reliabilitätsprüfung zeigten sich 
MECmax/LOECmin)-Werte >0.1 bei mehr als 3 Organismengruppen jedoch nur noch für Diclofenac. Als 
weitere wichtige Pharmazeutika wurden Propranolol, Sulfamethoxazol, Bezafibrat, 17α-
Ethinlyestradiol, 17β-Estradiol und Oxytetrazyclin mit MECmax/LOECmin)-Werten >0.1 bei 2 
Organismengruppen identifiziert.  
Als sensitivste Organismen für Arzneimittel hatten sich vor der Reliabilitätsprüfung der Ciliat 
Tetrahymena pyriformis, der Zebrabärbling (Danio rerio), die Regenbogenforelle (Oncorhynchus 
mykiss), Medaka (Oryzias latipes), die Muschel Elliptio complanata und die Zwergdeckelschnecke 
Potamopyrgus antipodarum erwiesen. Die sensitivsten Effektendpunkte waren Chemotaxis, 
Verhalten, Vitellogeninsynthese, Wachstum, Reproduktion, histopathologische Veränderungen, 
molekulare und oxidative Stressmarker, Genexpression und Rezeptorbindung. Alle extrem niedrigen 
LOECs (im Bereich von pg/L) für die Beeinflussung der Chemotaxis bei Tetrahymena pyriformis 
stammen allerdings von einer einzigen Publikation von Lang & Köhidai (2012) [3], die sich in der 
durchgeführten Reliabilitätsprüfung als „nicht reliabel“ erwies, so dass der Zebrabärbling als 
bedeutendster Testorganismus und das Verhalten als sensitivster Wirkendpunkt nachrückt.  
Im zweiten Teil der Studie wurde eine Literaturrecherche durchgeführt, die zum Ziel hatte, den 
Wissensstand im Bereich von in vitro-Verfahren zum Nachweis von Arzneimittel-Effekten zu 
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beleuchten, Vor- und Nachteile von biochemischen und zellbasierten Assays herauszuarbeiten und 
Möglichkeiten für die Realisierung von in vitro Testsystemen für ein Wirkmechanismus-basiertes 
Biomonitoring von Arzneimitteln vorzuschlagen. Am Ende dieses Teils werden vielversprechende 
Wege zur Etablierung solcher Testsysteme für den Nachweis der Wirkungen von ß-Blockern und 
Cyclooxygenase-Hemmern (Schmerzmitteln) dargestellt.  
Für ein künftiges Biomonitoring von Arzneimitteln wird empfohlen, Wirkstoffklassen-spezifische in 
vitro-Testsysteme für ß-Blocker und Schmerzmittel zu entwickeln. Durch parallel durchzuführende in 
vivo Untersuchungen soll überprüft werden, inwieweit diese Testsysteme geeignet sind, in vivo-
Reaktionen von Organismen abzubilden, die in Teil 1 der vorliegenden Studie als sensitiv für 
Arzneimittel identifiziert wurden, oder die als relevant für deutsche Fließgewässer bekannt sind. 
List of Abbreviations - Part 1  
CAS: Chemical Abstracts Service  
DOI: Digital Object Identifier  
LOEC: Lowest observed effect concentration  
LOEC min: Minimum of lowest observed effect concentrations reported  
LogKOW: Octanol/water partitioning coefficient (logarithmic form)  
MEC: Measured environmental concentration  
MECmax: Maximum of measured environmental concentrations reported  
MOA: Mode of action  
NOEC: No observed effect concentration  
NSAID: Non-steroidal anti-inflammatory drug  
PBT: persistent, bioaccumulating, and toxic  
PEC: Predicted environmental concentration  
PNEC: Predicted no effect concentration  
TER: Toxicity exposure ratio  
UBA: Umweltbundesamt der Bundesrepublik Deutschland 
1. Introduction  
Chemical analysis has regularly revealed the presence of human and veterinary pharmaceuticals in 
wastewater and surface water in nanogram to microgram per liter concentrations (e.g. Fent et al., 2006 
[4], Brauch, 2011 [5]). Decisions on the environmental relevance of these substances usually rely on 
data recorded for current and future consumption rates, environmental concentrations, 
environmental fate and pathways (persistence), and ecotoxicological effects recorded in laboratory 
studies. The problem with this approach is the fact that ecotoxicological routine testing mainly focuses 
on acute or chronic unspecific toxicity, whereas pharmaceuticals, according to their envisaged specific 
action in man (human medicine) or companion animals (veterinary drugs) more likely exert specific 
effects based on their mode of action (MOA) (Brausch et al. 2012 [6]). Information on the effects of 
active pharmaceutical ingredient classes, either acting on targets or exerting unwanted adverse side 
effects are, therefore, mandatory prerequisites for an effect-directed monitoring of pharmaceuticals 
in aquatic ecosystems.  
One focus of the present literature review study thus was on the question which organisms sensitively 
respond to pharmaceuticals and which sublethal parameters can be used as warning sentinels 
(biomarkers) to monitor action of pharmaceuticals in a sensitive and specific way.  
In a comprehensive report of Bergmann et al. (2011) [1] a prioritization of human and veterinary 
pharmaceuticals was undertaken on the basis of data on the presence of compounds in the aquatic 
environment, their ecotoxicological effects, and their consumption rates up to the year 2011. This 
report lists analytical data for 274 ingredients and ecotoxicological effect data for 251 ingredients, all 
of them incorporated in both the MEC (Measured Environmental Concentrations) and ÖKOTOX (effect 
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data) databases. Bergmann et al. (2011) [1] have outlined 24 substances with high priority for 
environmental monitoring programs. However, the databases also provide evidence that 31 
pharmaceuticals with partially high and steadily increasing consumption rates lacked ecotoxicological 
data until 2009 resulting in a very high uncertainty regarding the assessment of their environmental 
relevance. Supplementary to the substances regarded as relevant for further research by Bergmann et 
al. (2011) [1], the German Federal Ministry for the Environment, Nature Conservation and Nuclear 
Safety has identified further substances as to be of high priority for an evaluation with respect to 
possible environmental effects. In the present study, we therefore focused on a set of 90 substances, 
prioritized by Bergmann et al. (2011) [1] and UBA, for which literature was analyzed.  
Bergmann et al. (2011) [1] concluded from their research that already the number of substances with 
high priority (24) would exceed the capacity of routine chemical monitoring. They therefore suggested 
having leading substances defined for particular ingredient classes that should be included in 
monitoring programs. The apparent but crucial drawback of such an approach, however, lies in the risk 
of overlooking effective concentrations of non-leading substances. In contrast to it, the use of tests 
that could visualize specific molecular interactions of chemicals exhibiting the same mode of action 
may enable a monitoring of an entire class of compounds. Particularly in view of the vast number of 
pharmaceuticals with increasing consumption rates but lacking ecotoxicological effect data, a mode 
of-action-specific in vitro assay is a matter of paramount interest; also because new and future 
compounds that act in the same way on the same molecular target can easily be traced, once such an 
assay has been established.  
In vitro systems using highly sensitive fluorescence detection technologies are already used by the 
pharmaceutical industry to identify compound classes as promising candidates in the development of 
new pharmaceuticals (Eggeling et al., 2003) [7]. A biomonitoring on the basis of such specific 
mechanisms of action could be possible for e.g. non-steroidal anti-inflammatory drugs (NSAIDs) or ß-
blockers. For these, the inhibition of the cyclooxygenase and the blocking of β-receptors could be used 
as mode of actions to be targeted. In contrast to Escher et al. (2005) [8] who use “in vitro Assessment 
of Modes of Toxic Action” in that sense that specific mode of actions defined by the test system itself 
are investigated (e.g. photosynthesis inhibition of pharmaceuticals by a photosynthesis inhibition 
assay), we thus favor an approach to use the specific target molecules for pharmaceutical classes 
(responsible for the pharmacological effect of the respective substance class) as monitoring tools. In 
the second part of this study, we therefore evaluated different in vitro test systems with respect to 
their suitability as future test systems in routine monitoring of pharmaceutical classes.  
In summary, this study reviews (1) the current state of knowledge in effect-directed research and 
analyzes present data with focus on suitable compounds, organisms, and endpoints which may be 
combined in a monitoring approach, and (2) in addition, the state of knowledge for in vitro testing of 
pharmaceuticals as a prerequisite for the development of mode of-action-based monitoring tools. 
2. Materials and Methods  
2.1 Literature search and data collection  
The literature search is divided into two parts.  
In the first part, effect data for 90 pharmaceuticals defined as relevant according to either Bergmann 
et al. (2011) [1] or UBA were collected for several biota classes (bacteria, protists, plants/algae, 
mollusks, crustaceans, insects, fish, tetrapods, others incl. communities). The list of pharmaceuticals 
and the priority classes are shown in table 1. The prioritization of UBA is based on MECs obtained from 
the German counties, consumption rates (tendencies between 2002 and 2012), effect values of UBA-
internal studies or literature, suspicion to be a PBT compound, degradability and metabolism. The 
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prioritization of Bergmann et al. (2011) [1] is only based on literature data which resulted in partial 
differences between the two lists of priority substances available.  
The search was restricted to literature published between 2011 and 2013, since all earlier published 
data have been analyzed by Bergmann et al. (2011) [1]. For the search, Web of Knowledge (including 
the databases “Web of Science®”, “BIOSIS Citation IndexSM”, “BIOSIS Previews®”, “MEDLINE®” and 
“Journal Citation Reports®”) were used. The following search items were defined:  
For Reviews: pharma* AND eco*, limited by “review”  
For single substances: the specific search entry for each pharmaceutical (see table 1) combined with 
the search terms: aqua* OR eco* OR tox*  
The following research areas were seen as irrelevant and therefore excluded from the literature 
search:  
Anesthesiology, Anthropology, Biomedical, Social Sciences, Biophysics, Business Economics, 
Communication, Computer Science, Criminology Penology, Critical Care Medicine, Cultural Studies, 
Demography, Dentist, Oral Surgery Medicine, Dermatology, Education, Educational Research, 
Electrochemistry, Emergency Medicine, Energy Fuels, Engineering, Ethnic Studies, Food Science 
Technology, General Internal Medicine, Genetics Heredity, Geography, Geology, Geriatrics, 
Gerontology, Government, Law, Health Care Sciences, Services, History, Imaging Science, Photographic 
Technology, Infectious Diseases, Information Science, Library Science, Instruments Instrumentation, 
Integrative Complementary Medicine, International Relations, Legal Medicine, Materials Science, 
Mathematical Computational Biology, Mathematics, Medical Informatics, Medical Laboratory 
Technology, Meteorology Atmospheric Sciences, Nursing, Nutrition Dietetics, Obstetrics, Gynecology, 
Oncology, Ophthalmology, Orthopedics, Otorhinolaryngology, Parasitology, Pediatrics, Pharmacology, 
Pharmacy, Physics, Polymer Science, Psychiatry, Psychology, Radiology, Nuclear Medicine, Medical 
Imaging, Rehabilitation, Research Experimental Medicine, Respiratory System, Social Issues, Sociology, 
Sport Sciences, Substance Abuse, Surgery, Transplantation, Tropical Medicine, Urology, Nephrology, 
Virology  
Table 1: List of pharmaceuticals with defined priority classes  
P: high priority according to Bergmann et al. and UBA 
Pu: high priority according to UBA 
Pb:  high priority according to Bergmann et al. 
(P): medium priority according to Bergmann et al.  
?: substances requiring further information 
none: substances without priority according to Bergmann et al. 
Pharmaceutical Search entry 
Priority 
class 
(UBA) 
Priority 
class 
(Berg 
mann) 
Priority 
class 
(final) 
Class CAS 
"Sartanic acid" sartane* P   Pu antihypertensive   
14-Hydroxyclarithromycin hydroxyclarithromycin* P  Pu antibiotic 110671-78-8 
17alpha-Ethinylestradiol ethinyl* estradiol* P P P contraceptive 57-63-6 
17beta-Estradiol estradiol* AND pharma*  P Pb hormone 50-28-2 
4-N-Methylaminoantipyrin methylaminoantipyrin* P  Pu analgesic 519-98-2 
6(carboxymethoxy)-4-(2-
chlorophenyl)-5-
(ethoxycarbonyl)-2-
methylpyridine-3-carboxylic acid 
amlodipin* P  Pu antihypertensive  
Acetyl cysteine acetyl cystein*  ? ? mucolytic agent 616-91-1 
Acetylsalicylic acid acetylsalic*    NSAID 50-78-2 
Aciclovir aciclovir*  ? ? antiviral drug 59277-89-3 
Allopurinol allopurinol*    
xanthine oxidase 
inhibitor 
315-30-0 
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Pharmaceutical Search entry 
Priority 
class 
(UBA) 
Priority 
class 
(Berg 
mann) 
Priority 
class 
(final) 
Class CAS 
AMDOPH AMDOPH  (P) (P) analgesic  
Amlodipine amlodipin* P  Pu antihypertensive 88150-42-9 
Amoxicilline amoxicillin* P P P antibiotic 26787-78-0 
Atenolol/ Atenolol acid atenolol*, tenormin* P  Pu betablocker 29122-68-7 
Azitromycin 
azitromycin*, zithromax*, 
azithrocin*, azin*  
P  Pu antibiotic 83905-01-5 
Bezafibrate bezafibrat*  (P) (P) lipid regulator 41859-67-0 
Bisoprolol bisoprolol* P ? Pu betablocker 66722-44-9 
Capecitabin capectiabin*, xeloda* P  Pu cytostatic 15361-50-9 
Carbamazepine carbamazepin* P P P anticonvulsant 298-46-4 
Cefaclor cefaclor* OR cefachlor*  ? ? antibiotic 53994-73-3 
Cefuroxime axetil cefuroxim* axetil*  ? ? antibiotic 64544-07-6 
Chloramphenicole chloramphenicol*  P Pb antibiotic 56-75-7 
Chlortetracycline chlortetracyclin*  P Pb antibiotic 57-62-5 
Ciprofloxacin ciprofloxacin* P P P antibiotic 85721-33-1 
Clarithromycine clarithromycin* P P P antibiotic 81103-11-9 
Clindamycin clindamycin* P ? Pu antibiotic 18323-44-9 
Clopidogrel clopidogrel*  ? ? antiplatelet agent 113665-84-2 
Clotrimazole clotrimazol*  (P) (P) antimycotic 23593-75-1 
Deltamethrin 
deltamethrin*, 
decamethrin* 
P  Pu antiparasitic 52918-63-5 
Desflurane desfluran*  ? ? anesthetic 57041-67-5 
Diatrizoic acid 
diatriz*, iotalam*,  
amidotriz* 
 (P) (P) contrast agent 737-31-5 
Diazepam diazepam*  (P) (P) 
antidepressant/ 
antipsychotic 
439-14-5 
Diclofenac diclofenac* P P P NSAID 15307-86-5 
Dienogest dienogest*, visanne* P  Pu gestagan 65928-58-7 
Dipyridamole dipyridamol*  ? ? antiplatelet agent 58-32-2 
Doxycycline doxycyclin*  P Pb antibiotic 564-25-0 
Duloxetine duloxetin*, cymbalta* P  Pu 
antidepressant/ 
antipsychotic 
116539-59-4 
Entacapone entacapon*  ? ? C-O-M-Inhibitor 130929-57-6 
Eprosartan eprosartan*  ? ? antihypertensive 133040-01-4 
Erythromycin erythromycin*  P Pb antibiotic 114-07-8 
Gabapentin gabapentin*, neurotin*  ? ? anticonvulsant 60142-96-3 
Gemfibrozil gemfibrozil*, lopid* P  Pu lipid regulator 25812-30-0 
Glutaral glutaral*   ? ? desinfectant 111-30-8 
Hydrochlorothiazide hydrochlorothiazid*  ? ? antihypertensive 58-93-5 
Ibuprofen ibuprofen* P (P) P NSAID 15687-27-1 
Imatinib imatinib*, gleevec*, glivec* P  Pu cytostatic 152459-95-5 
Indometacin 
indometacin*, 
indomethacin* 
 (P) (P) NSAID 53-86-1 
Iohexol iohexol*, omnipaq* P (P) P contrast agent 66108-95-0 
Iomeprol iomeprol* P (P) P contrast agent 78649-41-9 
Iopamidol iopamidol*  (P) (P) contrast agent 60166-93-0 
Iopromide iopromid*, ultravist*  (P) (P) contrast agent 73334-07-3 
Ivermectin ivermectin*, stromectol* P  P Antiparasitic 70288-86-7 
Lamotrigin lamotrigin*, lamictal* P  Pu anticonvulsant 84057-84-1 
Levetiracetam levetiracetam*  ? ? anticonvulsant 102767-28-2 
Lincomycin lincomycin*  (P) (P) antibiotic 154-21-2 
Mesalazine mesalazin*  ? ? NSAID 89-57-6 
Mestranol mestranol*  P Pb contraceptive 72-33-3 
Metamizole metamizol* P  Pu analgesic 68-89-3 
Metformin metformin* P  Pu antidiabetic 657-24-9 
Metoprolol metoprolol* P  Pu betablocker 51384-51-1 
Naproxen naproxen* P P P NSAID 22204-53-1 
Norethisterone norethisteron*  P Pb contraceptive 68-22-4 
Opipramol opipramol*  ? ? 
antidepressant/ 
antipsychotic 
315-72-0 
Oxytetracycline oxytetracyclin*  P Pb antibiotic 79-57-2 
Pantoprazole pantoprazol*  ? ? 
proton pump 
inhibitor 
102625-70-7 
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Pharmaceutical Search entry 
Priority 
class 
(UBA) 
Priority 
class 
(Berg 
mann) 
Priority 
class 
(final) 
Class CAS 
Paracetamol 
paracetamol*, 
acetaminophen* 
 P Pb analgesic 103-90-2 
Piperacillin piperacillin*  ? ? antibiotic 61477-96-1 
Pregabalin pregabalin*  ? ? anticonvulsant 148553-50-8 
Primidone primidon*   P Pb anticonvulsant 125-33-7 
Propranolol propanolol*, propranolol*  (P) (P) betablocker 525-66-6 
Quetiapine quetiapin* P ? Pu 
antidepressant/ 
antipsychotic 
11974-69-7 
Ramipril ramipril*  ? ? antihypertensive 87333-19-5 
Roxithromycine roxithromycin*  P Pb antibiotic 80214-83-1 
Sevelamer sevelamer*  ? ? 
phosphate binding 
drug 
52757-95-6 
Simvastatin simvastatin* P ? Pu lipid regulator 79902-63-9 
Strontium ranelate strontium ranelat*  ? ? osteoporose 135459-90-4 
Sulbactam sulbactam*  ? ? antibiotic 68373-14-8 
Sulfadimethoxine sulfadimethoxin*  P Pb antibiotic 122-11-2 
Sulfadimidine 
sulfadimidin*, 
sulfamethazin* 
 P Pb antibiotic 57-68-1 
Sulfamethoxazole sulfamethoxazol* P P P antibiotic 723-46-6 
Tazobactam tazobactam*  ? ? antibiotic 89786-04-9 
Telmisartan telmisartan*  ? ? antihypertensive 144701-48-4 
Tetracycline tetracyclin*  P Pb antibiotic 60-54-8 
Tiamulin tiamulin* P P P antibiotic 55297-95-5 
Tilidine tilidin*  ? ? analgesic 51931-66-9 
Torasemide torasemid*, torsemid*  ? ? diuretic drug 56211-40-6 
Tramadol tramadol*, ryzolt*, ultram* P  Pu analgesic 27203-92-5 
Valproic acid valpro*  ? ? anticonvulsant 99-66-1 
Valsartan 
valsartan*, angiotan*, 
diovan* 
P ? Pu antihypertensive 137862-53-4 
Venlafaxine venlafaxin*   ? ? 
antidepressant/ 
antipsychotic 
93413-69-5 
 
       
2.2. Created library and data files  
2.2.1 Endnote library  
All references analyzed were included into an Endnote library (“EndNote Library – Pharmaceuticals – 
Literature study part 1 / 2 /3”) in the format “.CIW”.  
The three partners involved in the literature search used the following labels for their citations:  
BER 1-x: GWT Dresden (R-: Review, A-: Additional Information, I-: Irrelevant)  
SCH 1-x: University Tübingen (R-: Review, A-: Additional Information, I-: Irrelevant)  
FRE 1-x: STZ Frey  
The library contains the following folders:  
Part 1:  
Tuebingen - relevant studies: Studies on vertebrates, plants, protozoans and bacteria, which were 
directly included into the database.  
Tuebingen - additional information: Studies, mainly reviews, on vertebrates, plants, protozoans and 
bacteria, which were used as help for the general interpretation of the data, but not directly included 
into the database.  
Tuebingen - irrelevant studies: Studies, which were analyzed but were not included into the database.  
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Tuebingen- evaluation not possible: Studies, for which an evaluation was not possible because the full 
text was not available and the abstract did not contain sufficient information.  
Dresden - relevant studies: Studies on invertebrates, which were directly included into the database.  
Dresden - additional information: Studies, mainly reviews, on invertebrates, which were used as help 
for the general interpretation of the data, but not directly included into the database.  
Dresden - irrelevant studies: Studies, which were analyzed but were not included into the database.  
Part 2:  
Mannheim - in vitro techniques: Studies on in vitro techniques, which were used for the second part 
of the literature study.  
Part 3:  
Additional literature used for this report  
2.2.2 OEKOTOXupgrade  
In part 1 of the study, all publications available for the 90 substances were analyzed and evaluated 
with respect to the following criteria:  
Name of effective substance, investigated form of the substance (salt/conjugate), synonyms, CAS 
number, LogKow, molar mass, substance class, field of application, effective substance or medical 
product, single substance or mixture, test organisms (species), biota group, field/lab/mesocosm test, 
effect endpoint, population relevance yes/no, standard method yes/no, test concentration in water 
(μg/L, mol/L), test concentration in sediment (if necessary), applied dose (if necessary), duration of 
test, acute/chronic/sub-acute, chemical analyses present, accumulation data present, 
bioaccumulation factor, NOEC (μg/L, μmol/L), LOEC (μg/L, μmol/L), EC10 (μg/L, μmol/L), EC50 (μg/L, 
μmol/L), citation, DOI, full text available, Endnote label, chemical present in priority list yes/no, 
comments, reliability analysis (only for selected publications).  
In case no effect was observed in the study, the highest concentration tested (without effect) has been 
included as „NOEC” without corresponding LOEC. Furthermore, numerous studies reported effects 
already at the lowest tested concentration. These values are recorded as LOECs without a 
corresponding NOEC. It should be kept in mind that there is a possibility that lower values than the 
reported may also cause an effect.  
Besides data for the priority substances defined in table 1, data for several other pharmaceuticals is 
also reported in the database. These effects were reported in the analyzed publications besides the 
ones for the target substances, and therefore included. However, the data sets for these substances 
are not complete, since they are mere “byproducts” of the original search.  
All data were included into the database OEKOTOXupgrade  
A separate row was created for every chemical, species and endpoint used in each study. Each single 
row was defined as a “database entry”. Because many publications report on multiple chemicals, 
organisms or endpoints, the total number of database entries is much higher than the number of 
publications.  
2.2.3. “Evaluation database” for assessment of data  
With the aim to evaluate the collected data with respect to (1) their suitability for the study, (2) data 
number per pharmaceutical and organism group, (3) most sensitive organisms, (4) lowest effect 
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concentrations, (5) mixture toxicity, and (6) population relevance, the “evaluation database” has been 
created.  
In data sheet (4) the lowest and second lowest effect data and measured environmental 
concentrations (MECs) obtained either from the MEC database of Bergmann et al. (2011) [1] or UBA 
were included with the aim to assess the environmental relevance of the lowest effect data. However, 
not for all 90 substances both values MECs and LOECs were available. As a result, only for 32 substances 
a risk quotient (MECmax/LOECmin) could be calculated as a proxy for their environmental relevance. 
These substances were: paracetamol, tramadol, amoxicilline, chloramphenicole, chlortetracycline, 
ciprofloxacin, doxycycline, erythromycin, lincomycin, oxytetracycline, sulfadimethoxine, 
sulfadimidine, sulfamethoxazole, carbamazepine, diazepam, clotrimazole, ivermectin, atenolol/ 
atenolol acid, metoprolol, propranolol, 17alpha-ethinylestradiol, 17beta-estradiol, norethisterone, 
diatrizoic acid, bezafibrate, gemfibrozil, acetyl cysteine, acetylsalicylic acid, diclofenac, ibuprofen, 
indometacin, naproxen. For tetracycline, quetiapine, venlafaxine and deltamethrin no MECs were 
available.  
With the aim to compare mixture toxicity data with LOECs for isolated substances, the “mixture 
toxicity” datasheet was created. The data sheet “population relevance” has been used as a basis to 
quantify available data with relevance for the population level. 
3. Results  
3.1. Effects of pharmaceuticals in vivo  
3.1.1 Number of publications and database entries  
Altogether, 452 publications were analyzed for 90 pharmaceuticals. 325 papers contained data for 
vertebrates, plants/algae, protozoa, or bacteria (analyzed by the University of Tübingen), 179 papers 
contained data for invertebrates (analyzed by the GWT, TU Dresden) , and 50 of them contained data 
for invertebrates and either vertebrates, plants, protozoa or bacteria (analyzed by both, University of 
Tübingen and GWT TU Dresden). 232 of these publications were of relevance for the database, 95 
provided additional information, 134 were not relevant, and for 6 publications the evaluation was not 
possible, since the full PDF was either not available or did not contain enough information to analyze 
the study.  
All in all, 1678 entries were included in the database OEKOTOXupgrade (1434 for vertebrates, plants, 
protozoa and bacteria and 244 for invertebrates). Because many studies investigated multiple 
chemicals and endpoints, the number of database entries is much higher than the number of studies.  
Figs. 1 and 2 show that most of the studies were conducted with antibiotics, followed by NSAIDs, 
anticonvulsants, antiparasitics, ß-blockers and contraceptives, and that the number of publications per 
pharmaceutical class is reflected by the number of database entries.  
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Figure 1: Number of publications per substance class  
 
Figure 2: Number of database entries per substance class 
3.1.2 Number of publications per organism group  
Most publications on effects of pharmaceuticals in biota have been found for fish, followed by 
mollusks, plants/algae, crustaceans, and bacteria (Fig. 3). In general, this distribution pattern for the 
publication number is reflected by the number of database entries per organism group (Fig. 4), 
however, for plants/algae more data were available per publication than for mollusks, and for bacteria 
more database entries have been conducted than for crustaceans. 
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Figure 3: Number of studies per biota group 
 
Figure 4: Number of database entries per biota group 
3.1.3. Evaluation of data  
3.1.3.1 Most sensitive biota classes for pharmaceuticals  
In a first step, the lowest and second lowest effect data were analyzed with respect to their relation to 
distinct organism classes (Fig. 5).  
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It became evident that most of the lowest plus second lowest effect values were recorded for 
protozoans (represented by only a single test species: Tetrahymena pyriformis). Mollusks were shown 
to be very sensitive for anticonvulsants, antipsychotics, lipid regulators, analgesics (other than NSAIDs), 
hormones and contraceptives. The LOECs were in the range of ng/L – lower μg/L values.  
Lowest or second lowest effect values for fish (several species) were determined for hormones, 
mycolytica, anticonvulsants, antiparasitics and lipid regulators. Also for them, the LOECs are in the 
range of ng/L - lower μg/L values.  
Bacteria and plants were shown to be highly sensitive to antibiotics, crustaceans were very sensitive 
to antiparasitics.  
In a second step, data were analyzed in a more detailed way by determining the number of 
pharmaceuticals for which defined LOECs (< 0.1, 1 or 10μg/L) were reported for the investigated 
species in order to identify the most sensitive species for pharmaceuticals.  
Figure 6 shows that the most sensitive species with LOECs < 0.1 for 2-8 pharmaceuticals were the ciliate 
Tetrahymena pyriformis, zebrafish (Danio rerio), rainbow trout (Oncorhynchus mykiss), medaka 
(Oryzias latipes), the mussel Elliptio complanata and the mudsnail Potamopyrgus antipodarum.  
All extremely low LOECs (in the range of pg/L) for Tetrahymena pyriformis derive from only a single 
publication by Lang & Köhidai (2012) [3], the reliability of which, however, could not be proven 
(chapter 3.1.5). Additionally, the conclusion on the most sensitive species is biased by the fact that 
these species are also among the most frequently used test organisms. 
 
Figure 5: Number of lowest plus second lowest effect values for 13 pharmaceutical classes 
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Figure 6: Number of pharmaceuticals with defined LOECs for investigated species 
3.1.3.2 Most sensitive effect endpoints per substance classes  
In order to identify most sensitive effect endpoints for pharmaceuticals, data were analyzed with 
respect to the number of pharmaceuticals with defined LOECs (< 0.1, 1 or 10 μg/L) for the investigated 
effect endpoints. Figure 7 makes evident that the most sensitive endpoints with LOECs < 0.1 for 3-8 
pharmaceuticals were chemotaxis, behavior, vitellogenin induction, growth rate, reproduction, 
histopathological alterations, molecular stress biomarkers, oxidative stress markers, receptor binding, 
and gene expression. All extremely low LOECs (in the range of pg/L) for chemotaxis derive from the 
above mentioned study of Lang & Köhidai (2012) [3] who used Tetrahymena pyriformis as test 
organism. As mentioned above, the reliability of this study, however, could not be proven (shown in 
chapter 3.1.5). 
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Figure 7: Number of pharmaceuticals with defined LOECs for investigated effect endpoints 
3.1.3.3 Identification of pharmaceuticals of highest relevance  
To identify the risk exerted by chemicals for the aquatic environment, different types of risk quotients 
are calculated in ecological risk assessment (PEC/PNEC ratios for industrial chemicals and 
pharmaceuticals, TER for pesticides). The PEC/PNEC ratio is defined by (1) the PEC, which represents 
the concentration of a chemical supposed to occur in the environment (predicted environmental 
concentration), and (2) the PNEC (predicted no effect concentration) which is calculated on the basis 
of the lowest observed effect concentration in any group of biota (LOEC), divided by a safety factor 
which itself depends on the size and quality of the data for different trophic levels. A possible risk for 
the environment is indicated by a risk quotient larger than 1. 
In the present study, the calculation of the risk quotient slightly differs from this routine procedure: 
For those pharmaceuticals, for which both Measured Environmental Concentrations (MECs) (either 
from Bergmann et al., 2011 [1] or UBA; summarized in data sheet ““MECs & LOECs”)”) and LOEC values 
were available, MEC/LOEC quotients were calculated as a proxy for the environmental relevance of 
LOECs by using the highest available MEC (MECmax) and the lowest LOEC (LOECmin). In contrast to the 
established prospective risk assessment procedure, we used LOECs (lowest observed effect 
concentrations) instead of NOECs. This can be justified by the necessity to identify threshold values for 
effects as a prerequisite for pharmaceutical monitoring. A further reason is that our literature survey 
aims at identifying pharmaceuticals of environmental concern retrospectively, and thus had to take 
into consideration concentrations measured in the environment (MECs). Finally, only for 37% of the 
LOECs corresponding NOECs were available. If NOECs were used, the database would have become 
too small for the envisaged analyses.  
For the calculations of MECmax/LOECmin values also data from Bergmann et al. (2011) [1] were analysed.  
Figure 8 makes evident that most pharmaceuticals with LOECs leading to risk quotients above 0.1 were 
antibiotics and NSAIDs followed by β-blockers and lipid regulators, analgesics different from NSAIDs 
and contraceptives/hormones.  
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When analyzing data with focus on MECmax/LOECmin values for the respective biota classes (Fig. 9) it 
became evident that most pharmaceuticals, for which risk quotients >0.1 were calculated were 
investigated in plants/algae and invertebrates closely followed by vertebrates. For bacteria, only few 
risk quotient > 0.1 were found.  
For the following substances, the risk quotient values were >1 (>0.1):  
Vertebrates: >1: atenolol, carbamazepine, diclofenac, 17α-ethinylestradiol, 17β-estradiol, gemfibrozil, 
ibuprofen, metoprolol, paracetamol, propranolol (>0.1: bezafibrate).  
Invertebrates: >1: bezafibrate, carbamazepine, diclofenac, erythromycin, 17α-ethinylestradiol, 
ibuprofen, ivermectin, oxytetracycline, paracetamol, propranolol, sulfamethoxazole (>0.1: 
ciprofloxacin, gemfibrozil, 17β-estradiol)  
Plant/Protozoa: >1: acetylsalicylic acid, diatrizoic acid, diclofenac, erythromycin, lincomycin, 
metoprolol, naproxen, oxytetracycline, paracetamol, propranolol, sulfadimidine, sulfamethoxazole 
(>0.1: clotrimazole, ibuprofen)  
Bacteria: >1: paracetamol, erythromycin, sulfadimidine, sulfamethoxazole (>0.1: diclofenac, 
gemfibrozil). 
 
Figure 8: Number of pharmaceuticals per pharmaceutical class with MECmax/LOECmin values >0.1 
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Figure 9: Number of pharmaceuticals with defined MECmax/LOECmin values per organism group 
Table 2 makes evident that, according to the calculated risk quotients, the pharmaceuticals of highest 
relevance (with MECmax/LOECmin>0.1) in at least three different biota classes were:  
- Paracetamol (analgesic, acetaminophen),  
- Diclofenac, ibuprofen (analgesic, NSAIDs - non-steroidal anti-inflammatory drugs)  
- Propranolol (ß-blocker)  
- Sulfamethoxazole, Erythromycin (antibiotics)  
- Gemfibrozil (lipid regulator) 
Table 2: Priority pharmaceuticals for which MECmax/LOECmin values were >0.1 in 1, 2, 3 or 4 biota groups before 
reliability evaluation, including data from OEKOTOXupgrade and Bergmann et al. (2011) [1] 
MECmax/LOECmin >0.1 in 4 
organismic groups 
MECmax/LOECmin >0.1 in 3 
organismic groups 
MECmax/LOECmin >0.1 in 2 
organismic groups 
MECmax/LOECmin >0.1 in 1 
organismic groups 
Paracetamol Ibuprofen Bezafibrate Acetylsalicylic acid 
Diclofenac Propranolol Carbamazepine Atenolol 
 Sulfamethoxazole 17β-estradiol Ciprofloxacin 
 Gemfibrozil 17α-ethinylestradiol Clotrimazole 
 Erythromycin Metoprolol Diatrizoic acid 
  Oxytetracycline Lincomycin 
  Sulfadimidine Naproxen 
   Ivermectin 
 
3.1.3.4 Data for mixtures  
In general, only for a few cases, a direct comparison between LOECs for an isolated substance and its 
toxicity in a pharmaceutical mixture could be realized, since data differed with respect to species, 
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effect endpoints or test designs. However, for a few substances, such a comparison was possible 
(summarized in Table 3)  
The table makes evident that, dependent on - at least - the chemical tested and the effect endpoint 
under investigation, the toxicity of a single pharmaceutical could be lower, higher or equal to its toxicity 
when applied in a mixture with other compounds.  
However, since no mode of action-based effect endpoints were investigated in any of these studies, 
the specific contribution of the respective substance to the toxicity of the chemical mixture cannot be 
quantified. 
Table 3: Comparison of pharmaceutical effect concentrations applied either isolated or mixture of pharmaceuticals 
 Species Effect LOEC single Effect conc. 
Mixture 
Reference 
Paracetamol Danio rerio Reproduction 
output 
10 0.5 Galus et al. 2013a 
[9, 10] 
 Danio rerio Mortality 0.5 10 Galus et al. 2013a 
[9, 10] 
Propranolol Mytilus 
galloprovincialis 
cAMP-level, PKA 
activity 
0.0003 NOEC 0.0003 Franzelitti et al. 
2011, 2013 [11, 12] 
Diclofenac Dreissena polymorpha Molecular stress 
level 
0.3 0.1 Parolini et al. 2013 
[13] 
 
3.1.3.5. Data with population relevance  
All data collected in the present study were investigated with respect to their population relevance. 
We defined data as being relevant for the population level as containing information on effects related 
to (1) community changes, (2) reproduction, fecundity, fertility, embryo development, sex ratio, 
intersex, imposex (summarized as “reproduction”), (3) behavior including mating behavior, (4) growth, 
and (5) survival / mortality. 
Altogether, 106 studies and 561 database entries were found to be related to population-relevant 
endpoints. Figure 10 shows that most database entries contained information of influences of 
pharmaceuticals on survival and mortality, growth and reproduction. Studies related to behavioral and 
community changes were in the minority. Hormone-like acting substances did induce population-
relevant effects already in relatively low concentrations. 
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Figure 10: Number of database entries with population-relevant endpoints 
3.1.4 Reliability of publications  
For those studies which contained data for the most relevant pharmaceuticals (lowest LOECs) and for 
the most sensitive endpoints and organisms, the reliability was investigated according to the criteria 
of Wright-Walters et al. (2011) [2].  
These are the following:  
“ 
1) A thorough description of the experimental design, including exposure regime and replication,  
2) Analytical confirmation of test concentrations  
3) Description of ecologically relevant endpoints and all supplemental morphological information 
collected  
4) Use of test procedures that are based, at least generally, on internationally accepted 
procedures and practices. Newly developed test procedures must be able to be repeated, and 
meet all other required criteria  
5) Clear linkage of reported findings with the exact experimental design, and  
6) Sufficient reporting of results, including system performance, toxicity results, and statistical  
methods employed to ascertain how the data support the conclusions that are drawn  
“ 
If criteria 1, 2, 3 and 6 were met the study was designated as “reliable”. If only 3 of these criteria were 
met, it was designated as “conditionally reliable”, If less than 3 criteria were met or mistakes became 
obvious, the study was designated to be “not reliable”.  
Consideration was also given to whether the studies were conducted according to GLP and whether 
both NOEC and LOEC values were provided; however, these criteria did not influence the decision 
about reliability.  
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Taking all together, 72 publications have been checked for reliability. Nine of them were reliable, 49 
conditionally reliable and 14 not reliable (of which 4 were, in part, conditionally reliable). In Table 4, 
the results of the reliability assessment are summarized. For studies which were not reliable, further 
information is given in Table 5. Except for the study of Fairchild et al. (2011) [14], none of the 
investigations were conducted under GLP. 
Table 4: Publications checked for reliability, reliability criteria met, and decision on reliability 
Reference 
Reliability criteria 
met Reliabilty 
Antunes et al., 2013 [15] 1,3,6 conditionally reliable 
Backhaus et al., 2011 [16] 3, (6) not reliable 
Bajet, 2012[17] 1,3,6 conditionally reliable 
Benstead, 2011 [18] 1,2,3 conditionally reliable 
Boltes et al., 2012 [19] 1,3,6 conditionally reliable 
Boonstra et al., 2011 [20] 1,2,3 conditionally reliable 
Chandra et al., 2012 [21] 1,3,6 conditionally reliable 
Chen et al., 2012 [22] 1,3, 6 conditionally reliable 
Claessens et al., 2013 [23] 1,3,6 conditionally reliable 
Contardo-Jara, 2011 [24] 1,2,3 conditionally reliable 
Doyle et al., 2013 [25] 1,3,6 conditionally reliable 
Fairchild et al., 2011 [14] 1,2,3,6 reliable 
Feito et al., 2012 [26] 1,3,(6) 
conditionally reliable (mitochondrial activity, DNA content), not reliable 
(lipid peroxidation, chlorophyll content) 
Feito et al., 2013 [27] 1,3, (6) conditionally reliable (DNA-content), not reliable (mitochondrial activity) 
Finn et al., 2012 [28] 2,3,6 conditionally reliable 
Fong & Hoy, 2012 [29] 1,3,6 conditionally reliable 
Franzellitti et al., 2011 [11] 1,3,6 conditionally reliable 
Franzellitti et al., 2013 [12] 1,3,6 conditionally reliable 
Gagné et al., 2012 [30] 2,3,6 conditionally reliable 
Galus et al., 2013 [10] (1),2,3,(6) not reliable 
Gonzalez-Rey, 2011 [31] 1,3,6 conditionally reliable 
Gust et al., 2012 [32] 1,3,6 conditionally reliable 
Gust et al., 2013 [33] 1,3,6 conditionally reliable 
Hallgren et al., 2011 [34] (1),3,6 conditionally reliable 
Hallgren et al., 2012 [35] 1,2,3,6 reliable 
Hillis et al., 2011 [36] 1,3,6 conditionally reliable 
Hoffmann & Kloas, 2012 [37] 1,3,6 conditionally reliable 
Huynh Thi et al., 2012 [38] 1,2,3,6 reliable 
Ings et al., 2012 [39] 1,3,6 conditionally reliable 
Johns et al. 2011 [40] 1,3,6 conditionally reliable 
Kaptaner et al., 2011 [41] 1,3,6 conditionally reliable 
Lang & Kohidai, 2012 [3] 1,3,(6) not reliable 
Lange et al., 2012 [42] 2,3,6 conditionally reliable 
Lawrence et al., 2012 [43] 1,3,6 conditionally reliable 
Lei et al., 2013 [44] 1,3,6 conditionally reliable 
Liu et al., 2011 [45] 1,3,6 conditionally reliable 
Liu et al., 2011 [46] 1,2,3,6 reliable 
Madureira et al., 2011 [47] 1,3,6 conditionally reliable 
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Meina et al., 2013 [48] 1,3,6 conditionally reliable 
Notch &Mayer, 2013 [49] 3,(6) not reliable 
Oliveira et al., 2012 [50] 1,3,6 conditionally reliable 
Ozdemir et al., 2011 [51] (1),3,6 conditionally reliable 
Parolini et al., 2011 [52] 3,6 not reliable 
Parolini et al., 2011 [53] 1,3,6 conditionally reliable 
Parolini et al., 2013 [13] 3,6 not reliable 
Ragugnetti et al., 2011 [54] 1,3,6 conditionally reliable 
Reyhanian et al., 2011 [55] 1,3,6 conditionally reliable 
Ribeiro et al., 2012 [56] 1,3,6 conditionally reliable 
Rocco et al., 2012 [57] (3), 6 not reliable 
Rocco et al., 2012 [58] (3), (6) not reliable 
Saravanan et al., 2011 [59] 1,3,6 conditionally reliable 
Sarria et al., 2011 [60] 1,3,(6) conditionally reliable, 
Shen et al., 2012 [61] 1,2,3,6 conditionally reliable 
Shi et al., 2012 [62] 1,3,(6) conditionally reliable (chronic test), not reliable (acute test) 
Silva et al., 2012 [63] 1,2,3,6 reliable 
Skolness et al., 2012 [64] 1,2,3,(6) reliable 
Sponchiado et al. 2011 [65] 3,6 not reliable 
Stange et al., 2012 [66] 1,3,6 conditionally reliable 
Stange et al., 2012 [67] 1,3,(6) cond. reliable (reproduction), not reliable (gene expression) 
Thomas et al., 2012 [68] 1,3,6 conditionally reliable 
Toumi et al., 2013 [69] 1,2,3,6 reliable 
van Leeuwen et al., 2012 [70] (1),3,6 conditionally reliable 
Veach et al., 2012 [71] 1,3,6 conditionally reliable 
Wang & Gunsch, 2012 [72] 1,2,3,6 reliable 
Wang et al., 2011 [73] 1,3,6 conditionally reliable 
Wu et al., 2012 [74] 1,3,6 conditionally reliable 
Yan et al., 2013 [75] 1,2,3,6 reliable 
Yergeau et al., 2012 [76] (1), 6 not reliable 
Yonar et al., 2011 [77] 1,3,6 conditionally reliable 
Zhang & Gong, 2013 [78] 1,3,6 conditionally reliable 
Zhang et al., 2012 [79] 1,3,6 conditionally reliable 
Zhang et al, 2012 [80] 1,3,6 conditionally reliable 
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Table 5: Further information on pharmaceuticals tested, test organisms, effect endpoints and reasons for lacking reliability for 
not reliable studies 
Reference Pharmaceutical 
tested 
Test organism Effect endpoint Reason for lacking reliability 
Backhaus et 
al 2011 [16] 
Fluoxetine, 
Propranolol, 
Clotrimazole 
Periphyton 
community 
Inhibition of total 
pigment content 
(biomass) 
Lacking replicates for some test substances, but not 
specified (N= 1 to N=5). Results from other studies were 
involved for calculations of some concentration-response-
curves without representing them. 
Feito et al 
2012 [26] 
Diclofenac Danio rerio, 
Polystichum 
subspicatum 
Lipid peroxidation, 
Chlorophyll 
autofluorescence 
Partly not reliable for lipid peroxidation in zebrafish and 
Chlorophyll content in Polystichum due to lacking 
concentration-effect relationships. . 
Feito et al 
2013 [27] 
Venlafaxine Polystichum 
spicatum 
Mitochondrial 
activity 
Partly not reliable for mitochondrial activity due to lacking 
concentration-effect relationships. 
Galus et al 
2013 [10] 
Paracetamol, 
Venlafaxine, 
Carbamazepine; 
Gemfibrozil 
Danio rerio Reproductive output, 
Embryonic mortality, 
Developmental 
malformations; 
Histopathological 
changes, Plasma 
estradiol level, Blood 
11-Ketotestosterone 
level 
Experimental mistake obvious with high concentrations of 
pharmaceuticals in control treatments, for Gemfibrozil 
higher than the treatment “low”. This information can be 
obtained from the “Supplementary data”, and it is 
mentioned in one sentence of the discussion. The effective 
concentrations highly differ from the nominal 
concentrations for which results are presented. For 
acetaminophen, e.g., the effective concentrations were only 
about 10% of the nominal concentrations. 
Láng & 
Köhidai 2012 
[3] 
Acetylsalicylic 
acid, Diclofenac, 
Fenoprofen, 
Ibuprofen, 
Naproxen, 
Paracetamol, 
Erythromycin, 
Lincomycin, 
Sulfamethoxazole, 
Trimethoprim, 
Metoprolol, 
Propranolol, 
Timolol, Diatrizoic 
acid 
Tetrahymena 
pyriformis 
Growth rate, 
Chemotactic 
behaviour 
Calculation of EC50 values for growth inhibition unclear; no 
concentration-effect relationships for chemotaxis; authors 
recommend themselves to use the test system not as a 
quantitative, but a qualitative assay to prove for 
environmental effects of chemicals. 
Notch & 
Mayer 2013 
[49] 
17alpha-
ethinylestradiol 
Danio rerio Embryonic 
vitellogenin mRNA, 
embryonic Cyp1a 
mRNA, embryonic 
XPC mRNA (genome 
repair pathway), 
embryonic XPA 
mRNA (genome 
repair pathway) 
Lacking replicates and insufficient description of exposition 
conditions. Effects for XPC/XPA-mRNA und CYP1a-mRNA 
which only occurred after 24h or 48 h. The authors wanted 
to show that some effects disappear after longer exposure 
times. Effects for vtg-mRNA remained stable for the entire 
exposure time. 
Parolini et al 
2011 a [52] 
Ibuprofen Dreissena 
polymorpha 
Molecular stress 
biomarkers 
Lacking replicates. Chemical analysis only in stock solution. 
Parolini et al 
2013 [13] 
Ibuprofen, 
Diclofenac, 
Paracetamol 
Dreissena 
polymorpha 
Molecular stress 
biomarkers 
Lacking replicates. Chemical analysis only in stock solution. 
Rocco et al 
2012 a [57] 
Gemfibrozil Danio rerio Comet assay, 
Diffusion assay, 
RAPD-PCR 
Insufficient description of experimental design (replica, 
organisms, test concentrations); results from controls not 
presented. 
Rocco et al 
2012 b [58] 
Lincomycin, 
Erythromycin 
Danio rerio Micronucleus test, 
Comet assay 
Insufficient description of experimental design (replica, 
organisms, test concentrations); no significant effects. 
Shi et al 
2012 [62] 
Clotrimazole Xenopus 
laevis 
Embryo mortality, 
Embryo body length 
lacking concentration-effect relationships in acute test 
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Sponchiado 
et al 2011 
[65] 
17beta-estradiol Oreochromis 
niloticus 
Micronucleus test, 
Nucleus 
abnormalities, Comet 
assay 
Lacking replicates. Exposure from 5 to 35 days, but no 
renewal of test substances. 
Stange et al 
2012b [67] 
17alpha-
ethinylestradiol 
Potamopyrgus 
antipodarum 
Gene expression 
(estrogen receptor) 
Effects on gene expression of estrogen receptor only 
occurred after 7 days, but not after 28 days, lacking time-
effect relationship. 
Yergeau et al 
2012[76] 
Erythromycin, 
Sulfamethoxazole, 
Sulfadimidine, 
Gemfibrozil, 
Erythromycin 
Bacterial 
community 
Microbial community 
composition (DNA 
level) 
Insufficient description of experimental design (substances, 
solvents for stock solution, organisms). Exposure time 8 
weeks without renewal 
3.1.5 Consequences of reliability assessment for the described results  
Our literature study revealed Tetrahymena pyriformis as the most sensitive test organism for 
pharmaceuticals prior to the reliability check of the publications. This assessment, however, is based 
on the fact, that for this protozoan extremely low LOECs are reported for a total of 8 substances by 
Láng & Köhidai (2012) [3] who used “chemotaxis” as an effect endpoint. Since the reliability 
assessment could not prove the reliability of this publication, three fish species (zebrafish, rainbow 
trout and medaka) can be identified as most sensitive organisms for pharmaceuticals followed by 
bivalves and snails. The publications which provide the lowest LOECs for these species did successfully 
pass the reliability assessment. Table 6, however, also makes evident, that for the three fish species 
the database was much larger (in total 489 database entries) than for the mentioned molluskan species 
(only 8 database entries). Also for crustaceans which represent ecologically important species of 
aquatic ecosystems only few data are available compared to fish. 
Table 6: Assessment of data for most sensitive species with respect to reliability of publications 
 
Number of 
publications 
Number of 
database 
entries 
Number of 
database entries 
with LOEC ≤0.1 
Number of reliable 
database entries 
with LOEC ≤0.1 Lowest LOEC [μg/L] 
Lowest reliable LOEC 
[μg/L] 
Tetrahymena 
pyriformis 1 28 13 -- 
0,0000151 (Láng & 
Köhidai 2012) [3] -- 
Zebrafish (Danio 
rerio) 36 333 36 21 
0,0104 (Lange et al 
2012) [42] 
0,0104 (Lange et al 
2012) [42] 
Rainbow trout 
(Oncorhynchus 
mykiss) 18 92 5 5 
0,00266 (Ings et al 
2012) [39] 
0,00266 (Ings et al 
2012) [39] 
Medaka (Oryzias 
latipes) 8 64 12 12 
0,001 (Lei et al 
2013) [44] 
0,001 (Lei et al 2013) 
[44] 
mussel (Elliptio 
complanata) 2 4 3 3 
0,04 (Gust et al, 
2012) [32] 
0,04 (Gust et al, 2012) 
[32] 
mudsnail 
(Potamopyrgus 
antipodarum) 2 4 4 3 
0,05 (Stange et al, 
2012a) [66] 
0,05 (Stange et al, 
2012) [66] 
Daphnia magna 12 42 2 2 
0,011 (Toumi et al, 
2013) [69] 
0,011 (Toumi et al, 
2013) [69] 
Gammarus spec 6 11 0 0 
1 (Boonstra et al, 
2011) [20] 
1 (Boonstra et al, 
2011) [20] 
 
With respect to the determination of the most important pharmaceuticals for environmental effects 
the reliability assessment had a more important influence on the final result. In chapter 3.1.4.3 all data 
available from the OEKOTOX and the OEKOTOXupgrade databases were assessed with the result 
summarized in table 2. Since the publications of the OEKOTOX database analyzed by Bergmann et al. 
(2011) [1], however, were not at our disposal for reliability checks, we could only compare the results 
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for the most important pharmaceuticals based on data of the OEKOTOXupgrade database prior (table 7) 
and after reliability assessment (table 8). The results of the analyses based on data from OEKOTOXupgrade 
only before reliability evaluation did not differ much from those when the OEKOTOX data were 
included. . This is due to the fact that the original OEKOTOX database mainly reports on EC50 values and 
includes only a low number of LOECs. Only a slight difference becomes obvious for Metoprolol with 
MECmax/LOECmin>0.1 in only 1 organismic group instead of 2. After assessment of publication reliability, 
however, only for diclofenac MECmax/LOECmin-values >0.1 were found in >3 biota classes. As further 
important pharmaceuticals propranolol, sulfamethoxazole, bezafibrate, 17α-ethinlyestradiol, 17β-
estradiol and oxytetracycline were identified with MECmax/LOECmin-values >0.1 for 2 biota classes. 
Table 7: Priority pharmaceuticals before reliability evaluation, only based on data from OEKOTOXupgrade 
MECmax/LOECmin >0.1 in 4 
organismic groups 
MECmax/LOECmin >0.1 in 3 
organismic groups 
MECmax/LOECmin >0.1 in 2 
organismic groups 
MECmax/LOECmin >0.1 in 1 
organismic groups 
Paracetamol Ibuprofen Bezafibrate Acetylsalicylic acid 
Diclofenac Propranolol Carbamazepine Atenolol 
 Sulfamethoxazole 17β-estradiol Ciprofloxacin 
 Gemfibrozil 17α-ethinylestradiol Clotrimazole 
 Erythromycin Oxytetracycline Diatrizoic acid 
  Sulfadimidine Lincomycin 
   Naproxen 
   Metoprolol 
 
Table 8: Priority pharmaceuticals after reliability evaluation, only based on data from OEKOTOXupgrade 
MECmax/LOECmin >0.1 in 4 
organismic groups 
MECmax/LOECmin >0.1 in 3 
organismic groups 
MECmax/LOECmin >0.1 in 2 
organismic groups 
MECmax/LOECmin >0.1 in 1 
organismic groups 
Diclofenac  Propranolol Ibuprofen 
  Sulfamethoxazole Paracetamol 
  Bezafibrate Carbamazepine 
  17β-estradiol Erythromycin 
  17α-ethinylestradiol Gemfibrozil 
  Oxytetracycline Sulfadimidine 
   Atenolol 
   Ciprofloxacin 
 
3.1.6 Summary of part 1  
The literature survey conducted in the present project reviewed publications on pharmaceutical 
effects in the environment from 2011- July 2013, and thus completed the database OEKOTOX 
established by Bergmann et al. (2011) [1] with the database OEKOTOXupgrade. An Endnote library was 
created which contains all publications analyzed. In addition, a data evaluation sheet was created as a 
base for the identification of the most sensitive organisms, the most sensitive effect endpoints, and 
the ecologically most relevant pharmaceuticals.  
For data published between 2011 and 2013, the following results were found:  
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- Most studies were conducted with antibiotics, followed by NSAIDs, anticonvulsants, 
antiparasitics, ß-blockers and contraceptives.  
- Most of the research data are related to pharmaceutical effects in fish, followed by effects in 
mollusks, plants/algae, crustaceans, and bacteria.  
- After the reliability evaluation three fish species (zebrafish, rainbow trout and medaka) were 
identified as most sensitive organisms for pharmaceuticals followed by bivalves and snails.  
- Sensitive effect endpoints were behavior, vitellogenin induction, growth rate, reproduction, 
histopathological alterations, molecular stress biomarkers, oxidative stress markers, receptor 
binding, and gene expression  
In order to evaluate the lowest and the second lowest effect values from both the OEKOTOX and the 
OEKOTOXupgrade database with respect to their ecological relevance, risk quotients were calculated as 
MECmax/LOECmin. Risk quotients >0.1 were defined as to be of ecological relevance. The analyses 
provided the following results:  
- Most pharmaceuticals for which risk quotients >0.1 were calculated were investigated in 
plants/algae and invertebrates closely followed by vertebrates. For bacteria, only few risk 
quotient >0.1 were found.  
- Antibiotics, analgesics (NSAIDs), and ß-Blockers were the pharmaceutical classes for which 
data with the highest ecological relevance were found.  
- After reliability assessment diclofenac was identified as the pharmaceutical of highest 
relevance (with MECmax/LOECmin >0.1 in > 3 biota classes). For propranolol, sulfamethoxazole, 
bezafibrate, 17α-ethinlyestradiol, 17β-estradiol and oxytetracycline MECmax/LOECmin-values 
>0.1 were calculated for 2 biota classes.  
Only in a few cases, the toxicity of an isolated substance could be compared to its toxicity in a 
pharmaceutical mixture. It could be shown that, at least dependent on the chemical tested and the 
effect endpoint under investigation, the toxicity of a single pharmaceutical can either be lower, higher, 
or equal to its toxicity when applied in a mixture together with other compounds. Since no mode of 
action-based effect endpoints were investigated it was impossible to quantify the specific contribution 
of the respective substance to the toxicity of the chemical mixture under investigation.  
106 studies and 561 database entries were found to be related to population-relevant endpoints with 
most data on survival/mortality followed by growth and reproduction. Studies related to community 
changes and behavioral endpoints were in the minority. Direct population relevance, for example 
induced changes in the composition of bacterial, protozoan or algal communities could only be shown 
in few studies.  
From part 1 of this literature review the following shortcomings could be identified: 
 More studies which fulfill the reliability criteria are necessary, especially more chemical 
analyses should be integrated  
 Only few data for invertebrates are available  
 Data for ecologically relevant crustaceans are lacking  
 Data on sediment toxicity are lacking  
 More population-relevant community data are necessary  
 In order to be able to identify the contribution of isolated pharmaceuticals to chemical 
mixtures, mode of action-based effect endpoints have to be investigated.  
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4. Conclusions  
As a basis for the development of an effect-based strategy to biomonitor pharmaceuticals, a literature 
review has been conducted which revealed the necessity to develop mode of action-based biotests for 
routine monitoring of distinct pharmaceutical classes. In this context, a strategy to monitor entire 
classes of pharmaceuticals with the same mode of action is given preference because a monitoring 
programme comprising different biotests for each single substance would cause unrealistically high 
costs, and a monitoring programme which focusses on just a few lead substances would drastically 
underestimate the risk exerted by a plethora of pharmaceuticals excluded from analysis. 
Consequently, priority should be given to develop effect-oriented in vitro tests for pharmaceutical 
classes and, within those, to analgesics, ß-blockers, and antibiotics. Such in vitro assays need to be 
evaluated with in-vivo test systems in parallel. In view to incorporate living organisms here, the 
literature review revealed ciliate, fish, and mollusk species to exhibit particular sensitivity to 
pharmaceuticals. Most sensitive endpoints were behavior (chemotaxis), vitellogenin synthesis, 
growth, reproduction, histological responses, biochemical stress markers, changes in gene expression 
profiles, receptor binding, and, with reservation, the heart rate. Numerous pharmaceuticals have also 
been tested for their impact on parameters that directly influence population development: 
reproduction, fecundity, ontogeny, mating patterns. Here, most significance has been assigned to 
pharmaceuticals with endocrine action. In contrast to single substances, effects of mixtures of 
pharmaceuticals can hardly be assessed reliably, since data are not consistent. Consequently, mode of 
action-based biotests are necessary to decipher the contribution of single substances to the toxicity 
exerted by a mixture of pharmaceuticals. Endpoints which may be candidates to track mode of action-
specific effects of pharmaceuticals are receptor affinity, vitellogenin induction (for estrogenic 
hormones), specific induction of gene expression, specific repression of enzymes (e.g. COX) or the 
formation of biochemical secondary products (e.g. lipid peroxides).  
Overall, the constructed database represents an extensive compilation of recently generated data on 
pharmaceutical effects, which will help researchers orienting in this quickly growing field. Besides the 
identification of certain promising test species and effect endpoints, there is growing evidence that 
several pharmaceuticals bear the potential to exhibit effects at environmentally relevant 
concentrations. They may therefore pose serious risks towards aquatic ecosystems and further studies 
are urgently needed.  
The evaluation also showed that researchers need to put a higher effort into improving the reliability 
of their reported data; this includes a conclusive experimental design as well as a comprehensibly 
documentation and interpretation of the results. 
5. Identification of shortcomings  
The literature review generally revealed a strong heterogeneity of data, frequently resulting in just a 
single dataset for a species. Furthermore, in fish, most studies have been conducted with model 
species or with species of only local relevance. Consequently, single studies providing numerous data 
for a large number of chemicals which have been conducted with a single test organism in a single test 
run will bias the empirical evidence, particularly if the reliability of this test or study is in question.  
In view to the relevance of data for Germany, a major shortcoming is the scarcity of data on ecologically 
relevant invertebrates (gammarids or biota of the sediment). Thus, the sensitivity of key species of 
home waters cannot be reliably assessed. Generally, data on sediment toxicity are limited in number. 
Only few publications report on studies that have used the same endpoint in the same test organism 
for different pharmaceuticals, and mode of action-specific endpoints are rarely used both in studies 
on single substances and mixtures. Quite often, chemical analytics supplementing biological tests is 
missing, and only about 70% of publication reviewed met the reliability criteria of Wright-Walters et 
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al. (2011) to a sufficient extent. In general, a mode of action-based in vitro test for non-hormonal 
pharmaceuticals does not exist.  
 
6. Future perspectives in the biomonitoring of pharmaceuticals  
 We suggest to coin biotests that are based on mode of action-specific mechanisms and thus 
are specific for pharmaceutical classes and can be implemented in monitoring programs. 
Advantages of such biotests would be  
o the integration of overall chemicals belonging to an mode of action-specific class of 
pharmaceuticals, irrespective of their accessibility by chemical analytics which can be 
limited by constraints posed by methodological detection limits, laboratory 
capacities, or budgetary limits,  
o a pre-adaptation for the monitoring of future pharmaceuticals that exhibit the same 
mode of action as those the test has been developed for,  
o and the integration of combinatory effects of mixtures of pharmaceuticals.  
 
 Suitable prototypes implementing this idea would be in vitro tests for analgesics, like 
NSAIDs, and in vitro tests for ß-blockers.  
 The development of these in vitro biotests must go in line with in vivo experiments on 
ecologically relevant species which represent water and sediment biota in order to validate 
the sensitivity of the novel in vitro tests and to “ecologically calibrate” their signals. In these 
in vivo studies, identical endpoints shall be investigated in the laboratory and in field-
relevant exposure systems, both for single pharmaceuticals and their mixtures. This strategy 
will provide necessary information regarding  
o the relevance of in vitro test signals for the situation in vivo,  
o the necessity to artificially concentrate water samples,  
o the relevance of laboratory studies for the field situation,  
o the significance of mixture toxicity, and  
o differences in the toxicity of pharmaceuticals to water- and sediment-living biota.  
 These suggestions are completely in line with the postulations of Ankley et al. (2007) who 
emphasize the impotance of mode of action-based studies for pharmaceutical monitoring, 
and of Brausch et al. (2012) [6] who stress the necessity of  
“…(a) chronic toxicity data for individual pharmaceuticals to benthic invertebrates, 
including bivalves, and fish is lacking;  
(b) Effects of pharmaceuticals on threatened or endangered species, which warrant 
protection at the individual level of biological organization;  
(c) MOA-based studies, in which biochemical and histological alterations are 
investigated or studies in which genetic alterations are monitored in response to 
long-term pharmaceutical exposure;  
(d) Techniques capable of detecting sensitive endpoints in aquatic organisms, such as 
in vitro and computational toxicology, for prioritizing chemicals and pathways for 
future studies;  
(e) Data on complex mixtures of pharmaceuticals that found in WWTP effluents” 
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The continuously growing and aging world population and the intensified livestock farming worldwide 
are expected to raise the global consumption and the number of human and veterinary 
pharmaceuticals on the market in the future. As a result, pharmaceuticals that are incompletely 
removed by wastewater treatment will occur in higher concentrations and in immense multiplicity in 
the water cycle. Except for synthetic steroid hormones, environmental monitoring of pharmaceuticals 
still remains to be based upon analytical chemistry of single substances which is incapable to 
encompass entities of pharmaceutical compounds with, for example, the same mode of action (MOA) 
at once, and thus will soon be overstrained by the sheer number of compounds, metabolites, and new 
product developments. For all the major classes of pharmaceuticals, we will therefore need MOA-
based cell culture assays that report on the immediate interaction of compounds with their specific 
molecular target and, thus, on possible effects on organisms in the environment. 
The topic’s relevance is without doubt. Globally, pollution by pharmaceuticals has been identified as a 
matter of concern by environmental policy. Recently, a nomination dossier was submitted to the 
United Nations that proposed ‘environmentally persistent pharmaceutical pollutants’ as an emerging 
policy issue under the framework of the ‘Strategic Approach to International Chemicals Management’. 
Last year, representatives of 24 countries and representatives of industry and academia agreed on the 
necessity to establish systematic and global monitoring programs on pharmaceuticals as a basis for a 
constant evaluation of potential risks to man and the environment.1 Moreover, in the last amendment 
of the European Water Framework Directive, the European Commission was mandated to develop a 
strategy to reduce possible environmental impacts of pharmaceuticals. As a consequence, diclofenac, 
17β-estradiol and 17α-ethinylestradiol are discussed to be placed on a watch list for which EU-wide 
monitoring data must be gathered. According to the EU, new pharmaceuticals have to undergo an 
environmental risk assessment (ERA) before marketing approval. For several pharmaceuticals, 
potential risks have been already identified and, in contrast to human medication, marketing 
authorization can be denied or restricted for veterinary medicinal products (VMP). A major drawback 
of the current approach for pharmaceutical ERA, however, is the lack of suitable data on exposure and 
ecotoxicological effects for the vast majority of the “old” active ingredients in pharmaceuticals which 
were already on the market before the requirement for an ERA was introduced into legislation. In 
addition, long-term effects resulting from chronic exposure of nontarget organisms and the potential 
of mixture effects as well as interactions with biotic and abiotic confounding factors are far from being 
well understood.  
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As an advanced tool for an ERA, different strategies of pharmaceutical prioritization have been 
proposed among which the most promising ones incorporate ecotoxicity data that are plausibly linked 
to specific modes of action (MOA). Furthermore, for monitoring purposes, MOA-based tools have been 
identified (e.g., in the U.S. Tox21 and ToxCast programmes) as auspicious instruments that can provide 
information on potential pharmaceutical class-related effects in environmental samples. A detailed 
study giving numerous examples of application of MOA-based techniques to environmental samples 
has been published recently.2 Nevertheless, all these approaches have focused on nonpharmaceutical 
compounds with the exception of synthetic steroid hormones. 
 
Figure 1: Pharmaceuticals may, phenomenologically, exert effects in nontarget biota and pose environmental risks. The vast 
number of these compounds and their metabolites makes it impossible to routinely screen their abundance by analytical 
chemistry. MOA specific life cell biosensing could trace primary action of pharmaceutical classes and attribute in vivo effects 
to them. 
However, MOA-based techniques are within reach also for other classes of pharmaceuticals. 
Theoretical approaches to predict interactions of human pharmaceuticals with receptors of wildlife 
species have already been developed.3 Even though a high diversity of biota with different physiology 
is potentially affected in the environment, the biochemical function of receptors remains rather 
phylogenetically conserved within a clade, at least among vertebrates. In vitro assays based on highly 
conserved signal transduction pathways including ligand-receptor interactions are, therefore, 
supposed to be relevant for a high number of vertebrate species, including fish. Although the use of 
such MOA-based in vitro assays for environmental monitoring is already common practice for 
nonpharmaceutical compounds or sex steroids, for other classes of pharmaceuticals such in vitro tests 
have not left a mark in ecotoxicology yet. This is the more surprising because target-based assays 
focusing on receptor-ligand binding, coupled to the generation of measurable signals have been, 
historically, the mainstay of substance screening in pharmacological research and development. 
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In this context, the most recent developments make use of the enormous potential of genetically 
encoded fluorescent sensors expressed by recombinant cell lines comprising a sensing unit that 
recognizes its interaction with a chemical and a reporting unit which indicates the sensing unit’s state 
and, accordingly, leads to immediate fluorescence signal changes4 - in contrast to reporter gene assays 
which generate a signal at the downstream end of a long signal transduction pathway allowing side 
effects by interfering substances at every step along this cascade. Adapting such methods to construct 
cell lines that generate immediate fluorescent signals following a pharmaceutical-target interaction 
should therefore substantially advance MOA-directed analysis of the primary impact of 
pharmaceuticals in environmental samples. Own current research revealed a fluorescence resonance 
energy transfer (FRET)-based cell line created to monitor β-adrenoreceptor binding to provide an 
optical signal for β-blockers in the concentrations range of the lowest observed effect concentration 
(LOECs) reported for the most sensitive biota (10 to 100 nmol/L).5 
Of course, the transfer of these cell culture technologies from the “clean” conditions of active 
component screening to the “dirty” composition of environmental samples will likely pose challenges 
for an appropriate processing of these samples. Furthermore, receptor activation as a primary effect 
of environmental compounds needs to be validated by biomarkers and population-relevant endpoints 
in environmentally relevant biota including fish, crustaceans, and sediment-dwelling organisms for the 
same environmental situation − a labor-intensive but achievable task (Figure 1). Consequently, novel 
MOA-directed in vitro assays on primary pharmaceutical action will serve as both compound class-
selective and effect-oriented tools, which bridge the still existing gap between the analytical chemistry 
of pharmaceuticals in waters and sediments and their in vivo effects in an elegant way. They need to 
be urgently implemented in environmental monitoring programmes and the routine assessment of 
environmental quality. 
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Abstract 
The NSAID diclofenac is controversially discussed with respect to its environmental relevance. Since 
further information is need to assess whether diclofenac should be included as substance of priority in 
the EU water framework directive, we investigated the impact of this analgesic on the embryonic 
development of brown trout (Salmo trutta f. fario) from fertilized egg until the end of sac-fry stage and 
studied effects in juvenile fish six months post hatch.  
Embryos were exposed to five test concentrations (0.1, 0.5, 1, 10, 100 µg/L) over 127 days at 7 °C. 
None of the treatments affected mortality, hatching, development or heart rate. Six months old 
juveniles exposed to five concentrations (0.1, 1, 10, 100, 200 µg/L) over 25 days at 7 °C, however, 
showed increased mortality, reaching significance at 100 µg/L. Furthermore, a significantly higher 
proportion of juvenile animals bore injuries at concentrations higher 10 µg/L. Neither the levels of the 
stress protein Hsp70, nor the amount of lipid peroxides was affected by any of the treatments. 
Histological analyses of gill, liver and kidney revealed visible tissue reactions in fish from all 
experimental groups. Histological responses in livers of diclofenac-exposed fish outstripped the status 
of laboratory control fish, particularly when exposed to the two highest concentrations. Chemical 
analyses of fish muscle tissue revealed concentration-dependent uptake of DCF into the animal, but 
no relevant bioconcentration. 
Our study supports earlier findings indicating a lower sensitivity of trout early life stages compared to 
older individuals, suggesting that studies for risk assessment of diclofenac should predominantly focus 
on later life stages. Furthermore, fish mortality was found to increase with rising diclofenac 
concentrations, and the lowest observed effect concentration of 10 µg/L on the organismic level 
emphasises the classification of diclofenac as a micropollutant that requires close attention. 
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1. Introduction 
As a result of the rising production of chemicals and their manifold usage in everyday life, the 
complexity of the micropollutant mixture in the water cycle is continuously growing (Schwarzenbach 
et al. 2006 Luo et al. 2014). Yet, much uncertainty remains concerning their risk for humans and 
wildlife. During the last decade, pharmaceuticals were targeted as environmentally relevant emerging 
pollutants (Triebskorn et al. 2014), which is not astonishing since they possess the innate and by design 
desired ability to elicit biologically relevant effects already at low concentrations. As such, effects on 
aquatic biota are within the realms of possibility, especially when considering that organisms are 
exposed throughout their entire life span (Fent et al. 2006).  
Within the wide range of pharmaceutically active compounds, the non-steroidal anti-inflammatory 
drug (NSAID) diclofenac is among the most frequently used, studied – and with respect to its 
environmental relevance - controversially discussed (Triebskorn et al. 2014, Lonappan et al. 2016). The 
therapeutic action of DCF is the inhibition of cyclooxygenase I and II, leading to reduced production of 
prostaglandins (Gan 2010). Prostaglandins are involved in a variety of physiological processes, 
including inflammation, platelet aggregation, vasodilation, renin release and presumably complex 
integrative functions in brain and autonomic nervous systems (Funk 2001, Simmons et al. 2004). The 
well-known side effects of this drug in humans, however, seem to be resembled by pathologies in 
other, even wildlife vertebrates. Since the discovery of diclofenac’s detrimental effects on vulture 
populations by eliciting acute renal failure and visceral gout (Oaks et al. 2004), a wide spectrum of 
studies focused on examining its risk for aquatic ecosystems.  
As a commonly used over-the-counter analgesic, its concentration in sewage treatment plant effluents 
can range up to several micrograms per litre (Meyer et al. 2016). As a direct consequence, measureable 
amounts of diclofenac are present in most European streams (Loos et al. 2009, Aus der Beek et al. 
2016b) and are occasionally found even in ground water (Monteiro and Boxall 2010). However, the 
reported surface water concentrations show great variation: while most reported medians and means 
are in the low ng/L-range between 5 and 32 ng/L, there remain various events where it was detected 
in concentrations above 100 ng/L (Ternes 1998, Loos et al. 2009, Aus der Beek et al. 2016b). Letzel et 
al. (2009), who based their study on measured data rather than available consumption data, calculated 
a worst case predicted environmental concentration (PEC) of 140 ng/L for German rivers.  
Although the detected concentrations are varying, the almost ubiquitous presence of diclofenac in 
surface waters is undoubted. Far more discordance exists on effect concentrations in non-target 
organisms. While several studies found lowest observed effect concentrations (LOECs) in close range 
to the PEC (Schwaiger et al. 2004, Triebskorn et al. 2004, Hoeger et al. 2005, Triebskorn et al. 2007, 
Mehinto et al. 2010, Ribeiro et al. 2015, Näslund et al. 2017), others feature effect values that exceed 
the environmental concentrations by several orders of magnitude (Lee et al. 2011, Memmert et al. 
2013). Currently, diclofenac has been included into the watch list of chemicals that are in discussion as 
priority substances in the European Water Framework Directive (EU 2006a, EU 2012, EU 2013). 
Therefore, further information regarding effects of diclofenac on aquatic organisms is crucially needed. 
The aim of our study was to further substantiate the knowledge on this controversially discussed 
pharmaceutical by testing two supposedly sensitive life stages of brown trout. Tests on embryos and 
sac-fry stages are common for other fish species like zebrafish or medaka, but are rarely applied for 
cold-water fish. The main reasons for this may be the long embryonic development period, which 
exceeds several months, and the fact that eggs are only available for a short time frame once per year. 
However, as brown trout are a species of high local ecological relevance for Central European stream 
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ecosystems (Dußling and Berg 2001), their examination provides crucial information for the evaluation 
of potential adverse effects related to chemical exposure. Juveniles of about 6 months post hatch pose 
another sensitive life stage, since these animals are still in growth and lack the constitution and energy 
reserves of fully grown adults.  
The major aim of the test with embryos and sac-fry stages was to examine developmental parameters 
like mortality, hatching rate and time, malformations and heart rate, accompanied by histological 
examinations. In the experiment with juveniles, the focus originally was put on sublethal parameters. 
Several NSAIDs are suspected to alter the level of oxidative stress, but there are reports on decreases 
as well as increases (Hickey et al. 2001, Fernandez et al. 2013, Gonzalez-Rey and Bebianno 2014, Nunes 
et al. 2015). Consequently, we wanted to have a closer look at one of these parameters – lipid 
peroxides. Lipid peroxide formation is among the final results of imbalances in the dynamic steady 
state of reactive oxygen species, and increased levels lead to compromised cellular function (Lushchak 
2011). Moreover, the proteotoxic action of a substance can be assessed via measurements of the stress 
protein Hsp70. The Hsp70 system is induced by intracellular malfolded and degraded proteins, and 
assists in the restoration of damaged proteins. Therefore, increased levels of Hsp70 are a general sign 
of proteotoxic stress (Sørensen et al. 2003). Besides these biochemical analyses, histopathological 
examination was a further part of the study. Tissue integrity is a parameter that can react sensitively 
and integrate over a broad range of adverse effects – making it a suitable tool for the assessment of 
general health condition (Triebskorn et al. 2007). Furthermore, biometric measurements, mortality, as 
well as morphological and behavioural peculiarities of the test animals were recorded in the 
experiment.  
Our objective was to identify whether diclofenac has the potential to adversely affect the development 
of brown trout; and whether the health of juveniles is compromised after sub-chronic exposure. To 
achieve this, we applied a battery of different tests to different life stages of the same fish species, 
complemented by chemical analyses, to shed further light on the risk emanating from the NSAID 
diclofenac for aquatic wildlife.  
2. Materials and Methods 
2.1 Test organism 
Brown trout (Salmo trutta f. fario) is a salmonid teleost native to Central European countries. As a 
typical inhabitant of the upper river regions, it prefers cool, oxygen-rich waters (Dußling and Berg 
2001). Embryonic development from fertilised egg to fully developed larvae requires several months, 
strongly depending on the ambient temperature (Killeen et al. 1999a).  
Fertilised eggs and juvenile animals were obtained from a commercial fish breeder (Forellenzucht 
Lohmühle, D- 72275 Alpirsbach-Ehlenbogen). The breeding facility is subject to regular controls and 
rated as category I, disease-free (EU 2006a, Council Directive 2006/88/EC) . Since the breeder supplies 
animals for fishery restocking campaigns in German streams, the chosen variety is considered robust 
and close to feral forms. Eggs were exposed directly after purchase. Juvenile animals were acclimatized 
to lab conditions in two 250 L aquaria (filtered, aerated tap water – iron filter, particle filter, activated 
charcoal filter; constant particle filtration and aeration during exposure) for one week prior to the 
experiments.  
2.2 Test substance 
In all experiments, diclofenac was applied as sodium salt (CAS 15307-79-6, Sigma-Aldrich, 89555 
Steinheim, Germany). The addition of organic solvents was not necessary. In the following, all given 
concentrations refer to the amount of pure diclofenac, not the salt. 
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2.3 Exposure of trout embryos and sac-fry stages 
The experiment followed the OECD guideline 212 (OECD 1998): in the semi-static test setup freshly 
fertilized eggs of brown trout (Salmo trutta f. fario) were exposed to diclofenac in concentrations of 0, 
0.1, 0.5, 1, 10, and 100 µg/L at 7 °C. Until the eyed ova stage, the embryos developed in darkness - 
subsequently the conditions changed to a 10 h/14 h light/dark cycle. Treatments were tested in 
triplicates, where each replicate consisted of a glass Petri dish containing 200 mL test medium and 30 
individual eggs. Every second day, in each Petri dish 150 mL of test solution were replaced with fresh 
solution prepared from aerated artificial water (294 mg/L CaCl2 x 2 H2O, 123.25 mg/L MgSO4 x 7 H2O, 
64.75 mg/L NaHCO3, 5.75 mg/L KCl). Water conditions (pH, oxygen content, temperature) were in a 
tolerable range at the end of the experiment (mean pH = 6.8 ± 0.21, mean oxygen = 8.4 ±  0.68 mg/L, 
mean temperature = 7.2 ± 0.19 °C). Oxygen saturation was above the threshold level of 60 % in all 
vessels except for one, which had a final oxygen saturation of 59.6 % (block 1 – 0.1 µg/L diclofenac). 
The exposure lasted for 127 days and was terminated before the fry had fully consumed their yolk-sac. 
Recorded parameters were the time until eyed ova stage, time to hatch, heart rate one week post 
hatch and survival (excluding unfertilized eggs). At the end of the experiment, all larvae were 
anesthetised and killed by an overdose of MS-222 (tricaine methanesulfonate, 1 g/L, buffered with 
NaHCO3). Three larvae were fixed in a solution of 2 % glutardialdehyde diluted in 0.1 M cacodylate 
buffer (pH 7.6) for further histological examination of kidney and liver. The remaining larvae (between 
20 and 26 individuals per treatment) were used to determine body mass.  
2.4 Exposure of juvenile trout 
Juvenile brown trout (approx. 6 months post hatch) were exposed for 25 days in a semi-static three-
block design. Each block consisted of six 25 L aquaria (0, 0.1, 1, 10, 100, 200 µg/L diclofenac) containing 
13 individual fish each. This led to a total of 234 fish exposed in 18 different aquaria. Ambient 
conditions of the thermoconstant chamber were set to 7 °C and a 12 h/12 h light/dark cycle, with the 
aquaria being shaded from direct light. Twice a week, in each aquarium one third of the test medium 
was exchanged with fresh diclofenac solution (prepared from filtered, aerated tap water – iron filter, 
particle filter, activated charcoal filter). Additionally, excess food and faeces were removed. Water 
conditions (pH, oxygen content, temperature, conductivity) were checked regularly and remained 
within the acceptable range throughout the experiment (mean pH = 8.5 ± 0.04, mean oxygen = 
10.97 ± 0.15 mg/L, mean temperature = 6.9 ± 0.18 °C, mean conductivity = 446 ± 5.5 µS/cm). Fish were 
fed twice a day with commercial trout feed (1.5 mm, Biomar, Brande, Denmark), and mortality was 
recorded. At the end of the exposure period, fish were anesthetised and killed by an overdose of MS-
222 (1 g/L, buffered with NaHCO3), followed by a neck-cut. Two researchers recorded body lengths, 
body mass, as well as any apparent morphological abnormalities. This included the assessment of 
mutually inflicted injuries (bite marks on fins, snout and opercula) by scoring whether they were absent 
or present. Histological samples of gill, liver, and trunk kidney were fixed in a solution of 2 % 
glutardialdehyde diluted in 0.1 M cacodylate buffer (pH 7.6). Samples of liver (for stress protein 
analysis), trunk kidney (for lipid peroxide analysis), and all remaining fish tissue (for chemical analysis 
of diclofenac concentration in tissues) were frozen in liquid nitrogen and stored at - 80 °C until further 
usage. 
In addition to the lab exposure, 20 animals were sampled directly at the fish hatchery at time points 
comparable to start and end of the experiment. Dissection and preparation of samples followed the 
same routine as described above. These “hatchery controls” were necessary to assure ourselves that 
the animal stock designated for our experiment was free of injuries, parasites and pathogens, and 
served as reference to check for potential effects of the lab exposure itself. 
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2.5 Chemical analyses 
The real concentrations of diclofenac in the test aquaria as well as concentrations in exposed fish were 
determined by chemical analyses. Water samples were taken at the start and the end of the 
experiment, as well as before and after the first water exchange – and frozen at -20 °C until processing. 
Analyses were performed on mixture samples of the three replicate aquaria belonging to the same 
treatment. If necessary, aqueous samples were enriched by solid-phase extraction (SPE). A 50 mL 
sample was adjusted to pH 3 with hydrochloric acid and the analyte was pre-concentrated with a 
polymeric sorbent material (Strata-X, 200 mg, Phenomenex, Aschaffenburg, Germany). Subsequently, 
the sorbent was dried under a gentle stream of nitrogen and eluted with 8 mL methanol and 2 mL 
acetonitrile. Diclofenac was analyzed by high performance liquid chromatography (HPLC, 1290 series, 
Agilent, Waldbronn, Germany) coupled to tandem mass spectrometry (MS/MS, API 5500, AB Sciex, 
Foster City, USA) by multiple reaction monitoring in positive mode by electrospray ionization. The 
optimized interface and MS/MS parameters are displayed in Table 1 in the supplementary information.  
For quantitative analyses, the isotopically labelled standard diclofenac-d4 was used for the correction 
of signal enhancement or suppression caused by matrix components. 
For the extraction and analysis of diclofenac in fish, several parameters for optimum extraction like 
organic solvents, extraction pH and injection volume were tested to assess the effect of co-extracted 
matrix. For this purpose, turtle food (Engergil, JBL GmbH, Neuhofen, Germany) containing complete 
freeze-dried fish and crustaceans was used as matrix. The matrix was ground in a blender to obtain a 
fine powder for extraction experiments. 0.5 g of freeze-dried matrix was extracted with 3 mL of the 
respective organic solvent for 15 min in an ultrasonic bath. After extraction, the vessel was centrifuged 
for 15 min at about 3,000 g and the supernatant was transferred into a glass vial. Extraction and 
subsequent centrifugation were repeated with the same amount of extraction solvent and the two 
supernatants were merged and blown down to dryness under a gentle stream of nitrogen. The dry 
residue was reconstituted with 200 μL of methanol and 0.8 mL of ultra-pure water. After micro-
centrifugation an aliquot was injected into the LC-MS/MS system. A matrix matched calibration with 
turtle food was prepared for quantification.  
For the analysis of biota, samples were treated with the same analytical instrumentation as described 
for water samples, but different LC buffers and another LC gradient program were used due to co-
eluting matrix components. Eluents were (A) ultrapure water + 5 mM ammonium formate + 0.05 % 
formic acid and (B) methanol / acetonitrile (⅓ / ⅔, v/v) + 5 mM ammonium formate. Chromatographic 
separation started with 10 % B, which was increased to 15 % within 2 min, further increased to 20 % 
within 6 min, to 50 % within 4 min, to 60 % within 8 min and to 100 % within 2 min. Then eluent 
composition was held at 100 % B for 6 min and decreased within one minute to the initial conditions 
(total gradient time 29 min). Between two injections the column was re-equilibrated for 6 min. After 
exposure time, fish were freeze dried, pooled and homogenized. By that means, two pool samples for 
every tests concentration including the control could be provided for analysis (total number of twelve). 
The extraction efficiency was ensured by supplementing one of the control samples from the test 
series with juvenile trout with 20 μg/kg diclofenac. All samples were spiked with the isotopically 
labelled internal standard diclofenac-d4 for the correction of matrix effects. 
2.6 Stress protein analysis 
The stress protein Hsp70 was quantified in liver of the exposed fish as described by Dieterich et al. 
(2015). After homogenisation and protein quantification (Bradford 1976), sample protein 
(standardized to 40 µg total protein) was separated via SDS-PAGE and blotted to a nitrocellulose 
membrane. Protein bands were immune-stained with a monoclonal α-Hsp70 IgG (Dianova, Hamburg, 
Germany) and a secondary peroxidase-coupled α-IgG (Jackson Immunoresearch, West Grove, PA) and 
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the optical volume was finally quantified and related to an internal Hsp70 standard. Details on the 
procedure are given in the supplementary information.  
2.7 Determination of lipid peroxides 
The FOX (ferrous oxidation xylenol orange) assay was conducted according to a modified version of 
the protocols proposed by Hermes-Lima et al. (1995) and Monserrat et al. (2003). Frozen kidney 
samples were diluted 1:7 in HPLC-grade methanol, homogenized and centrifuged at 15,000 rcf for 
5 min. The assay was performed in 96 well plates. Each well was filled with 50 µL of 0.75 mM FeSO4-
solution, 50 µL of 75 mM sulfuric acid, 50 µL of 0.3 mM xylenol orange solution, 15 µL of sample 
supernatant and 35 µL of bidestilled water. Each sample was tested in triplicate, and a sample blank, 
in which the FeSO4 solution was substituted with water, was added. All data were related to a master 
blank, which consisted of bidestilled water. The samples were incubated for 135 min at room 
temperature. The absorbance at 570 nm was measured using an automated microplate reader (Bio-
Tek Instruments, Winooski VT, USA). After the first measurement, 1 µL of 1 mM cumene hydroperoxide 
solution was added to each well. After another incubation period of 30 min, the absorbance at 570 nm 
was measured again. Cumene hydroperoxide equivalents (CHPequiv./mg wet weight) were calculated 
using the following equation: 
𝐴570𝑛𝑚
𝐴570𝑛𝑚𝐶𝐻𝑃
∗ 𝑣𝑜𝑙𝑢𝑚𝑒𝐶𝐻𝑃 ∗
𝑡𝑜𝑡𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒
𝑠𝑎𝑚𝑝𝑙𝑒 𝑣𝑜𝑙𝑢𝑚𝑒
∗ 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 =
𝐴570𝑛𝑚
𝐴570𝑛𝑚𝐶𝐻𝑃
∗ 1 ∗
200
15
∗ 7 
2.8 Histological analyses 
Three samples per aquarium were further processed for the exemplary histological evaluation. Prior 
to embedding, the fixed tissue samples were washed three times for ten minutes in 0.1 M cacodylate 
buffer (pH 7.6), followed by three 15 min washing steps in 70 % ethanol. For gills and kidney, an 
additional step for decalcification in a 1:2 mixture of concentrated formic acid and 70 % ethanol was 
added between these steps. Dehydration and paraffin embedding took place in an automated tissue 
infiltrator (TP 1020, Leica, Wetzlar). Histological sections were cut with a sledge microtome (SM 2000 
R, Leica, Wetzlar) set to a thickness of 3 µm. One part of the slices was stained with hematoxilin-eosin 
(to visualize nuclei, cytoplasm, connective tissue and muscles), the other part with alcian blue-PAS (to 
visualize mucus and glycogen). In a first evaluation step, slides were examined qualitatively to gain an 
overview and identify occurring pathologies. The second step was a semi-quantitative assessment 
performed in an observer-blinded way. The two slides per sample (AB-PAS/HE) were paired, the 
inscriptions masked, mixed and a random number was assigned to the slide pair. Each sample was 
classified into one of five different categories (1: control, 2: slight reaction, 3: medium reaction, 4: 
strong reaction, 5: destruction) according to the criteria published by Triebskorn et al. (2008). The 
classification of each number to the corresponding treatment was done after the assessment of all 
slides had been finished. 
2.9 Statistical analysis 
Statistical evaluation was done using R 3.2.1 (packages: lme4, lmerTest) and SAS JMP 11. Mortality 
data were analysed using COX-regression, using experimental block as nesting factor. Embryonic body 
mass was analysed by linear mixed model with Petri dish identity as random factor. Juvenile body 
length and body mass were analysed via nested ANOVA, data on stress proteins and lipid peroxidation 
using a linear model, including test block as cofactor. For lipid peroxides, data had to be log-
transformed and sample mass was used as additional covariate. Occurrence of injuries was compared 
using a generalized linear mixed model (binomial distribution, aquarium identity as random factor). 
Base significance level was set to α=0.05; in cases of multiple comparisons α was adjusted via 
sequential Bonferroni. If visible differences between groups were absent, we refrained from applying 
statistical tests. Due to the exemplary nature of the histological analyses we did not perform a 
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mathematical test on these data and thus restricting ourselves to descriptive statistics. Hatchery 
controls were only used as qualitative reference and not included in the mathematical analyses.  
2.10 Animal welfare 
The conducted experiment on juvenile brown trout was approved by the animal welfare committee of 
the Regional Council of Tübingen, Germany (authorisation ZP1/12). 
2.11 Credibility of data 
For an overview on the fulfilment of the criteria proposed by Moermond et al. (2015), see 
supplementary information. 
3. Results 
3.1 Chemical analyses 
In the exposure experiment with larvae, the real water concentrations of diclofenac were slightly lower 
than the nominal concentrations (Table 1), while there were only minimal differences in the 
experiments with juveniles (Table 2). The limit of quantification (LoQ) for the analyses of water samples 
was 10 ng/L. 
When analysing biota samples, the extraction pH had a distinct impact on the extracted matrix 
components. Methanol extraction resulted in the most colored extract and produced a very fine 
precipitant, which may result in problems in subsequent clean-up steps. Acetonitrile and ethyl acetate 
extraction were additionally performed with the addition of 2 % formic acid or 5 % NH4OH for acidic 
and alkaline extraction, respectively. Best results were obtained for neutral extraction with acetonitrile 
(supplementary information – Figure 1). The LoQ of the analytical method for biota samples was set 
to 5 μg/kg. At this concentration a signal-to-noise ratio of higher than 10 was achieved for diclofenac 
in the respective test matrix. Based on the LoQ, minimum bio-concentration factors (BCF) between 
50 L/kg and 0.025 L/kg were calculated for the different test concentrations (0.1 μg/L to 200 μg/L). 
In the control samples and the two lowest test concentrations (0.1 μg/L and 1μg/L) no diclofenac was 
detected in the fish in concentrations above the LoQ. In samples deriving from fish tanks with higher 
test concentrations of diclofenac, concentrations in the fish samples positively correlated with the test 
concentrations in the water (supplementary information – Figure 2). In the spiked control sample, the 
expected concentration was found proving the applicability of the method also for trout samples. 
3.2 Exposure of trout embryos and sac-fry stages 
Eye pigmentation started 30 days post fertilisation (dpf) and was finished 33 dpf; hatching began 64 
dpf and was finished 70 dpf. Both parameters did not differ between any of the tested treatments. The 
frequency of malformations was negligibly low. Furthermore, diclofenac affected neither embryo nor 
larvae survival and had no influence on heart beat rate (Table 1). The mean body mass was slightly 
lower at 10 µg/L, but these differences were due to a single replicate and no significant differences 
were found (linear mixed model, df=5/11.65, F=0.7623, p=0.5944). Histological examination revealed 
neither strong reactions in any of the examined larvae, nor any further effect of the exposure to 
diclofenac. 
Validity of the test was given, with control survival above 70 %, oxygen saturation above 60 % (sole 
exception: 59.6 % in block 1 – 0.1 µg/L diclofenac) and temperature differences smaller than 1.5 °C 
between test vessels.  
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Table 1: Summary on brown trout embryos and sac-fry stages exposed to diclofenac (DCF) for 127 days. Times until eyed ova 
stage and hatch are given in days post fertilisation [dpf]. Survival rates were calculated excluding unfertilised eggs. The heart 
rate is given in beats per minute [bpm]; for both heart rate and body mass both the arithmetic mean and the standard 
deviation (SD) are given.  
Treatment 
(nominal 
concentration) 
Real water 
concentration 
[µg/L] 
Mean time 
until eyed ova 
stage [dpf] 
Mean time 
until hatch 
[dpf] 
Overall survival 
rate [%] 
Mean ± SD 
heart beat rate 
[bpm] 
Mean ± SD 
body mass [mg] 
0 µg/L DCF < LoQ 30.46 65.08 97.57 50.8 ± 2.5 95.06 ± 10.93 
0.1 µg/L DCF 0.06 30.62 65.33 96.38 52.4 ± 2.9 94.81 ± 10.39 
0.5 µg/L DCF 0.51 30.61 65.70 98.77 50.9 ± 2.8 94.11 ± 11.44 
1 µg/L DCF 0.75 30.66 65.83 97.28 50.8 ± 2.5 94.58 ± 11.06 
10 µg/L DCF 7.8 30.52 65.05 95.06 51.0 ± 2.2 89.02 ± 13.87 
100 µg/L DCF 74.6 30.68 65.90 100.00 50.7 ± 2.4 95.05 ± 11.61 
 
3.3 Exposure of juvenile trout 
The biometric measurements did not show any differences between the treatments (body mass: 
nested ANOVA, df=5, n=231, F=1.1950, 0.3127; body length: nested ANOVA, df=5, n=232, F=1.4084, 
p=0.2224). Fish sampled at the hatchery resembled the lab-exposed animals in body size and weight 
at time point 1 (beginning of the experiment), but had grown considerably larger at time point 2 (end 
of the experiment).  
Juvenile fish showed a concentration-dependent increase in mortality (nested COX-analysis, df=5, 
n=234, χ2=13.457, p=0.0194) (Figure 1). Mortality rate exceeded 40 % in the two highest tested 
concentrations on day 25, while not exceeding 10 % in the control group. Step-wise comparison 
revealed significantly increased mortality at 200 and 100 µg/L, and a trend towards elevated mortality 
rates in the other test concentrations.  
Furthermore, the animals showed conspicuous bite marks on fins and opercula as signs of intraspecific 
aggression (Figure 2). We observed that in some aquaria, there was a higher tendency for bites on fins, 
while in other aquaria the animals bore a higher frequency of body injuries (snout and opercula). 
Evaluation was based on the prevalence of overall injuries, irrespective of harmed area and severity. 
While the frequency of these mutually inflicted injuries was low in the control group, it increased with 
diclofenac concentrations, with significant differences at concentrations of 10 µg/L and higher (GLMM, 
df=5, n=161, F=5.2463, p(10 µg/L)=0.0015).  
Biochemical analyses did not reveal any influence of diclofenac on the level of the stress protein Hsp70 
(linear model, df=5/151, F=1.046, p=0.3928), but revealed a slight increase of the Hsp70 level through 
the lab exposure itself. Lipid peroxidation was considerably higher in the lab exposure, compared to 
the samples from the hatchery. Results showed high variability, and were influenced by block and also 
the covariate sample mass, but not by diclofenac (linear model, df=35,123, F=1.639, p=0.02581). All 
presented biometric, biochemical and histological results are based on data from fish surviving until 
the termination of the exposure experiment. Data are summarized in Table 2; detailed results of 
statistical analyses are given in the supplementary information. 
Histopathological evaluation of juvenile fish revealed hypertrophy of gill pavement cells in all 
treatments, leading to an overall thickening of secondary lamellae. Livers, in general, exhibited low 
amounts of stored glycogen, dilated intercellular spaces, and frequent inflammative areas. Further 
effects were seen in kidney: most samples showed accumulations of hyaline material in tubular cells 
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and, frequently, high abundances of melanomacrophages. Moreover, several samples featured 
degenerative changes in the hematopoietic tissue leading to a “perforated” appearance. Individuals 
sampled directly at the hatchery (only evaluated for time point 1, since these animals were of 
comparable size to those in the experiment) showed a low frequency of histological alterations in 
kidney and gill – and slight reactions of the hepatic tissue (reduced glycogen, inflammations and 
aggregations of macrophages). Although most of the symptoms were also present in laboratory control 
animals, the frequency of strong reactions was higher in diclofenac-treated fish, especially in the liver. 
Most severe pathologies were observed in the two highest diclofenac treatments. A selection of 
observed pathologies is illustrated in Figure 3. 
These findings are reflected by the blinded semi-quantitative assessment. Regarding the gills, hatchery 
controls, kept in ponds, were predominantly in the control state, while lab controls, kept in aquaria, 
were in a state of slight to medium reaction. Diclofenac-exposed animals showed a slightly increased 
proportion of stronger reactions. While the kidneys of hatchery animals were in very good condition, 
most animals from the lab experiment had to be classified at least into the state of medium reaction. 
The two highest diclofenac concentrations also led, in few cases, to symptoms of severe destruction 
of renal tissue. The histology of the liver was already in a slight to medium reaction state in most 
samples from the hatchery. Lab-exposed animals often exhibited symptoms of medium to strong 
cellular reaction, but the proportion of strong reactions was considerably higher in fish exposed to 
diclofenac, particularly at 100 and 200 µg/L. Data are displayed in Figure 4. A detailed overview on the 
occurrence of the most frequent symptoms is given in the supplementary information. 
Table 2: Summary on juvenile brown trout exposed to diclofenac (DCF) over 25 days. LoQ was 0.01 µg/L for water and 5 µg/kg 
for biota samples. Injuries were only taken into account for animals surviving until day 25, and are displayed in total number 
of animals bearing injuries divided by the total number of surviving individuals. Mass, length, Hsp70 level and lipid 
peroxidation are displayed as arithmetic means and standard deviations (SD). Standard length refers to the length from snout 
to the base of the tail fin. Lipid peroxidation is given as cumene hydroperoxide equivalents per mg wet weight [CHPequiv./mg 
ww]. While the treatments did neither affect the biometric nor the biochemical measurements, increasing diclofenac 
concentrations elevated mortality rates and led to higher proportions of mutually inflicted injuries. Asterisks (*) depict 
significant differences at the adjusted α vs. the lab control; hatchery controls 1 and 2 were excluded from statistical 
comparisons. 
Treatment 
(nominal 
concentration) 
Real water 
concentratio
n [µg/L] 
Biota 
concentratio
n [µg/kg dw] 
Occurrence 
of injuries / 
number of 
survivors 
Mean ± SD 
body mass 
[g] 
Mean ± SD 
standard 
length [cm] 
Mean ± SD 
Hsp70 level 
[rel. grey 
value] 
Mean ± SD lipid 
peroxides 
[CHPequiv./mg 
ww] 
Hatchery 1 - - 0/20 3.25 ± 1.04 6.15 ± 0.54 1.34 ± 0.22 42.95 ±   20.71 
Hatchery 2 - - 0/20 7.29 ± 1.75 7.68 ± 0.56 1.24 ± 0.26 42.75 ±   23.41 
0 µg/L  DCF < LoQ < LoQ 7/35 3.18 ± 0.67 6.19 ± 0.46 1.52 ± 0.27 74.33 ±   26.83 
0.1 µg/L DCF 0.095 < LoQ 9/26 2.90 ± 0.65 5.96 ± 0.44 1.47 ± 0.27 85.18 ±   20.69 
1 µg/L DCF 0.975 < LoQ 14/30 2.81 ± 0.52 6.00 ± 0.38 1.46 ± 0.25 84.08 ±   23.47 
10 µg/L DCF 9.6 10.2 16/26* 2.82 ± 0.79 5.96 ± 0.47 1.52 ± 0.25 83.62 ±   21.32 
100 µg/L DCF 98.5 84.5 17/22* 3.03 ± 0.72 6.00 ± 0.49 1.37 ± 0.30 79.15 ±   26.84 
200 µg/L DCF 200 169.5 16/22* 2.84 ± 0.74 5.93 ± 0.51 1.45 ± 0.27 82.15 ±   18.28 
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Figure 1: Mean cumulative mortality of juvenile brown trout exposed to diclofenac vs. exposure time. Diclofenac led to a 
concentration-dependent increase of mortality, reaching significance at 100 µg/L and 200 µg/L (asterisks). 
  
 
 
Figure 2: Percentage of brown trout showing bite marks on fins and body after 25 days exposure to diclofenac. Filled circles 
indicate the mean, whiskers the minimum and maximum of the tree replicates. Diclofenac increased the frequency of mutually 
inflicted injuries from concentrations higher than 10 µg/L (asterisks). 
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Figure 3: Overview of selected histological findings (haematoxylin-eosin-stained sections) in brown trout juveniles: 1) Gill of a 
hatchery control individual, displaying secondary lamellae (SL) in the control state. 2) Gill of a lab control individual, featuring 
slight hypertrophy of gill epithelial cells, leading to thickened appearance of secondary lamellae (SL). 3) Gill of an individual 
exposed to 100 µg/L diclofenac, with thickened secondary lamellae (SL) resulting from strong hypertrophy of epithelial cells 
and ionocytes. 4) Kidney of a hatchery control individual, displaying the normal state of glomeruli (G), tubuli (T) and 
hematopoietic tissue (HT), as well as few melanomacrophages (MM). 5) Kidney of an individual exposed to 0.1 µg/L diclofenac, 
characterised by hyaline inclusions (HI) in tubular cells. 6) Kidney of individual exposed to 100 µg/L diclofenac, featuring 
hyaline inclusions (HI) in tubular cells, increased abundance of melanomacrophages (MM) and necrotic areas (N) leading to 
“perforated” appearance of hematopoietic tissue. 7) Liver of a hatchery control individual, characterised by hepatocytes with 
large light areas containing glycogen (GL); blood cells (BC) are visible between hepatocytes. 8) Liver of an individual exposed 
to 10 µg/L diclofenac: the highly vesiculated hepatocytes lack of glycogen. 9) Liver of an individual exposed to 100 µg/L 
diclofenac, characterised irregularly shaped and vesiculated hepatocytes with lack of glycogen storage and degenerating 
nuclei (DN); enlarged intercellular spaces (IC) are visible. 
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Figure 4: Semi-quantitative evaluation of histological sections of gill (left), kidney (middle) and liver (right). Hatchery controls 
(hc) are fish from the same stock, but sampled directly at the hatchery. Explanation is given in the text. Particularly for liver, 
there is a trend for increasing severity of pathological alterations at diclofenac exposure. 
4. Discussion 
Our results show that diclofenac can affect juvenile brown trout on the organismic level, even at 
concentrations as low as 10 µg/L. In contrast, no effects could be observed when examining early life 
stages of the same species. 
4.1 Internal diclofenac concentrations 
Chemical analyses of fish tissue confirmed diclofenac to be taken up by the animals, but did not 
indicate strong bioaccumulation. The samples used in our study consisted mainly of muscle tissue and 
spine. Due to the small size of the juvenile fish we were not able to provide enough material for further 
chemical analyses of liver or kidney after taking samples for biochemistry and histology. Our findings 
are in accordance with earlier studies (Schwaiger et al. 2004, Memmert et al. 2013), which reported 
high variability in bioaccumulation depending on the tissue type - with low bioaccumulative potential 
of muscle. This is supported by the low logPO/W of diclofenac at neutral or, in our case, slightly alkaline 
conditions (ca. 0.7 at a pH of 8.5) suggesting low potential for bioaccumulation. While our analyses are 
useful in confirming that concentration-dependent uptake has taken place, they do not allow direct 
inference on fish plasma concentrations. A simple fish plasma model based on lipophilicity (Fu et al. 
2009, Schreiber et al. 2011) would suggest a bioaccumulation factor of 2.5 at pH 7.6. However, 
lipophilicity may not be the only driving force behind uptake of NSAIDs because other, active 
mechanisms could contribute to this process (Choi et al. 2005). Cuklev et al. (2011) have measured 
plasma concentrations close to the human therapeutic level in trout exposed to 81 µg/L diclofenac, 
suggesting a BCF of 4. In a recent study by Bickley et al. (2017) on fathead minnow, accumulation in 
plasma was even higher, reaching the human therapeutic level at water concentrations of 25 µg/L. 
Effects in concentration ranges of 10 to 100 µg/L, as found in our study, may therefore be due to 
sufficiently large plasma concentrations to trigger a biological response. 
4.2 Embryo test 
The exposure of embryonic brown trout to diclofenac did not show any evidence for embryotoxicity 
of this pharmaceutical up to concentrations of 100 µg/L. These results match with a previous study on 
brown trout embryos, which reports a NOEC of 500 µg/L for mortality, hatching, development and 
teratogenicity (LfW 2004). Similar results were found for embryonic and larval stages of Danio rerio 
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(Hallare et al. 2004, van den Brandhof and Montforts 2010, Memmert et al. 2013), Oncorhyncus mykiss 
(Memmert et al. 2013) or Cyprinus carpio (Stepanova et al. 2013), where significant effects were found 
only at concentrations higher than 1 mg/L. 
4.3 Mortality 
On the contrary, juvenile brown trout responded in a far more sensitive way to diclofenac exposure 
than larvae. The increase in mortality, already occurring at diclofenac concentrations in the low µg/L-
range, is alarming. Aside the moderate mortality rate already at the lowest test concentration, the 
effect was concentration dependent. This result matches a recent study by Näslund et al. (2017), which 
reported concentration-dependent increases in  mortality of sticklebacks exposed to diclofenac, 
reaching significance at 320 µg/L. Assuming slight sensitivity differences attributable to species and life 
stage, the effect concentrations are in a similar range. Apart from this, diclofenac exposure-related 
mortality has never been reported in such low concentrations ranges before. Acute tests on adult fish 
reported an EC50 of 71 mg/L for carp (Islas-Flores et al. 2013, Saucedo-Vence et al. 2014), and none of 
the studies on trout that have examined a concentration range similar to our study (Schwaiger et al. 
2004, Hoeger et al. 2005, Mehinto et al. 2010, Memmert et al. 2013) has reported mortality increases 
worth mentioning. The present data suggest that the investigated life stage of brown trout (juveniles 
at an age of approx. 6 months post hatch) is far more susceptible to diclofenac than both the adult and 
early life stages.  
4.4 Behavioural effects 
Similarly surprising is the apparent effect of diclofenac on the inter-individual relationship in exposed 
fish. The proportion of individuals bearing marks of aggressive behaviour largely increased with 
increasing diclofenac concentrations, with a LOEC of 10 µg/L. The real frequency of fin bites was 
presumably even higher, since most carcasses recovered during the experiment bore bite marks. 
However, we could not clearly determine whether these damages were inflicted post mortem and 
have, consequently, excluded them from the analyses. The symptomatology of fin erosion is a 
frequently observed phenomenon in salmonids raised in commercial fish farming. Studies found the 
aggression behaviour to be influenced by stocking density (Jones et al. 2011), feeding conditions 
(Noble et al. 2007, Cañon Jones et al. 2010) and water parameters (Bosakowski and Wagner 1994). 
However, an effect of analgesics on the aggression behaviour has, to our knowledge, not been 
reported so far. Ajima et al. (2015) have reported behavioural changes of African catfish Rhamdia 
quelen at 25 mg/L diclofenac. Those included respiratory distress, loss of balance, and erratic 
swimming, but no signs of aggression. Besides a possible direct increase of aggressiveness, also a 
reduced ability or disposition for defensive actions might be the reason for this effect. As a pain 
reliever, diclofenac might dullen the senses of affected individuals, making them vulnerable to 
conspecific attacks. Furthermore, the generally weakened condition of the animals, suggested by the 
high mortality, may have a similar effect on the defensive abilities of the fish. Näslund et al. (2017) 
described sticklebacks leaving food and bearing higher proportions of skin ulcerations when exposed 
to diclofenac – which can be seen as signs of weakened body condition. Overall, a link between 
suffered injuries and mortality cannot be ruled out. Open wounds may act as entrance for various 
pathogens, rendering the animals prone to, potentially lethal, infections. On the other hand, 
diclofenac-induced mortality may have caused increasing aggression behaviour through fish density 
alterations. Young brown trout transcend from swarming to territorial behaviour when density is low, 
so high mortality rates could reduce the density below this threshold level. The main reason against 
this hypothesis is that no increased proportion of injuries was observed in the two lowest 
concentrations, despite higher mortality rates than in the control. One further possible explanation for 
the observed increased aggressiveness in juvenile fish derives from the study of Birzle (2015), who 
identified that diclofenac leads to perforations of the cornea in rainbow trout. Assuming a similar effect 
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for brown trout juveniles, the behavioural abnormalities could be attributed to panic reactions due to 
impaired eyesight. Macroscopic examination of the trout eye at our sampling did not reveal any 
abnormalities, but since the eyes of brown trout appear darker than those of rainbow trout, alterations 
per se cannot be recognized as easily. Since the behavioural effect was not anticipated at the beginning 
of our experiment, the set-up was not designed to answer these questions exhaustively. Further 
studies focussing on behavioural endpoints, e.g. via monitoring of activity and inter-individual 
behaviours, should help to put our findings into perspective.  
4.5 Histological effects 
Histological evaluation gives additional insights into the causes of the observed fatalities: the exposure 
in the laboratory itself elicited a physiological response in the animals. Tissue reactions can be seen as 
adaptations to altered water conditions (e.g. pH and salinity) - particularly in gill and kidney, organs 
that are directly involved in osmoregulation and electrolyte metabolism. Furthermore, livers showed 
symptoms of cellular reaction already in the individuals that have been sampled at the hatchery - a 
strong indication of the high energy demand and metabolic activity of the tested life stage. The high 
weight gain in fish sampled at the hatchery after the experiment supports this assumption. Commercial 
fish farming targets fast weight gain, while our feeding regime in the experiment aimed at 
maintenance. Therefore, the lab animals may have had less energy reserves to cope with stress than 
fish fed ad libitum. It must also be stressed out that the test could not be performed under flow-
through conditions, but in a semi-static set-up with regular water exchanges. These circumstances may 
have transferred the animals into an artificial situation they were not accustomed to. However, the lab 
situation alone cannot be seen as the sole reason for the observed fatalities, since lab controls showed 
a comparably low mortality rate of 10 %. The prevalence of strong reactions and destructions in tissue 
was by trend higher at diclofenac exposure, especially regarding the liver, pointing at an explicit 
negative effect of the pharmaceutical. We cannot attribute a specific pathology to the treatment, as it 
has been described in other studies for older individuals of rainbow trout (Schwaiger et al. 2004, Birzle 
2015), fathead minnow (Bickley et al. 2017) or stickleback (Näslund et al. 2017). In these published 
studies, the kidney is the major affected organ, showing the clearest pathological symptoms. Our 
results are, in this respect, less conclusive. The already high prevalence of reactions in control animals 
complicates the assessment of further deteriorations. The liver was the organ showing the clearest 
effects, in contrast to other studies where the liver histology was inconspicuous (Schwaiger et al. 2004, 
Näslund et al. 2017). However, ultrastructural examinations of rainbow trout livers revealed several 
comparable symptoms, like glycogen reduction and macrophage infiltration (Triebskorn et al. 2004). 
Differences in the severity of reactions between studies are in this case most likely attributable to 
species and life stage. Overall, no observed reaction type was exclusive to the diclofenac treatment, 
but we can see a qualitative difference in severity. Considering the high mortality in the diclofenac 
treatment, we also assume that animals suffering from the most severe pathologies, resulting in 
complete organ failure, did not survive until the time point of histological sampling. Based on the 
present data it is most likely that the basal level of stress, acting on a particularly susceptible life stage, 
led to highly sensitive reactions towards diclofenac and, consequently, resulted in fatal effects already 
at concentrations in the µg/L-range. We have to stress out that the purpose of the, exemplary, 
histological analyses in our study merely was the assessment of general health condition in view to 
assist in the interpretation of the other results. A more comprehensive description of histological 
alterations by diclofenac is given by Birzle (2015), who applied biometric measurements on histological 
samples, or the recent study by Näslund et al. (2017).  
4.6 Biochemical responses 
The lack of induction of the stress protein Hsp70 level is in accordance with studies on Danio rerio that 
did not reveal any effect of diclofenac on Hsp70 in concentrations up to 2 mg/L (Hallare et al. 2004). 
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Similar findings were obtained for the freshwater invertebrate Daphnia magna, for which a LOEC of 
30 mg/L has been reported (Haap et al. 2008). Gravel and Vijayan (2007), however, reported elevated 
Hsp70-levels in trout exposed to ibuprofen, another NSAID, but not salicylate, and complex 
interactions with heat shock-stimulated responses. Based on the results of our study, we draw the 
conclusion that the proteotoxic potential of diclofenac is negligible in trout and, probably, also in other 
teleost species.  
The amount of lipid peroxides was not affected by any of the treatments. Yet, the FOX-assay solely 
quantifies lipid peroxides but not the overall oxidative stress response of an exposed organism. The 
high complexity of the oxidative stress response system, however, in this context may be the reason 
for divergent findings that are present in the literature. A study on carp (Saucedo-Vence et al. 2014) 
found a significant increase of hydroperoxide content and lipid peroxidation at a concentration of 
7.1 mg/L diclofenac. However, the authors were not able to establish a concentration-response 
relationship as they had tested a single concentration only. Fernandez et al. (2013) have found a 
concentration-dependent induction of reactive oxygen species (ROS) by diclofenac in rainbow trout 
cell assays with an EC50 of 44.5 µg/L. On the contrary, Praskova et al. (2014) have reported a decrease 
of lipid peroxidation in Danio rerio at 20 µg/L diclofenac, without other parameters of the oxidative 
stress response being affected at concentrations up to 60 mg/L. A recent study by Ghelfi et al. (2016) 
found an increase in the activity of the enzyme superoxide dismutase in catfish kidney at 0.2 µg/L, but 
no influence on lipid peroxidation. If protection mechanisms against ROS, like superoxide dismutase, 
are induced by diclofenac, the final result – peroxidation of lipids, proteins, or DNA – may be 
prevented. Additionally, it has to be born in mind that the catalytic domains of cyclooxigenases possess 
peroxidase activity (Simmons et al. 2004). As a direct physiological consequence, COX-inhibitors may 
inhibit peroxidation of lipids. This could counterbalance the increase of lipid peroxides by cellular stress 
and, thereby, mask the actual effects.  
4.7 Comparisons of embryonic stages and juveniles 
In our study, two different life stages of the same species, originating from the same life stock, were 
exposed to similar concentrations of diclofenac. Yet, the responses were entirely different. Here, one 
may raise the difference in the pH between both studies. While the embryos developed in artificial 
water with neutral pH, juveniles were exposed in filtered tap water, which is typically alkaline in the 
test region. Earlier studies showed that the pH of the exposure medium can have a great influence on 
the toxicity of ionisable pharmaceuticals (Boström and Berglund 2015). However, for acidic substances 
like diclofenac one would assume a lower toxicity at higher pH, contrary to the findings in our 
experiment. Thus, our results lead to the conclusion that brown trout embryos and eleutheroembryos 
are more resilient towards diclofenac toxicity than older life stages. Reasons may be the independence 
from external feeding, but also differences in metabolic pathways. Studies on cell cultures have 
pointed out that the toxic action of diclofenac might be due to intermediate products of the CYP450-
metabolism (van Leeuwen et al. 2011). Life-stage dependent differences in the expression of CYP450 
(Andersson and Förlin 1992) or other enzymes therefore may influence the reaction towards toxicants. 
The low susceptibility of brown trout embryos to diclofenac, compared to older life stages, has been 
previously reported (LfW 2004). Memmert et al. (2013) exposed rainbow trout from early embryonic 
up to early juvenile stages, without finding effects until concentrations of 1 mg/L diclofenac. Studies, 
which actually reported effects of diclofenac in a low µg/L-range, were all conducted on older 
individuals (Schwaiger et al. 2004, Birzle 2015, Näslund et al. 2017). Solely relying on data obtained 
from early life stage tests would probably underestimate the risk. Consequently, future studies, 
particularly those with a focus on risk assessment, should address the differences in sensitivity in 
different life-stages of trout and other fish species to determine the most susceptible and, therefore, 
most relevant age class. 
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4.8 Environmental relevance 
Reported environmental concentrations of diclofenac are diverse and can reach the high ng/L-range. 
Measured environmental concentrations (MECs) differ considerably depending on the country and, 
frequently, data availability is lower than desired. In an extensive summary, Aus der Beek et al. (2016b) 
have reported a mean concentration of 0.16 µg/L for surface waters in Germany, for which the largest 
set of environmental data is available. These results fit well to the study of Letzel et al. (2009), from 
whose study a worst-case PEC of 0.14 µg/L has derived. Other PECs range in the low to medium ng/L-
range (Letzel et al. 2009, Johnson et al. 2013), rarely exceeding 0.1 µg/L. Our lowest tested diclofenac 
concentration of 0.1 µg/L is, therefore, in a range that is not the normal case but can be found in 
surface waters. The second-lowest concentration of 1 µg/L is still in the range of wastewater treatment 
plant effluent concentrations (Ternes 1998, Letzel et al. 2009). Higher concentrations, which elicited 
significant effects in our study, have not been measured in the environment so far. Nevertheless, our 
results are alarming since the safety margin between worst-case environmental concentration and 
experimental lowest effect concentration is small. Especially since the affected parameters mortality 
and behaviour are on an organismic level, which is of high relevance for the whole population and 
would warrant the application of further safety factors. Furthermore, survival rates, inviolacy, and the 
histological integrity of liver were, by trend albeit not significantly, affected at even lower 
concentrations. Even though deduction of environmental risks from laboratory experiments is always 
associated with uncertainty, the intensity of basic but moderate stress factors elicited by, e.g. the 
fishkeeping conditions in aquaria can be regarded comparable to other confounding stress conditions 
that frequently occur in the environment. Feral fish encounter various events, like seasonal or irregular 
changes in water parameters, periods of limited food availability, intraspecific competition or co-
exposure to other chemicals (e.g. nitrite or ammonia). In all these cases, further chemical stressors like 
diclofenac may act as a final trigger leading to detrimental effects on the individual and population 
level. To date, we are not aware of any study clearly linking fish population declines to contaminations 
with NSAIDs. Nevertheless, in view of other effects reported for diclofenac in the low µg/L-range in 
freshwater (Schwaiger et al. 2004, Triebskorn et al. 2004, Birzle 2015, Näslund et al. 2017) as well as 
in marine organisms (Ribeiro et al. 2015), the currently proposed environmental quality standards of 
0.1 µg/L and 0.01 µg/L, respectively, (EU 2012, EU 2013, Schröder et al. 2016) seem very reasonable. 
4.9 Perspectives 
Targeting diclofenac alone would be a grave underestimation of the general situation in the 
environment. The wide abundance of a range of other NSAIDs and further micropollutants is current 
reality in our aquatic ecosystems. Reliable effect-based tools would be a great gain for further 
evaluation of environmental risks (Triebskorn et al. 2015, Brack et al. 2017). In a recent study, Bernhard 
et al. (2017) have reported on novel mode-of-action based bioassays for the quantification of 
cyclooxygenase-inhibitors, like diclofenac, in aqueous samples. Assuming that the observed effects of 
diclofenac in aquatic species depend on the pharmaceutical’s physiological mode-of-action, future 
studies will relate the collective inhibitory action of NSAID mixtures to the effects observed in exposed 
biota. This change from substance-based to mode-of-action based evaluation will be a necessary step 
towards a more holistic assessment of the risk posed by pharmaceuticals in our environment. 
5. Conclusions 
Our results clearly indicate that embryos and larvae of brown trout are more resilient against the 
NSAID diclofenac than six months-old juveniles, which exhibited drastic effects. Environmentally 
relevant endpoints like mortality and behaviour were significantly affected at concentrations 10-100 
times above reported effluent and surface-water concentrations. Since the range between lowest 
effect and highest surface water concentration are within only two orders of magnitude, the results 
are alarming. Particularly because other NSAIDs that are also present in surface waters likely will exert 
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concomitant effects via the same mode-of-action pathway. Other studies also reported on adverse 
effects of diclofenac, on the histological as well as organismic level, in a comparably low concentration 
range. Taking this into account and applying a precautionary principle, it seems appropriate to monitor 
diclofenac closely and aim for compliance to the proposed environmental quality standard. 
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Here, only the abstract and summary are shown. The study report is too long to be included in this 
section and is available on the attached CD. 
Abstract 
As tools for environmental monitoring of pharmaceuticals, mode of action (MOA)-based in vitro-assays 
were developed for beta-blockers, as e.g. metoprolol, and non-steroidal anti-inflammatory drugs 
(NSAIDs), as e.g. diclofenac. For this purpose stable cell lines were generated which expressed 
recombinant MOA-based sensing and reporting units allowing for rapid live-cell visualization of 
immediate fluorescence signal changes. Sensitive cell based assays developed in microtiter plate 
format facilitated the quantitative determination of metoprolol and diclofenac activities in effluents of 
wastewater treatment plants. 
In order to validate these tests for their suitability to reflect in vivo-effects in environmentally relevant 
aquatic organisms, toxicity tests and biomarker studies were conducted with fish (brown trout), 
crustaceans (gammarids, daphnia), snails and sediment-dwelling invertebrates (annelids). Test were 
conducted (1) in the laboratory under controlled experimental conditions with isolated substances and 
binary mixtures, (2) in aquatic mesocosms and (3) under field conditions in a bypass-system connected 
to the effluent of a municipal wastewater treatment plant. In addition to population relevant 
endpoints as e.g. reproduction, development or fertility, also individual health parameters were 
investigated by means of stress protein analyses, histological investigations and studies revealing the 
oxidative stress status of the exposed organisms. 
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Summary 
A literature review conducted in phase I of the project “From theory to reality – Evaluation of 
suitable organisms and test systems for the biomonitoring of pharmaceuticals” (Triebskorn et al., 
2013) made evident that mode of action (MOA)-based in vitro-biotests are necessary for an effect-
directed biomonitoring of pharmaceuticals in the context of environmental risk assessment and eco-
pharmacovigilance. It has also been emphasized that validation of such biotests with respect to in 
vivo-responses in sensitive and ecologically relevant organisms should be realized in parallel to their 
establishment. 
In phase II of this project with the acronym “Eff-Pharm”, MOA-based biotests were developed for 
Beta-blockers and nonsteroidal anti-inflammatory drugs (NSAIDs). In parallel, in vivo-experiments 
were conducted with fish, crustaceans, molluscs and annelids. These case studies focussed on effects 
of diclofenac as a representative pharmaceutical of NSAIDs and metoprolol representing beta-
blockers aiming at determining threshold values for mode of action- and side effect-driven 
biomarkers as well as for population-relevant endpoints in these organisms. The approaches of Eff-
Pharm are illustrated in Figure 1. 
Figure 2 summarizes the project structure of Eff-Pharm: In two modules running in parallel, in vivo-
testing and in vitro-test development and validation of methods were realized. By a stepwise approach 
from laboratory to field via semi-field mesocosms, results that are mandatory to validate in vitro-
biotests have been generated for key biota of surface water and sediments, i.e. fish, gammarids, 
molluscs and sediment- dwelling annelids. Also the MOA-based biotests followed the steps from the 
laboratory to the field: it was the aim to provide test systems which are, on one hand, sensitive and 
specific for the respective groups of pharmaceuticals but also robust enough to serve as tools for 
wastewater and surface water biomonitoring in the field. 
 
 
Figure 1: Summary of the approaches followed in the EFF-Pharm project 
 135 
 
 
Figure 2: Structure of the project “From theory to reality – Evaluation of suitable organisms and test systems for the 
biomonitoring of pharmaceuticals – case studies” (Eff-Pharm) 
The project consisted of 12 work packages among which 8 addressed scientific questions (Table 1). The 
work packages were funded in two steps as EFF-Pharm 2 and 3. Supplementary experiments with 
Daphnia magna were conducted by the German Environmental Agency (part 4).  
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Table 1: Work packages (WPs) of Eff-Pharm 
WP Content 
1 (Eff-Pharm 2, 3) Coordination, project management 
2 (Eff-Pharm 2) Kick-off-meeting 
3A (Eff-Pharm 2) Laboratory tests surface water: single substances 
Test 1. Biomarker studies with juvenile trout 
Test 2. Embryo tests with trout 
Test 3: Tests with gammarids 
3B (Eff-Pharm 3) Laboratory tests surface water: mixtures 
4 (Eff-Pharm 3) Semi-field mesocosm experiments surface water 
5 (Eff-Pharm 2) Field experiments (waste water effluents) 
5A: Fish embryo tests 
5B: gammarids 
6 (Eff-Pharm 2b) Sediment toxicity: single substances and mixtures 
7A (Eff-Pharm 2) Chemical analyses in obligatory tests 
7B (Eff-Pharm 2b and 3) Chemical analyses in optional tests 
8 (Eff-Pharm 2) Development of in vitro-test systems 
9 (Eff-Pharm 2) Verification of in vitro-test systems 
10A (Eff-Pharm 2) Validation of in vitro-test systems 
10B (Eff-Pharm 3) Further validation of in vitro-test systems 
11 (Eff-Pharm 2, 3) Interim reports, final report 
12 (Eff-Pharm 2, 3) Presentation of results, organization final symposium 
 
The different tasks of the project were allocated as follows: 
Project coordination, management and reports: Steinbeis Transfer Center for Ecotoxicology and 
Ecophysiology, Rottenburg and University of Tübingen, Animal Physiological Ecology 
 Tests with fish: University of Tübingen, Animal Physiological Ecology 
 Tests with gammarids: GWT-TUD GmbH, Dresden 
 Tests with sediment-dwelling worms and snails: University of Frankfurt, Aquatic Ecotoxicology 
 Tests with Daphnia magna: German Environmental Agency 
 Chemical analyses: DVGW Water Technology Center, Karlsruhe 
 Biosensor development: Steinbeis Innovation Center Cell Culture Technology, Mannheim 
 The cooperation partners are responsible for their respective parts of the present report.  
As mentioned above, Eff-Pharm focussed on effects of beta-blockers (represented by metoprolol) and 
nonsteroidal anti-inflammatory drugs (represented by diclofenac), both representing pharmaceutical 
classes which are frequently used in Germany, which occur in relatively high concentrations in aquatic 
ecosystems and which therefore were classified as to be environmentally relevant (Ebert et al., 2014). 
In surface waters, diclofenac and metoprolol occur in the ng/L - µg/L range, in sewage treatment plant 
effluents concentrations of both pharmaceuticals reach the µg/L range. In river sediments, 
concentrations of up to 52 µg/kg diclofenac and 33 µg/kg metoprolol have been reported (Ramil et al., 
2010; Camacho-Muñoz et al., 2013).  
Single substance in vivo-tests with these two pharmaceuticals revealed the following results:  
In a range of different concentrations (0.1 – 1000 µg/L diclofenac or metoprolol) embryos of brown 
trout (Salmo trutta f. fario) did not show any alterations of development, survival, heart rate and body 
mass. In contrast, concentrations of 100 µg/L diclofenac or higher drastically increased the mortality 
of juvenile brown trout. Furthermore, these juveniles displayed an increased number of bite marks, 
indicative for elevated aggressiveness, following exposure to 10 µg/L diclofenac or higher. Metoprolol 
did not cause such effects. As well, the Hsp70 and lipid peroxidation levels in juvenile brown trout were 
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not affected by the two pharmaceuticals. Histopathology pointed in the direction of moderate stress 
experienced by the fish during lab exposure plus indicated proceeding degradation of renal tissue 
diclofenac concentrations of 10 µg/L and higher. In general, juvenile individuals of brown trout were 
shown to respond more sensitively to pharmaceuticals than the early embryonic stages inside the 
chorion. 
Gammarus fossarum was exposed to a range of 0.49 – 40 mg/L diclofenac or 5 – 405 mg/L metoprolol 
and investigated for mortality, juvenile/adult ratio, the number of precopula stages and the number 
of eggs per female. The most sensitive endpoint for diclofenac effect was the juvenile/adult ratio with 
a NOEC of 0.79 mg/L and a LOEC of 2.62 mg/L. The most sensitive endpoint for metoprolol effect also 
was the juvenile/adult ratio and the number of eggs per female, each with a NOEC of 5 mg/L and a 
LOEC of 15 mg/L. As in trout, Hsp70 and lipid peroxidation levels in gammarids remain unaffected by 
both pharmaceuticals. 
The snail Potamopyrgus antipodarum was exposed to a series of concentrations of metoprolol only. 
Significantly elevated Hsp70 levels were found in response to 3.2 mg/L metoprolol (NOEC: 1mg/L) or 
higher. After exposure to 10 mg/L metoprolol a 10% reduction in offspring production became obvious. 
In Daphnia magna, mortality, number of offspring, time until reproduction and behaviour was 
monitored following exposure to either 1.9 – 50 mg/L diclofenac or 0.1 - 25 mg/L metoprolol. The most 
sensitive parameter in this species was reproduction with a LOEC of 6.25 mg/L for diclofenac and 2.5 
mg/L for metoprolol.  
Mixture toxicity experiments, conducted with fish, gammarids, and daphnids, failed to reveal 
synergistic (more-than-additive) effects for all combinations, test species, and investigated endpoints. 
In sediment toxicity tests with the sediment-dwelling oligochaete worm Lumbriculus variegatus , the 
LOEC for reproduction was 100 mg/kg sediment dry wt (diclofenac), and 255 mg/kg sediment dry wt 
(metoprolol). A mixture of both substances did not exert synergistic effects. Consistent with the above-
mentioned results, Hsp70 and lipid peroxidation levels were not altered by the pharmaceuticals.  
Mesocosm experiments conducted in artificial indoor streams investigated the impact of 0,47; 1,9; 7,5; 
and 30 mg/L metoprolol (nominal) on G. fossarum, P. antipodarum, and L. variegatus, either exposed 
directly to the running water (“free living”) or sheltered in enclosures. Results largely resembled the 
findings obtained in the above-mentioned single species toxicity experiments. For some parameters, 
however, the conditions in the indoor streams (and here, most likely, the water current) fortified the 
metoprolol effects. Thus, “free-living” gammarids in the indoor streams exhibited a reduction in 
precopula number with increasing metoprolol concentrations, and the EC10 for reproduction 
impairment (28d) was found to be lower (0,594 mg/L) than in the single species experiment. Also for 
the other species, highest metoprolol toxicity was found for “free living”individuals (L. variegatus: EC10 
reproduction (40d): 0,569 mg/L; P. antipodarum: EC10 reproduction (40d): 0,253 mg/L). 
In order to approach conditions of environmental exposure, brown trout embryos and gammarids 
were exposed to effluent water from a sewage treatment plant (Eriskirch, close to Lake Constance), 
containing mean concentrations of 1,3 µg/L diclofenac and 1,4 µg/L metoprolol. Embryos of brown 
trout exhibited reduced lipid peroxides and body mass reduction after exposure to the effluent, wheras 
in gammarids, the effluent caused a decreased number of eggs per female in parallel to a higher body 
weight. 
The results of the in vivo-tests (LOECs and most sensitive parameters) are summarized in Table 2 
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Table 2: Most sensitive parameters and lowest LOECs (Real concentrations) 
    Species  Diclofenac  Metoprolol  
Single substances  
(laboratory studies)  
Fish: Salmo trutta f. fario  Behaviour, histology: 10 µg/L  Histology kidney > 745 µg/L  
Crustacea: Gammarus fossarum  Ratio juveniles / adults: 2.6 mg/L  Ratio juveniles / adults and  
number eggs /egg-bearing 
female: 15 mg/L  
   Crustacea: Daphnia magna  Reproduction: 6.25 mg/L  Reproduction:  2.5 mg/L  
   Mollusc: Potamopyrgus 
antipodarum  
 
Proteotoxicity 3.2 mg/L  
   Annelids: Lumbriculus variegatus  Reproduction (28d): 100 mg/kg  Reproduction (28d): 255 mg/kg  
Mixture toxicity  
(laboratory studies)  
Fish: Salmo trutta f. fario  Histology: 68.6/676 µg/L (¾ TU DIC + ¾ TU MET)  
Crustacea: Gammarus fossarum  No significant effecs at 1.97/11.25 mg/L (¾TU DIC + ¾ TU MET)  
   Crustacea: Daphnia magna  Reproduction: 4.69 / 1.88 mg/L (¾ TU DIC + ¾ TU MET)  
   Annelids: Lumbriculus variegatus  Reproduction: 203.6 mg/kg  
Mesocosm experiments  Crustacea: Gammarus fossarum     number eggs /egg-bearing 
female:           3 mg/L  
   Snail: Potamopyrgus antipodarum     Reproduction enclosures (28d):           
0.22 mg/L  
   Annelids: Lumbriculus variegatus     Reproduction (free living 
animals): EC50 (40d): 3.38 
mg/L  
Field experiments  Fish: Salmo trutta f. fario  Lipid peroxides (reduction), body mass reduction  
   Crustacea: Gammarus fossarum  Number eggs / egg-bearing female  
 
For both classes of pharmaceuticals, beta-blockers and NSAIDs, sensitive biosensors were raised and 
established.  
For the effect-based detection of beta-blocker effects, the beta-blocker CEPAC sensor assay showed 
the best test performance and was therefore used for further development of a mode of action based 
in vitro-assay. In contrast, several published roGFP redox sensors, which were tested in CHO cells after 
stable transfection, only showed a weak fluorescence signal and a poor signal-to-noise ratio. Although 
H2O2 induced oxidative stress could be measured by fluorescence microscope measurements it was 
not possible to transfer this assays into a microplate format due to low signal intensity. Therefore, the 
new roGFP mutant roGFP3 with a strongly improved fluorescence signal was created. Here the fusion 
of Grx-1 to roGFP3 resulted in the improved redox sensor Grx-roGFP3. This redox sensor was used for 
further development of NSAID biosensor cell lines. Based on this new redox sensor an assay was 
developed for redox based measurement of Cox-1 activity. 
Subcloning of beta-blocker and NSAID biosensor mixed cell populations resulted in single cell clones 
with enhanced signal to noise ratio. Such clones were used for measuring IC50 concentrations of the 
beta-blocker metoprolol or the NSAID diclofenac. Best beta-blocker biosensor clones showed a half 
maximal signal reduction at a metoprolol concentration of around 15nM. Best NSAID biosensor clones 
showed a half maximal signal reduction at a diclofenac concentration of around 2nM. The fast signal 
output of both assay formats requires only short incubation times of sensor cells with analyte 
solutions. Consequently there is no need for working under sterile conditions during the 
measurements which are particularly advantageous over reporter gene assays.  
Municipal wastewater samples, enriched by solid phase extraction, were diluted in assay buffer and 
tested in beta-blocker and NSAID assays. Beta-blocker and NSAID activities of SPE enriched wastewater 
samples could be measured and were comparable with concentrations of metoprolol and diclofenac 
concentrations determined by LC-MS. 
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Due to the high sensitivities of the in vitro-assays it is possible to directly measure NSAID and beta-
blocker activities in samples that are not enriched by solid phase extraction. It turned out that beta-
blocker activities of wastewater samples were significantly higher than metoprolol concentrations 
measured by LC-MS of corresponding SPE enriched samples, but the difference could be explained by 
LC-MS-based proofs of beta-blockers other than metoprolol in these wastewater samples. Such effect 
was not found for NSAID activities that could largely be related to diclofenac residues in these samples. 
During further experiments validations with internal standards for checking possible matrix effects will 
be performed. Different wastewater samples will be characterized and undiluted as well as SPE 
enriched samples will be compared. 
The results of this project undoubtedly revealed the precision and the high sensitivities of both 
biosensors which (a) correspond to environmental concentrations of beta-blockers and NSAIDs and (b) 
cover the known LOEC and NOEC ranges even for the most sensitive species and endpoints. Such 
biosensors are thus highly promising in view to their integration in environmental monitoring. 
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(2017), 52/3, 189-200 
Abstract 
The aim of this study was to determine the effect data for metoprolol as a model substance for 
betablockers in aquatic invertebrates. The results will be used as a basis for the validation of future 
mode of action-based in vitro test systems targeting this class of pharmaceuticals. Effects of metoprolol 
were investigated in two autochthonous species with high relevance in stream ecology: the amphipod 
Gammarus fossarum and the oligochaete Lumbriculus variegatus. Mortality in G. fossarum was not 
observed in acute toxicity testing (48 h), and a significant increase of mortality at 45 mg/L was found 
when amphipods were exposed chronically (40 days). The most sensitive population-relevant 
endpoints were the juvenile-adult ratio and number of egg-bearing females with NOEC/LOEC-values 
of 5/15 mg/L. No proteotoxic effects were identified in G. fossarum. The sediment toxicity test with L. 
variegatus according to the OECD Guideline 225 with an exposure time of 28 days resulted in EC10-
values of 92.5 and 126.1 mg/kgdw for the endpoints reproduction and biomass, respectively. In L. 
variegatus the response kinetics of Hsp70 showed no significant difference between the treatments. 
A tendency for rising lipid peroxide concentrations was found between 0.03 and 10 mg/kg dw, which 
were significant between the treatments, but not to the control. 
Introduction 
The increasing use of human and veterinary pharmaceuticals and their incomplete removal in 
wastewater treatment plants (WWTP) has led to increased concentrations of these compounds in the 
environment.[1] As a consequence, concerns about possible negative effects on organisms, particularly 
in aquatic ecosystems, have been expressed. Exposure monitoring in WWTP effluents as well as in 
receiving surface waters have detected an increasing number of pharmaceuticals over time and in all 
investigated aquatic habitats.[2–7] 
The calculation of the trigger value for a possible environmental risk is the quotient of exposure 
(Predicted Environmental Concentration, PEC; Measured Environmental Concentration, MEC) and 
hazard (Predicted No Effect Concentration; PNEC). Therefore, with increasing environmental 
concentrations, the risk quotient (RQ) increases and risk becomes more probable. Up to now, data for 
the identification of risk are scarce for many pharmaceuticals.[8] 
In order to address risks posed by pharmaceuticals it is important to keep in mind that pollution with 
human pharmaceuticals mainly originates from point sources (e.g. WWTP). On the contrary, veterinary 
pharmaceuticals often reach the aquatic environment from diffuse sources of input (e.g. by runoff 
from pasture and from industrialised stock farming).  
Currently, chemical analysis is the method of choice to trace pharmaceuticals in the environment. The 
methodology is highly specific, and modern techniques are very sensitive down to the ng/L range. A 
considerable drawback of this approach, however, is the necessity to develop and establish a new 
analytical method for every novel, released pharmaceutical. 
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Bioassays could be a supplemental method to complement the chemical analysis for water quality 
assessment.[9] Their availability for many applications in medicine and ecotoxicology targeting health-
relevant biological endpoints makes them appropriate tools for mode of action-based investigations. 
In this context, a bioassay targeting the mode of action of e.g. beta-blockers will detect not only a 
single compound but the entirety of all beta receptor-binding compounds in the sample. This is a 
considerable advantage compared to the chemical analysis that detects solely specific compounds 
under investigation. With the exception of synthetic steroid hormones the majority of such approaches 
to date have mainly focused on non-pharmaceutical compounds. However, environmental monitoring 
of the multitude of other pharmaceuticals still remains to be mainly based upon highly developed 
analytical techniques.[8] A detailed description of mode of action based bioassays, cell based 
approaches, and currently established measures for bioassays are to be found in Triebskorn et al.[8] 
and Escher et al.[10] 
Before efforts are made that consider the development of new bioassays as a part of risk assessment, 
it is essential to characterise effect concentrations of pharmaceuticals for hazard identification. 
Despite this need, publicly available data from effect analyses are scarce for many pharmaceuticals. 
Recently, Triebskorn et al.[8] made a plea for developing a concept for such effect-oriented 
biomonitoring of pharmaceuticals by using a new mode of action-based in vitro test systems validated 
by in vivo effects in fish and invertebrates. Here we aim at investigating the effects of metoprolol, a 
pharmaceutical of high priority according to Triebskorn et al.,[11] in epi- and endobenthic invertebrates. 
Invertebrates have, compared e.g. to fish, a faster reproductive cycle and are therefore useful to 
investigate impacts of chemicals on reproduction. Consequently, two autochthonous organisms with 
high relevance in stream ecology were chosen. 
In the following sections, results from toxicity tests with Gammarus fossarum as representative for 
epibenthic freshwater invertebrates and Lumbriculus variegatus as model organism for the 
endobenthic fauna are presented. We report observations on population-relevant endpoints in G. 
fossarum and in L. variegatus. In addition, results from biomarker tests (alterations of stress proteins 
and the formation of lipid peroxides) both serve as health markers and indicators for proteotoxic and 
oxidative stress, respectively. 
Materials and methods 
Metoprolol properties and chemical analysis 
The pharmaceutical metoprolol is a selective blocker of the beta-1 adrenergic receptor and was 
purchased from Sigma Aldrich as tartrate (CAS 56392-17-7) with purity >98%. Log Kow is 1.9 and water 
solubility is unknown, however higher than 1.0 g/mL. 
An external calibration with directly injected standards was setup to determine linearity of detection. 
The injector needle and the injection port were washed with methanol after every injection to avoid 
potential carryover. Instrumental and sample preparation contaminations were controlled by 
measuring blanks at regular intervals of every ten injections. With retention time for metoprolol of 
10.5 min the compound eluted several minutes after potential inorganic contaminants, which normally 
elute in the void volume of the analytical column. The limit of detection (LOD) was 1 mg/kg if 1 g of 
sediment was used for extraction and increased by a factor of ten if 0.1 g sediment was used. Peaks at 
the LOD level still showed a signal- to-noise ratio that is higher than ten. 
At respective sampling times during exposure, 1.5 mL water samples were taken, transferred to glass 
vessels (1.5 mL short thread brown glass flask, Fisher Scientific) and immediately frozen and stored at 
-20°C. Collected samples were sent to TZW and analysed within 48 h after thawing. Metoprolol was 
analysed by high performance liquid chromatography (HPLC, Agilent 1290, Waldbronn, Germany) 
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coupled to a tandem mass spectrometer (Tandem-MS, API 5500, AB Sciex, Foster City, CA, USA) 
including an electrospray interface with positive ionization in the respective experiments to verify the 
real concentration. Samples were injected on an Ultra Aromax HPLC column (150 x 2.1 mm, 3 mm, 
Restek, Bad Homburg) operated at a flow rate of 220 mL/min. The used solvents were (1) ultrapure 
water provided by an Arium 611 laboratory water 
purification system (Sartorius AG, Göttingen, Germany) and (2) HPLC-grade methanol/acetonitrile 
(33%/66%, Promochem LGC Standards, Wesel, Germany/VWR, Fontenay-sous-Bois, France) both with 
5 mM ammonium formate (purity >99%, Sigma-Aldrich, Steinheim Germany). The gradient started 
with 20% B, increased within 5 min to 100% B and was held for 6 min before returning to the initial 
conditions within 1 min. Depending on the spiked concentration 0.1 g (for 20 and 320 mg/kg) or 1 g 
(for 0.03 mg/kg) of sediment was extracted twice with 5 mL methanol in an ultrasonic bath (Sonorex 
RK 510H, Bandelin electronic, Berlin, Germany). After the first extraction, the samples were 
centrifuged for 30 min at 3,000 rpm. The supernatant was removed and combined afterwards with the 
one obtained after the second extraction. An aliquot of 5 mL was diluted with 500 mL water and 
cleaned-up with solid phase extraction (SPE). For SPE 200 mg polymeric sorbent was used (Strata-X, 
phenomenex, Aschaffenburg, Germany). After drying the sorbent material under a gentle stream of 
nitrogen, it was eluted with organic solvent. The eluate was blown down with nitrogen to dryness and 
reconstituted with the buffers used for HPLC. Geometric means were calculated as described in the 
OECD guideline.[12] 
Test organisms and test design 
Acute and chronic tests with Gammarus fossarum 
G. fossarum was collected at the Tännichtgrundbach, a small second-order mountain stream that joins 
the river Elbe downstream of the city Dresden (Germany).[13] Organisms were obtained by kick 
sampling,[14] transferred to plastic boxes filled with stream water and transported immediately to the 
laboratory. In the laboratory, gammarids were cultured until use in modified Borgmann media [15] (LO4-
S and additives E C H). Ingredients were solved in particle free and activated carbon filtered tap water 
for culturing purposes and in double-deionized water (Milli-Q, Millipore) for toxicity experiments. 
Further modifications were made concerning the original CaCO3 concentration in the media, which was 
reduced to 12.5%. The gammarids were kept in enclosures in artificial indoor streams at 15°C at low 
flow and fed with leaves as described in detail by Ladewig et al.[16] 
 
Sorption of metoprolol to organic food source 
Leaves from alder (Alnus glutinosa) which were handled and conditioned as described in detail by 
Jungmann et al.[17] were used as food. Discs with a diameter of 28 mm were punched out of conditioned 
leaves and served as a food source for gammarids during exposure. Sorption of metoprolol from the 
water phase to leaf discs was investigated in 50 mL Borgmann medium [15] in 100 mL glass beaker with 
5 and 45 mg/L metoprolol over 48 h in a greenhouse. One disc was exposed per beaker and tests were 
run in triplicate per treatment. Metoprolol in the water was analysed at the beginning and the end of 
the exposure. Water samples of 500 mL per beaker were sampled (Eppendorf-pipette) and the 3 
samples per treatment were pooled in 1.5 mL short thread brown glass flask (Fisher Scientific). After 
48 h leaf discs were freeze-dried (Alpha 1–2, Christ) and metoprolol analyses were carried out as 
described above. Water samples were diluted 100 and 200 times before HPLC analysis. Leaves were 
extracted with ultrapure water and adjusted to pH 5 with formic acid (Sigma-Aldrich) in an ultrasonic 
bath for 15 min. Water content was calculated as the difference in weight between wet and freeze-
dried leaf discs. 
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Acute toxicity of metoprolol to Gammarus fossarum 
Ten gammarids of similar size (7 ± 0.5 mm) per treatment were individually exposed in 15 mL glass 
beakers filled with 10 mL of Borgmann medium at 15 ± 1°C in a greenhouse. Five nominal 
concentrations of metoprolol (3.1, 12.5, 50, 200 and 800 mg/L) with a spacing factor of 4 were 
investigated. The 7 ± 0.5 mm sized animals were sorted using reference organisms which were 
accurately measured with a binocular (Thalheim Spezial Optik, Germany), and were then transferred 
to a glass beaker. Equally sized animals were selected from the population of the field sample with 
bare eye by comparison with the reference organisms. Chemical analysis was conducted at the 
beginning of the experiment and after 48 h of exposure. Each beaker was sampled (150 mL) and 
replicates were pooled in each treatment. Analysis was carried out as described above. 
Chronic test with Gammarus fossarum 
Chronic exposure was carried out in 2 L glass beakers with five different treatments (5–405 mg /L, 
spacing factor 3) and a control with four replicates in 1 L Borgmann medium. Twenty animals were 
exposed per treatment. Each beaker contained two unglazed ceramic tiles (5.5 x 4.1 cm) and a pebble 
stone (3 x 5 cm) as artificial substrate. Five conditioned leaf discs per beaker served as food source. 
The leaf discs were exposed for 2 days in the same concentration of metoprolol before they were 
transferred to the exposure vessels. After 7 days evaporated water was replaced by double-deionised 
water (-18.2 MΩ; Millipore). Subsequently 80% of the medium was exchanged, the old leaf discs 
substituted and the medium was than filled up to the original volume with the respective metoprolol 
concentrations in Borgmann medium. To ensure survival of the gammarids during the experiments, 
oxygen was supplied by aeration with compressed air. Oxygen saturation and concentration was 
analysed 3 times a week, soluble reactive phosphorus [18] nitrate (LCK 339, Hach Lange) and ammonium 
[19] were determined on day 28 before and after medium exchange. For the quantification of nitrogen 
and phosphorus a 100 mL water sample per treatment was taken and stored in the freezer at ¡18_C 
until analysis. 
To determine Hsp 70 responses, 47 gammarids were randomly taken from the experimental 
population prior to the start of the exposure, subsequently shock frozen in liquid nitrogen, and stored 
at -80°C (Sanyo Ultra Low) until further processing. The same was done with 33 individuals per 
treatment at the end of the experiment. Samples were sent to Tübingen University overnight on dry 
ice. After arrival samples were stored at -80°C until further processing. The biomarker tests were 
carried out according to the protocols given in detail below. 
Toxicological endpoints on the individual level were mortality, number of precopulae, number of egg-
bearing females, number and size of juveniles and number of eggs per eggbearing female. 
Water samples for chemical analyses were taken as described above at day 0, day 7, and day 35 after 
replacing evaporated water but before water renewal, and at day 28 after water renewal. Due to 
limitations in capacity of chemical analysis samples were taken only in the control, the 5 and 15 mg/L 
treatment. The latter are those two concentrations at which relevant effects occurred. 
Chronic test with Lumbriculus variegatus 
L. variegatus has been used as a standard organism [20] in sediment toxicity tests.[21–24] The oligochaetes 
were established as an in-house culture and were kept in continuously aerated tap water in 10-L glass 
aquaria at 20 ± 1°C under a 16 h light to 8 h dark photoperiod. For the breeding culture, artificial 
sediment with a mean particle size of 175 mm was used. Worms were fed once a week with TetraMin. 
Reproduction is mainly asexual by self-fragmentation.[25,26] In the experiment we used synchronised 
worms only. Therefore, fragmentation was induced by cutting the worms in the middle of their body. 
The posterior end will regenerate a new head within 2–3 weeks before start of the test to ensure that 
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all worms were in a similar physiological status at the start of the experiment. Thus an increased 
variance in the data set was avoided (for detail cf.[14]). 
Two kinds of 28-day sediment toxicity tests were conducted: (1) using high but still sublethal 
concentrations (high concentration tests) for population-relevant endpoints according to OECD 
guideline 225 and (2) using low concentrations for biomarker studies (low concentration tests). For the 
high concentration tests 0, 20, 40, 80, 160, and 320 mg/kgdw were investigated and effects on 
reproduction and biomass were studied. For the low concentration tests 0, 0.039, 0.078, 0.156, 0.312, 
0.62, 1.25, 2.5, 5 and 10 mg/kgdw were investigated and solely their effects on biomarkers were 
analysed. According to the OECD guideline 225, the test included a water control, a solvent control and 
five concentrations of the pharmaceutical in four replicates each.[20] Sediment was prepared as 
described by [22] with the exception that methanol was used as solvent. The tests were conducted in 
250 mL beakers containing 2 cm of spiked artificial sediment, 150 mL of reconstituted water [20] and 
aerated with compressed air (2 bubbles/s). 
The artificial sediment was prepared according to [20]. Peat (5% dry weight, Floragard, Oldenburg) and 
powdered leaves of Stinging Nettle (0.5% (dry weight), powder manufactured by Ceasar & Loretz, 
Hilden) were treated at the beginning with the appropriate volume of reconstituted water. This 
mixture was put on a shaker for 1 day (Society for Laboratory Technology (GFL) 3017, Großburgwedel). 
Thereafter, the other ingredients kaolin (19.8%, dry weight, Merck, Darmstadt) and cellulose (0.5%, 
dry weight, Sigma-Aldrich, Steinheim) were added, and then shaken for another day. The pH value was 
adjusted to 6.5–7.5 using calcium carbonate (VWR, Darmstadt, Germany). First, each 250 mL beaker 
was filled with 10 g of quartz sand. After that, metoprolol was dissolved in 50 mL methanol (Merck, 
Darmstadt) to produce a concentrated stock solution. The quartz sand was spiked with an appropriate 
amount of metoprolol, and the same volume of solvent was used for every treatment. The solvent 
control was spiked with an appropriate volume of solvent only. After the solvent had evaporated 
overnight, each beaker was filled with the remaining 27.5 g of quartz sand as well as 20 mL of the 
sediment components that was taken from the shaker. Finally, the whole sediment was mixed to 
obtain a homogenous solution. Each beaker was filled carefully with 150 mL reconstituted water.[20] As 
recommended in the OECD guideline 225, a positive control with 30 mg/kgdw pentachlorophenol 
(Sigma-Aldrich, Steinheim) was used. The beakers were arranged in a controlled-climate room at 
constant room temperature (20 ± 1°C) and at a light/dark period of 16 to 8 h with a light intensity of 
500–1000 lux. Under these conditions, the sediment was aged for 2 days to ensure equilibrium. Before 
starting, water conditions (temperature, pH, conductivity and dissolved oxygen) were measured with 
a Multi340i (WTW, Weilheim). These measurements were repeated once a week during the 28-days 
toxicity tests. In addition, the ammonium concentration was measured in the water at the start (day 
0) and end (day 28) of the test using an ammonium test (Merck Darmstadt). At the start of the 
experiment, 10 synchronized [20] worms were added to each beaker. During the tests, aeration was 
checked daily. After 28 days, the number of individuals per beaker was recorded. In addition, the 
biomass per concentration (dry weight) was determined. In case of the low concentration experiments, 
worms were frozen in liquid nitrogen and sent to the University of Tübingen on dry ice for further 
analyses of biomarkers (Hsp70 and lipid peroxidation). 
Biomarker tests 
Hsp70 quantification 
The level of the stress protein family, Hsp70, was quantified according to Köhler et al.[27] and Dietrich 
et al.[28] Frozen samples were homogenized on ice (G. fossarum samples were analysed individually, L. 
variegatus samples were analysed in pools of three individuals (because of their smaller size)) in 50 mL 
extraction buffer (80 mM potassium acetate, 5 mM magnesium acetate, 20 mM HEPES and 2% 
protease inhibitor at pH 7.5) in case of G. fossarum, or 40 mL in case of L. variegatus. Following 
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centrifugation (10 min at 20,000 relative centrifugal force (RCF) at 4°C in an Eppendorf 5804 R 
centrifuge), one part of the supernatant was used for total protein quantification according to 
Bradford.[29] The other part was processed for minigel SDS-PAGE (12% acrylamide, 0.12% bisacrylamide, 
30 min at 80 V plus 90 min at 120 V) where 40 mg of total protein from G. fossarum and 60 mg from L. 
variegatus was used for each sample. Proteins were transferred to a nitrocellulose membrane via semi-
dry blotting, incubated with the first antibody (mouse anti-human Hsp70, Dianova, Hamburg, 
Germany, dilution 1:5000 in 10% horse serum/TBS) overnight, rinsed and incubated with the secondary 
antibody (goat anti mouse IgG conjugated to peroxidase, Jackson Immunoresearch, West Grove, PA, 
dilution 1:1000 in 10% horse serum/TBS) for 2 h at room temperature. The membranes were stained 
(1 mM 4-chloro(1)naphthol, 0.015% H2O2, 30 mM TRIS pH 8.5 and 6% methanol), scanned, and the 
optical volume (band area x average grey scale value) of each protein band was determined using 
E.A.S.Y.Win 32 (Herolab, Wiesloch, Germany). To allow comparability between the minigels, each 
optical volume was related to an internal Hsp70 standard (full body homogenate of Salmo trutta f. 
fario) and was run in duplicate on each gel. 
Quantification of lipid peroxides 
To quantify the amount of lipid peroxidation, a modified version of the FOX assay described by Hermes-
Lima [30] was employed. Pools consisting of 3 L. variegatus individuals were homogenized in ice-cold 
HPLC-grade methanol (dilution 1:10) and centrifuged at 14,000 rpm (Eppendorf centrifuge 5804 R with 
rotor F-45-30- 
11) at 4°C. The supernatants were stored at -80°C until further usage. The assay was conducted in 96-
well plates; each well was filled with 50 mL of 0.25 mMFeSO4, 25 mMH2SO4 and 0.1 mM xylenol orange; 
20 mL of supernatant was added and the volume adjusted to 200 mL using bidistilled water. Each 
sample was tested in triplicate, and a blank sample in which the FeSO4 solution had been added was 
substituted with water. All data were related to a master blank, which consisted of bidistilled water. 
The samples were incubated for 48 h at room temperature. The absorbance was measured at 580 nm 
using an automated microplate reader (Bio-Tek Instruments, Winooski VT, USA). After the first 
measurement, 1 mL of 1 mM cumene hydroperoxide solution was added to each well. After another 
incubation period of 1 h, the absorbance was measured again at 580 nm. Cumene hydroperoxide 
equivalents (CHPequiv./mg wet weight) were calculated according to Eq. (1): 
𝐴580 𝑛𝑚
𝐴 580 𝑛𝑚 𝐶𝐻𝑃
∗ 𝑣𝑜𝑙𝑢𝑚𝑒 𝐶𝐻𝑃 ∗
𝑡𝑜𝑡𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒
𝑠𝑎𝑚𝑝𝑙𝑒 𝑣𝑜𝑙𝑢𝑚𝑒
∗ 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 (1) 
Statistical analysis 
Statistical analysis was conducted using SAS JMP 11.0 and Tox- Rat software (ToxRat Solutions, Version 
2.10.05, Aachen, Germany). Data were checked for normal distribution using the Pearson-D’Agostino 
Omnibus test. If necessary, data were transformed using square root or third root transformations to 
fit normal distribution. Data were checked for homogeneity of variance using Levene’s test. If the 
requirements for parametric tests were fulfilled, an ANOVA (if necessary, combined with Tukey-
Kramer HSD or Dunnett’s post hoc test) was used to compare the means between the different 
treatment groups. If the data did not show homogeneity of variance a Welch- ANOVA was used 
instead. In cases of obvious trends of data to increase or decrease with rising test concentrations, a 
correlation analysis was conducted using Kendall’s Tau test. ECx-values (EC10 and EC50, respectively) 
were computed using probit and Weibull analysis depending on the best fit to distribution, 
respectively. The significance level was set to α = 0.05 for all tests. Figures were made by software R 
(version 3.1.1). 
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Results 
Chemical analysis of metoprolol  
Metoprolol concentrations in the water phase 
In water samples from the natural habitat (Tännichtgrundbach, near Dresden, Germany) of G. 
fossarum, metoprolol was not detected (limit of detection <0.01 mg/L). In the acute toxicity 
experiment with G. fossarum the relative difference between nominal and measured concentrations 
in the three analysed approaches at the beginning of the experiment fitted well and only differed 
approximately by 13%. The relative difference between the measured concentration at the beginning 
and at the end of the experiment was 12% (cf. Table A1). Hence the calculation of the effect 
concentration was based on nominal concentrations. 
Sorption of metoprolol to the organic fraction, especially to the leaf discs, was estimated. The decrease 
of the water concentration was calculated to be 5% within 48 h. At the beginning the measured 
concentration of 44.5 mg/L (2.23 mg total) fitted well to the nominal concentration of 45 mg/L. After 
48 h, the analysed concentration was 42.6 mg/L (2.13 mg total). Within 48 h 1.8% of the total 
metoprolol amount was sorbed to the leaf discs which corresponds to 0.041 mg per leaf disc. 
The lowest and medium concentrations from the chronic exposure experiment were analysed. Table 
1 shows the analysed concentrations and the relative decrease over time. At t0 the metoprolol 
concentrations fit well with the nominal concentrations with a relative difference of 10.0% and 11.3%, 
respectively. Analyses at day 7 and 35 reflected the dissipation of metoprolol over 7 days of exposures 
from the water phase at an early and later period of the experiment, respectively. In both analyses, 
data showed a minor concentration dependent decrease of 4% in the lower and 12% in the higher 
concentration compared to the nominal concentration. The concentrations in the renewed medium 
are represented by the results of the analyses at day 28 and Table 1 depicts that deviations from 
nominal concentrations were again low with 10% and 11%, respectively. Hence, the following 
calculation of the effect concentrations was based on nominal concentrations. In the control 0.0002 
mg/L metoprolol was detected, close to the limit of quantification. The test setups were aerated and 
a weekly loss of 50–100 mL of the exposure medium was observed and we assume that metoprolol 
contamination in the control took place via aerosol transfer. 
 
Table 1.  Nominal and measured concentrations of metoprolol in the chronic experiment with G. fossarum. 
 mg/L % 
Nominal t0 t7 t20 t25 Delta(n/0) Delta(n/28) Delta(n/7;35) 
5.0 4.5 4.4 4.5 4.4 10.0 10.0 4.4; 4.4 
15.0 13.3 12.4 13.3 12.7 11.3 11.3 12.4; 12.7 
t: time (with numbers indicating the respective day). t0 was the beginning of the experiment and t7 samples were taken after balancing 
evaporated water but before water replacement. Delta: relative decrease of measured concentrations after 7 days compared to the nominal 
concentration. 
 
Metoprolol concentrations in the sediment 
The measured concentrations in the sediment at day 0 showed major differences compared to the 
nominal concentration (Table 2). The highest difference was found for the lowest concentrations with 
82%. For the highest concentration, the difference was at least 20%. After 28 days of exposure, the 
differences even increased to 98% for the lowest, 85% for the medium, and 51% for the highest 
concentration. Therefore, the geometric mean was calculated according to the polynomial function (y 
D 0.0011x² C 0.2788x - 0.0079) to estimate the effective concentration of sediment exposure to L. 
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variegatus depicted in Table 2 with 0.003, 6, and 200 mg/kg, respectively. For 160 mg/kg exposure, 
the extrapolation of a geometric mean led to 72.8 mg/kg. 
Table 2. Nominal and measured concentrations in the sediment and the overlaying water in the exposure test with L. 
variegatus according to OECD 225. 
Sediment Water (mg/L) measured 
Nominal Measured Geom. Delta (%) 
 0 28  (n/0) (n/28) 0 28 
SC <0.001 n.d. -   0.00005 <0.00005 
0.039 0.0068 <0.001 0.003 82 98 0.00055 0.0003 
20 12.5 3.1 6 38 85 3.1 n.d. 
320 255 156 200 20 51 7.4 11 
geoM: geometric mean. n/0: relative decrease between nominal and measured concentration at day 0. n/28: relative decrease between 
nominal and measured concentration at day 28. n.d.: not determined. 
 
Effects of metoprolol 
Gammarus fossarum 
Up to the highest concentration of 800 mg/L no significant immobility of the gammarids was detected 
after 48 h in the acute toxicity experiment. 
In Table A2 the median values of pH, conductivity, and oxygen concentration in the chronic test with 
G. fossarum are shown. Neither of the values were significantly different to the control, nor were any 
values detected that raised issues of concern for the development of the gammarids. 
In the chronic exposure experiment with G. fossarum elevated mortality occurred. In the control the 
median mortality was 35% which was not significantly different from the two lowest test 
concentrations with 30% and 5%, respectively. Significant differences to the control occurred at 
concentrations of 45, 135, and 405 mg/L with 88%, 100% and 100%, respectively. Figure 1 shows the 
concentration-response curve for mortality in the chronic experiment. The calculated EC10 was 17 
mg/L. Due to the non-monotonic character of data distribution data obtained for 5 and 15 mg/L 
metoprolol had to be excluded from ToxRat analysis. Table 3 shows the investigated endpoints and 
the respective no/lowest observed effect concentrations (NOEC/LOEC). The most sensitive endpoints 
were the “ratio juvenile to adults” and “egg number per egg-bearing female,” both with NOEC/LOEC 
values of 5/15 mg/L, respectively. Figures 2 and 3 show the results for the most sensitive endpoints in 
the chronic exposure test with G. fossarum. Both, the ratio of juveniles to adults as well as the egg 
number per egg bearing female, showed a clear concentration-effect relationship with NOEC/LOEC 
values of 5/15 mg/L, respectively. The relative abundance of precopulae were not affected below 135 
mg/L at which 100% mortality occurred. 
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Figure 1. Concentration-response relationship (black line) for mortality of gammarids exposed to metoprolol for 40 days. 
Dashed line is the 95% confidence interval. For calculations of metoprolol toxicity lowest concentrations were excluded 
because the concentration-response relation deviated from the concentration-response model. 
Table 3.  Investigated endpoints in the chronic exposure experiment with G. fossarum and the corresponding no/lowest 
observed effect concentrations (NOEC/LOEC). 
Metoprolol 
Endpoint NOEC (mg/L) LOEC (mg/L) 
Ratio juvenile/adults 5 15 
Egg number/ egg bearing female 5 15 
Relative number of egg bearing females* 15 45 
Relative abundance of precopula* ≥135 >135 
*Additional figures in Appendix. 
Lumbriculus variegatus 
In Figure 4, the effect of metoprolol on the endpoint reproduction is shown. The number of individuals 
hardly changes with increasing beta-blocker concentration, however, in the highest concentration 
(nominal 320 mg/kgdw) a maximal reduction of 24.3% of the reproduction (compared to the solvent 
control) was observed. Thus only a nominal EC10 value of 189.8 mg/kgdw was computable resulting in 
an effective concentration of 92.5 mg/kgdw. For the endpoint reproduction NOEC and LOEC values were 
nominal 160 and 320 mg/kgdw resulting in effective concentrations of 72.8 and 202 mg/kgdw., 
respectively (One-way ANOVA, Dunnett_s test). Also, the total biomass decreased slightly with 
increasing metoprolol concentration (cf. appendix). The EC10 was 126.1 mg/kgdw as effective 
concentrations (confidence intervals could not be calculated). 
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Figure 2. Box-Whisker plot of the ratio between juveniles and adults in the chronic exposure of G. fossarum with metoprolol. 
Asterisk: statistically significant different from the control (α = 0.05); †100% mortality. MET: metoprolol (α = 0.05). 
 
Figure 3. Box-Whisker plot of the egg number per egg bearing female in the chronic exposure of G. fossarum with metoprolol. 
Mean number of individuals (±75 interval and minimum and maximum values, n = 4 replicates). Asterisk: statistically 
significant different to the control (a = 0.05); †100% mortality. MET: metoprolol (α = 0.05). 
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Figure 4. 28-day sediment toxicity test with the oligochaete Lumbriculus variegatus and metoprolol according to the OECD 
guideline 225. Number of individuals (25-percentile, median, 75-percentile, min, max, n = 4 replicates). At the start of the 
experiment 10 synchronized worms were added to each beaker. One-way ANOVA with Dunnett’s post hoc test.*P < 0.05. 
Biomarkers Hsp70 and lipid-peroxidation 
Hsp70 levels in Gammarus fossarum 
In Figure A2 the Hsp70 levels of Gammarus are depicted. The data showed normal distribution after 
transformation using the second root (Pearson-D’Agostino-Omnibus, n = 102, P = 0.406), homogeneity 
of variance was obtained after transformation (Levene, df = 3, F = 1.4176, P = 0.2423). No statistically 
significant difference was observed between the treatments (ANOVA, df = 3, F = 0.1333, P = 0.94). 
However, Hsp70 levels of gammarids taken from the basic population from field samples showed a 
significantly lower Hsp70 level compared to the control treatment after 40 days of exposure (t-test, df 
= 58, t = -2.506, P = 0.015). 
Response of Hsp70 and lipid-peroxidation levels in Lumbriculus variegatus 
Figure 5 depicts the levels of Hsp70 after exposure of L. variegatus to metoprolol. Data showed normal 
distribution after transformation using the third root (Pearson-D’Agostino-Omnibus, n = 26, P = 
0.2364); homogeneity of variance was obtained after transformation (Levene, df = 5, 20, F = 0.5410, P 
= 0.7431).The stress protein level of L. variegatus exposed to metoprolol was not significant different 
between the approaches (ANOVA, df = 5, 20, F = 2.2054, P = 0.0942). 
Lipid-peroxidation levels 
Figure 6 shows the results of lipid-peroxidation levels after exposure of L. variegatus to metoprolol. 
Data showed a normal distribution after transformation using the square root (Pearson- D’Agostino-
Omnibus, n = 30, P = 0.6766), homogeneity of variance was not obtained (Levene, df = 5.24, F = 3.2112, 
P = 0.0233). There was a significantly positive correlation of the degree of lipid peroxidation with 
increasing metoprolol concentration (Kendall’s Tau, n = 30, t = 0.2847, P = 0.0371). The means showed 
a significant overall difference (Welch-ANOVA, df = 5, 10.9, F = 5.2488, P = 0.0107); however, there 
was no significant difference between any of the compared treatment groups and the control (Fig. 6). 
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Figure 5. Relative Hsp70 level (quantified as optical volume relative to standard compared to the standard) of L. variegatus 
exposed to increasing concentrations of metoprolol. SC, solvent control. The bar chart depicts arithmetic means plus/minus 
standard errors. There is a trend towards an increased Hsp70 level at the concentration of 0.039 mg/L, but not at the other 
tested concentrations. 
 
Figure 6. Lipid peroxidation (in cumene hydroperoxide equivalents per mg wet weight) of L. variegatus exposed to increasing 
concentrations of metoprolol. SC, solvent control. The bar chart depicts arithmetic means plus/minus standard errors. The 
degree of lipid peroxidation increased with rising metoprolol concentration (Welch-ANOVA). 
Discussion 
The aim of the present study was to provide effect data for metoprolol as a model substance for beta-
blockers in ecologically relevant aquatic invertebrates as a basis for the validation of future mode of 
action-based in vitro test systems targeting this class of pharmaceuticals. In the aquatic environment 
average metoprolol concentrations were reported to reach 404 ng/L in the water phase of sediments, 
33 mg/kg dw in sediments,[31] and up to 2.2 mg/L in surface waters.[32] The metoprolol concentrations 
in the Tännichtgrundbach, where gammarids were sampled, were below the limit of detection (<0.01 
mg/L). 
When metoprolol was applied via the water phase in our experiment with gammarids, the real 
concentrations were close to the nominal concentrations only differing by 10% and 13%, respectively. 
Water solubility of metoprolol is rather high with 1,000 mg/L (Merck Index 14: 6151), which in general 
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causes minor problems to achieve nominal concentrations. Dissipation from the water phase was low, 
between 12% and 10% over 2 and 7 days, respectively. The slightly higher dissipation of metoprolol in 
the 2 day acute toxicity experiment might be a result of a higher surface:volume ratio resulting from 
smaller vessels. The half-life time of metoprolol under natural conditions was estimated with 24 days, 
and direct photolysis follows pseudo-first-order kinetics under solar simulation and is strongly 
influenced by daylight surface conditions, light intensity of the light source or the sun at different 
latitudes and seasons.[33,34] In a greenhouse, which is shaded to simulate natural conditions of lower 
mountain streams,[35] a higher half-life time due to lower radiation intensity was observed, which is in 
agreement with our findings. To calculate the effect concentrations in the experiments with G. 
fossarum, the nominal concentrations were used. The extremely low amount of contamination with 
metoprolol in the control was assumed by transfer via aerosols. The detected concentration was 2.500 
times lower compared to the lowest LOEC, hence we suppose no impact on the results from the 
control. 
During short-term exposure to metoprolol with leaf discs as organic food source, only minor dissipation 
from the water phase was determined. Sorption processes of chemicals in the aquatic environment to 
organic material are well known and mainly depend on Kow or Koc values.[36] As the log Kow of metoprolol 
is 1.9 [37] a high sorption potential of metoprolol is not expected. Thus the major exposure pathway in 
the experiments with gammarids was via the water phase. 
In the experiment with L. variegatus exposure via the sediment showed a comparable pattern to water 
exposure, however, with strong impact on the sediment concentration over time. The measured 
concentrations in the sediment were out of the aimed range for recovery of 80–120%.[20] Due to the 
high water solubility and low log Kow value, metoprolol dissipated from the sediment, and its 
concentration in the water increased quickly. This became more obvious when comparing the mass 
balance, e.g. between the sediment and water at day 0 directly after the tests were started. In the 
experiment with the highest concentration the total mass of applied metoprolol was 2.5 mg in the 10 
g of sediment, and 1.1 mg in the 150 mL overlaying water. This means that approximately one-third of 
the applied metoprolol was found in the overlaying water. After 28 days of exposure the total mass in 
the overlaying water increased to 50% of the metoprolol concentration measured in the respective 
beakers. This was demonstrated in other experiments too, when sorption to different sediments,[38] 
mobility,[39] or dissipation under varying environmental conditions were observed.[34] Hence, nominal 
sediment concentrations are not suitable to express effective concentrations.[20] In this case the 
calculation of the geometric mean is recommended [12] and was applied. 
Acute toxicity tests with G. fossarum 
Acute toxicity of metoprolol to gammarids was not detected up to 800 mg/L. In the control no mortality 
occurred. Thus acute toxicity of metoprolol to G. fossarum can be regarded as low. In acute toxicity 
tests with Daphnia magna EC50 values for metoprolol ranged between 70 and 438 mg/L.[9,40,41] Hyalella 
azteca, another amphipod tested, showed an EC50 of 100 mg/L after 48 h of exposure. Hence, 
gammarids seem to be less sensitive to metoprolol compared to daphnids and Hyalella; however, all 
data lie in the upper milligram range which means that all the organisms tested are relatively 
insensitive to this compound under acute exposure. 
Chronic toxicity tests with G. fossarum 
The acute toxicity values from acute tests were taken to establish a suitable concentration range for 
the chronic exposure of G. fossarum over 40 days. At the end of the test, mortality in the control was 
35%. As no guideline and, therefore, no validity criteria for a chronic test with Gammarus exist, the 
mortality in the control could only be compared with results from other experiments. Schneider et 
al.[42] performed a flow-channel experiment in the lab (6.5_C) with G. pulex and found a mean mortality 
 153 
 
rate of 7.1% in the control after 30 days. Oskarsson et al.[43] observed a mortality rate of 28–70% during 
8 weeks at a temperature of 10–11_C in controls, which even increased, whenever individuals were 
exposed in the same vessel. Dietrich et al.[44] determined a mortality of 40% in controls at 12_C after 
100 days of exposure. After 103 days of exposure at 15_C, G. fossarum showed a mortality of 76% in 
controls.[45] Mortality rates that have been reported in other experiments and ours did not give reason 
to assume an exceptional situation in the study reported here, even though all these studies differ 
regarding boundary conditions like temperature, age of individuals, and exposure medium. In general, 
none of the measured physico-chemical parameters in the water gave rise to concern for the survival 
of the gammarids, neither in the control nor in the treatments. In the two highest tested 
concentrations 100% mortality occurred. 
At lower concentrations endpoints of relevance for population development were affected. The most 
sensitive endpoints were the ratio of juveniles to adults and the egg number per egg-bearing female 
with NOEC/LOEC values of 5 and 15 mg/L. To the best of our knowledge only chronic exposure 
experiments to metoprolol with other amphipods have been carried out by Dzialowski et al.[4] They 
found in Daphnia magna NOEC/LOEC values for reproduction of 3.1/6.2 mg/L and the heart beat rate 
was affected at the lowest tested concentrations of 3.1 mg/L. These results are of the same order of 
magnitude as in the chronic experiment with G. fossarum. In contrast to the results from acute toxicity 
tests, gammarids and daphnids showed similar sensitivity for population relevant endpoints. In a multi-
generation study with D. magna effects on the number and body length of neonates were found at 
lower concentrations of 0.012 mg/L.[6] This is the lowest effect concentration found in the literature for 
invertebrate species. In general a lower toxicity of metoprolol to invertebrate crustacean species is not 
surprising as these organisms use different hormones.[46]  
The Hsp70 level in G. fossarum did not show any concentration- dependent difference after exposure 
to metoprolol for 40 days. In general the stress level was higher in the control at the end of the 
experiment compared to the situation at the start of the experiment. Food shortage may not be the 
reason for intraspecific stress because food was renewed every 7 days during water exchange and it 
was never found to be consumed completely. Potentially the handling itself or the difference in age 
could be a reason for the increase in Hsp70 level, because this was a constant factor in all treatments. 
Possibly the concentrations of metoprolol were too high to meet the phase of Hsp70 elevation but 
rather reflect the breakdown of the Hsp70 response system in situations of high stress intensity (for 
Hsp70 induction kinetics see [47]). 
Toxicity tests with L. variegatus 
Effect data for metoprolol on endobenthic or sediment-associated invertebrates are currently not 
available in the literature. Initially, this is not surprising because the physico-chemical properties of 
metoprolol, specifically the log Kow and log Koc values do not implicate concern derived from sorption 
of metoprolol to the sediment. On the other hand the results of the experiment with L. variegatus 
show that a smaller, but nevertheless significant amount of metoprolol remained in the sediment. 
Hence, it may be good advice to address sediment as a compartment in pharmaceutical risk 
assessment. The sediment toxicity test with L. variegatus fulfills all validity criteria mentioned in the 
OECD guideline 225.[20] These are the first results for a sediment-dwelling organism exposed to 
metoprolol via sediment resulting in EC10 values of 126.1 mg/kgdw for biomass reduction and 
NOEC/LOEC-values of 72.8/202 mg/kg for decrease of reproduction. From these data it remains 
unknown, whether effects are driven via water exposure or sediment exposure. For Lumbriculus it was 
also shown that lipid peroxide levels did not differ compared to the control when exposure took place 
at lower concentrations. 
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For the environmental risk assessment the lowest effect concentration is implemented after a 
respective assessment factor was applied, which leads to the PNEC.[48] For our estimations an 
assessment factor of 50 was applied.[48] This leads to PNECs of 0.1 mg/L for G. fossarum and 1.45 
mg/kgdw for L. variegatus, in respect to organismic endpoints. Based on the results obtained in the 
present study, we demand a sensitivity of future in vitro tests for effect-based monitoring of beta-
blockers in the range of 0.374 up to 5.42 mmol in order to reflect effects of metoprolol in epibenthic 
and sediment-dwelling freshwater invertebrates. All determined values are far from environmentally 
relevant concentrations (MEC: 0.0022 mg/L[49]). Based on the results obtained in the present study the 
potential risk of metoprolol for gammarids and sediment dwelling organisms like Lumbriculus is low. 
However, in consideration of an effect concentration as low as 0.001 mg/L that has been reported for 
fish,[50] and an estimated PNEC of 0.0001 mg/L, metoprolol nevertheless seems to pose a risk in the 
aquatic environment. As fish species belong to vertebrates they use norepinephrine as 
neurotransmitter and the target specific β adrenergic receptor is present.[51] Therefore a higher 
sensitivity of vertebrate fish species compared to invertebrate crustacean is comprehensible. Hence, 
further investigations with fish as the most sensitive organism are recommended, in particular 
concerning population relevant endpoints to provide a basis for benchmarking future effect-based in 
vitro test systems for beta-blockers. 
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Appendix 
Table A 1. Nominal and measured (m) concentrations of metoprolol in the water in the acute toxicity test over 48 h of exposure. 
mg/L % 
Nominal Measured (0) Measured (48) Rel. diff. (n/0) Rel. diff. (n/48) Rel. diff. (0/48) 
3.1 2.63 2.3 15 26 13 
50.0 45.1 39.8 10 20 12 
800.0 691 620 14 23 10 
Number in brackets: time; n: nominal concentration; rel. diff.: relative difference. 
 
Table A 2. Nominal concentrations, mortality and relative mortality (rel. mortality) in the acute toxicity test with G. fossarum 
after 48 h of exposure with metoprolol. 
Concentration mg/L  C 3.1 12.5 50 200 800 
Mortality 48 h 0 0 0 0 0 0 
Rel. mortality (%) 0 0 0 0 0 0 
 
Table A 3. Median values of pH, conductivity and oxygen concentration in the prolonged test with G. fossarum. 
 Unit Control 5 15 45 135 405 
pH-Wert 
(min; max) 
- 7.88 
(7.74; 8.15) 
7.84 
(7.76; 8.1) 
7.84 
(7.71; 8.1) 
7.86 
(7.73, 7.86) 
7.9 
(7.74; 8.14) 
7.9 
(7.71; 7.97) 
Conductivity 
(min; max) 
µS/cm 424 
(385; 696) 
428 
(385; 676) 
428 
(386; 676) 
432 
(391; 686) 
426 
(403; 698) 
453 
(446; 462) 
Oxygen (min; 
max) 
mg/L 10.1 
(8.0; 10.7) 
10.1 
(7.9; 10.7) 
10.1 
(7.7; 10.5) 
10 
(7.5; 10.4) 
9.9 
(7.4; 10.4) 
8.3 
(7.8; 10.2) 
Min: minimum; max: maximum; S: Siemens. 
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Figure A 1. Definitive 28-day sediment toxicity test with the oligochaete Lumbriculus variegatus and metoprolol according to 
the OECD guideline 225. Mean number of individuals (±SD, n = 4 replicates, probit analysis) (A) and total biomass of L. 
variegatus (mean, data were pooled from four replicates, probit analysis) (B). At the start of the experiment 10 synchronized 
worms were added to each beaker. 
 
Figure A 2. Relative Hsp70 level (quantified as relative grey value compared to the standard) of in Gammarus after exposure 
to metoprolol. The two highest concentrations are excluded due to 100% mortality. Data showed normal distribution after 
transformation using the second root (Pearson-D’Agostino-Omnibus, n = 102, P = 0.406), homogeneity of variance was given 
(Levene, df = 3, F = 1.4176, P = 0.2423). 
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Appendix 
Artificial water for brown trout embryos and sac-fry stages 
 294 mg/L CaCl2 x 2 H2O,  
 123.25 mg/L MgSO4 x 7 H2O 
 64.75 mg/L NaHCO3  
 5.75 mg/L KCl 
 Added to deionized Millipore-filtered water 
Stress protein analysis 
Concentrated extraction buffer for Hsp70 analysis 
80 mM potassium acetate, 5 mM magnesium acetate, 20 mM Hepes in double-distilled water, adjusted 
to a pH of 7.5 
SDS buffer 
20 % glycerine, 3 % sodium dodecyl sulphate, 0.3 % β-mercaptoethanol, 10 mM Tris pH 7 and 0.005 % 
bromophenol blue in double-distilled water 
Bradford mixture 
0.001 % Coomassie brilliant blue G-250, 4.75 % ethanol, 8.5 % phosphoric acid in double-distilled water 
E-buffer + SDS 
0.19 M glycin, 25 mM Trisbase and 0.1 % SDS in double-distilled water 
Blocking solution 
TBS (0.88 % sodium chloride, 0.635 % Tris-HCl and 0.118 % Tris-base in double-distilled water, adjusted 
to a pH of 7.5) with horse serum in a mixture of 1:2 
Staining solution 
1 mM 4-chloro-1-naphtol, 6 % methanol, 0.015 % hydrogen peroxide in 30 mM Tris pH 8.5 
Minigels 
Reagents 
 30 % acrylamide, 0.8 % bisacrylamide in double-distilled water - ready for use preparation by 
Carl Roth GmbH + Co. KG, Karlsruhe 
 Separation gel buffer (4x): 18.5 g TrisHCl + 76.95 g Trisbase + 2 g SDS in 500 mL double-distilled 
water, adjusted to pH 8.8 
 Collection gel buffer (4x): 17.55 TrisHCl + 1.68 g Trisbase + 2 g SDS in 500 mL double-distilled 
water, adjusted to pH 6.8 
 10 % ammonium persulfate (APS) 
 Tetramethyleethylenediamine (TEMED) – ready for use by Merck Schuchardt OHG, 
Hohenbrunn 
Procedure 
 For two separation gels: 2.65 mL double-distilled water, 3 mL acylamide/bisacrylamide, 
1.87 mL separation gel buffer (4x), 40 µL APS, 20 µL TEMED 
 For two collection gels: 1.4 mL double-distilled water, 1 mL acylamide/bisacrylamide, 0.6 mL 
collection gel buffer (4x), 20 µL APS, 20 µL TEMED 
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Histology 
Embedding process 
Step Medium Duration 
Washing (three times) 0.1 M cacodylate-buffer 3 x 10 min 
Decalcification (only for gill and 
kidney) 
Formic acid 1:2 in 70 % ethanol 30 min 
Washing (three times) 70 % ethanol 3 x 15 min 
   
Dehydration 1 70 % ethanol 30 min 
Dehydration 2 70 % ethanol 90 min 
Dehydration 3 80 % ethanol 60 min 
Dehydration 4 90 % ethanol 60 min 
Dehydration 5 96 % ethanol 60 min 
Dehydration 6 100 % ethanol 60 min 
Dehydration 7 100 % ethanol 60 min 
Intermedium 1 – 1 Isopropyl alcohol 90 min 
Intermedium 1 – 2  Isopropyl alcohol 120 min 
Intermedium 2 Isopropyl alcohol/paraffin 1:2 180 min 
Infiltration 1 Paraffin 180 min 
Infiltration 2 Paraffin  480 min 
 
Staining Hematoxilin-Eosin (for paraffin-embedded samples) 
 Roti®-Histol: ready-to-use solution by Carl Roth GmbH + Co. KG, Karlsruhe 
 Hematoxilin (Mayer): ready-to-use solution by Carl Roth GmbH + Co. KG, Karlsruhe 
Medium Duration 
Roti®-Histol 5 min 
Roti®-Histol 5 min 
100 % ethanol 5 min 
90 % ethanol 5 min 
80 % ethanol 5 min 
70 % ethanol 5 min 
Distilled water 5 min 
Hematoxilin (Mayer) 4 min 
Distilled water 4 sec 
Tap water (flow-through) 20 min 
Eosin (5 g/L) 5 min 
70 % ethanol 10 sec 
80 % ethanol 5 min 
90 % ethanol 5 min 
96 % ethanol 5 min 
100 % ethanol 5 min 
Roti®-Histol 5 min 
Roti®-Histol 5 min 
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Staining Alcian blue – PAS (for paraffin-embedded samples) 
 Alcian blue solution: 10 g/L in 3 % acetic acid 
 Schiff reagent: ready-to-use solution by Sigma-Aldrich 
 Sulfite water: 22.5 mL HCl (1 M) + 11.25 g sodium disulfite + 2227.5 mL distilled water 
Medium Duration 
Roti®-Histol 3 min 
96 % ethanol 2 min 
80 % ethanol 2 min 
70 % ethanol 2 min 
Distilled water 5 min 
3 % acetic acid 3 min 
Alcian blue  30 min 
3 % acetic acid 3 min 
Distilled water 5 min 
1 % periodic acid 10 min 
Distilled water 5 sec 
Distilled water 5 sec 
Distilled water 5 sec 
Schiff reagent 5 min 
Sulfite water 2 min 
Sulfite water 2 min 
Tap water (flow-through) 15 min 
Distilled water 5 sec 
70 % ethanol 5 min 
80 % ethanol 5 min 
90 % ethanol 5 min 
100 % ethanol 5 min 
Roti®-Histol 5 min 
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